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Abstract 
While the fundamental role of tropomyosins (Tms) in the maintenance of the actin cytoskeleton 
in yeast is established, details of their exact regulatory functions in lower eukaryotes remains to 
be deciphered.  
Here, two novel Tms have been identified from the filamentous yeast Neurospora crassa: a 161 
residue protein spanning 4 actin monomers (crTm161p), and a 123 residue protein which spans 
3 actin monomers (crTm123p). The latter isoform is the shortest naturally occurring Tm known. 
The isoforms are produced as a result of alternative splicing from a single gene- a phenomenon 
that has not previously been observed in yeast Tms. Both Tms were cloned, purified and 
crystallised. They were also characterised biochemically and biophysically, giving some insight 
into their role in fungal cytoskeleton regulation. The crystals produced provide the potential for 
future structural studies, as a high resolution structure of a complete Tm is still not available.  
The N-terminal acetylation of Tms is essential for their function, and is catalysed in 
Saccaromyces cerevisiae by the N-terminal N-acetyltransferase (NAT) Nat3p. Nat3p was 
expressed and purified. Its functionality was investigated via acetyl coenzyme A binding assays. 
The molecular structure of Nat3p was modelled using existing data from structural homologues. 
The closely related N-terminal NAT, Nat5p, was also expressed, purified and its structure 
modelled. Nat3p was largely insoluble while Nat5p was soluble and was successfully 
crystallised. Structural insights from molecular modelling were able to provide some justification 
for these differences.  
Finally the in vivo effects of genetic knockouts of the TPM1 and NAT3 genes in yeast were 
analysed quantitatively. Complementation of the defective knockout phenotypes by over-
expression of various Tm and Nat3p constructs was also investigated. Quantifying the 
overlapping phenotypes of the NAT3Δ and TPM1Δ mutaunts has clarified their distinct impacts 
upon the cytoskeleton. The ability of the crTms to rescue TPM1Δ phenotypes implies they have 
roles similar to those of Tpm1p. 
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1 Introduction 
This thesis contains an in depth investigation of three fungal proteins: two novel tropomyosins 
(Tms) from the filamentous fungus N. crassa; and Nat3p, the catalytic core of a Saccharomyces 
cerevisiae N-terminal N-acetyl transferases (NAT) complex. Tmss and Nat3p are distinct both 
functionally and structurally; however, they are known to be intimately connected in the 
context of their functions in vivo: In yeast, Tm is known to stabilise actin filaments and Tm-
stabilised filaments are used by molecular motors to transport cargoes or to generate motile 
forces by altering the dynamics of filament growth and shrinkage. Genetic and in vitro studies 
have shown that Nat3p acetylates Tms at their N-termins: a modification essential for Tm 
function. Yet, information about the precise roles and mechanism of function of Tm and Nat3p 
in yeast remains limited, it is known that in their absence the cell is rendered unviable or 
severely defective, respectively (Polevoda et al., 1999, Drees et al., 1995).  The lack of existing 
knowledge about obviously essential processes was the primary motivation behind this 
particular study. This thesis is split into three distinct sections: 1) The isolation, purification and 
biochemical and biophysical characterisation of N. crassa Tms; 2) The purification and 
characterisation of Nat3p and 3) Cell biology studies in S. cerevisiae to investigate the roles of 
both, the novel Tms and Nat3p, in vivo.  The findings of these studies are preceded here by a 
detailed introduction to what is currently known about these proteins. 
1.1 Tropomyosin 
Tropomyosin was first isolated from rabbit cardiac and skeletal muscle by Bailey in 1948 
(Bailey, 1948).  It was named tropomyosin because its solubility and structural properties 
showed a similarity to those of myosin, and it was originally predicted to be a pre-cursor of 
myosin although this was later found to not be the case. Since then tropomyosins have 
appeared to be ubiquitous in organisms from yeast to man (Balasubramanian et al., 1992, 
Lees-Miller and Helfman, 1991, Liu and Bretscher, 1989a), and are known to be integral 
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components of the actin-based contractile apparatus and actin-based cytoskeleton of muscle 
and non-muscle cells.  
Structurally, Tm exists as a rod-shaped, α-helical coiled-coil dimer forming a head-to-tail 
polymer which wraps around the length of an actin filament (Phillips et al., 1986, Phillips et al., 
1979), as illustrated below (See Figure 1.1). Whitby and Phillips resolved the structure of 
skeletal Tm to 7 Å (Whitby and Phillips, 2000). Their results indicate approximately three full 
turns of the α-helix per molecule.  
 
 
Figure 1.1: Tropomyosin dimers polymerise head-to tail.  Above: Tropomyosin polymer wrapping around an actin 
filament. Below: two tropomyosin monomers joined together (Bárány, 1996) 
 
There have also, more recently, been some high resolution structural data obtained through 
crystallography of certain sections of the Tm molecule, including residues 1–80 at the N-
terminus (Brown et al., 2001), 254–284 at the C-terminus (Greenfield et al., 2003, Li et al., 
2002) and residues 176 – 273 at the C-terminus (Minakata et al., 2008). There is, however, no 
high resolution structural data of any complete Tm molecule available at present. 
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1.1.1 Role of Tropomyosins in Regulation of the Thin Filament 
 
Figure 1.2: The muscle sarcomere. Top: A simplified model of the muscle sarcomere in parallel. The sarcomere 
comprises thin filaments (actin, tropomyosin and troponin) and  thick filaments (mostly myosin). The thin filaments 
are anchored in the Z-line, where they are cross-linked by α-actinin. The thick filament is centrally located in the 
sarcomere and constitutes the sarcomeric A-band. Tropomyosin was initially found to be localized in the I band of 
striated muscle. Bottom: Electron microscope photograph of the structural organization of sarcomeres in parallel 
(Ottenheijm et al. 2008 (Ottenheijm et al., 2008)). 
 
Tropomyosin was initially found to be localized, along with actin, in the ‘I’  band of the striated 
muscle sarcomere (Bailey, 1948),  implicating the presence of some interaction between the 
two proteins and a role in muscle regulation (Corsi and Perry, 1958). Using X-ray fibre 
diffraction, Moore et al subsequently confirmed that the regulatory proteins Tm and troponin 
lay in the long pitch grooves of actin filaments (Moore et al., 1970). Because Tm NH2 and COOH 
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termini overlap, Tm forms a continuous polymer along each of the two major grooves in the 
actin thin filament (Figure 1.1). Further investigations into the structure of the myofibril by X-
ray fibre diffraction revealed that tropomyosin moves within the actin groove during muscle 
contraction (Parry and Squire, 1973, Spudich et al., 1972, Vibert et al., 1972). These 
observations led to suggestions that tropomyosin was involved in muscle regulation, and led to 
the development of the so-called ‘steric blocking model’ (Spudich et al., 1972, Parry and 
Squire, 1973, Vibert et al., 1972). 
The ‘thin filament’ comprises actin, Tm and troponin (Tn), and regulation of muscle contraction 
is known to involve interactions between these components, to regulate the binding of myosin 
heads to the actin filament. Because of the head-to-tail interaction of Tm molecules (Phillips et 
al., 1986), Tm takes the appearance of a continuous strand along the actin filament. One Tn 
subunit (comprising TnC-TnI-TnT) is bound to each Tm, making the structural repeat Tm-TnICT. 
The steric blocking model suggests that Tm, along with the Tn complex, forms a calcium-
sensitive switch, which regulates the cooperative binding of actin to myosin. In the relaxed 
state actin binding to myosin is inhibited as the Tm-Tn complex obscures the myosin-binding 
site on actin. Muscle stimulation causes an influx of calcium, which binds Tn, causing a 
conformational change. This leads to lateral movement of Tm, and the uncovering of the 
myosin-binding site on the actin filament. One molecule of skeletal Tm spans 7 actins.  A 
simplified illustration is presented in Figure 1.3: The thin filament and steric blocking. 
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Figure 1.3: The thin filament and steric blocking. (a)The myosin binding sites on the actin filament are blocked (b) 
an increase in the concentration of Ca2+ ions causes a conformational change, moving Tm azimuthally across the 
surface of actin and exposing the myosin-binding site (Whitmore et al., 2003). 
 
Many aspects of the detailed mechanisms of thin filament regulation of muscle contraction, 
however, remain to be fully explained. The cooperativity of the calcium regulatory process is 
still controversial, and several different models have been proposed:  
The first was a two-state model of the thin filament provided by Hill et al. in 1980 (Hill et al., 
1980). This model was based on the observation that in solution, the binding of S1 to the thin 
filament is cooperative both in the presence and absence of calcium (Hill et al., 1980).  The key 
data from this investigation are presented in Figure 1.4. 
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Figure 1.4: S1 binding to the thin filament. The upper solid curve through experimental points ο, is the theoretical 
curve at high Ca2+. The lower solid curve with experimental points •, is the corresponding curve without Ca2+ 
(Adapted from Hill, Eisenberg  and Greene  1980 (Hill et al., 1980)) 
 
The model proposes that each tropomyosin unit, including seven actin sites for S1 binding, can 
be in one of two states: ”closed”, where S1 binds weakly to actin (constant K1), or “open” , 
where S1 binds tightly to actin (with binding constant K2). These states are illustrated in a 
simple diagram in Figure 1.5. The “closed” state is favoured at low S1 concentrations in both 
the presence and absence of Ca2+. But the ”open” state dominates at high S1 concentrations 
because K2 >> K1.  Thus calcium binding alone is not sufficient to activate the thin filament. S1 
binding is required in order to switch the thin filament completely into the activated state. The 
transition from closed to open states is cooperative for two reasons: because seven actin sites 
in a unit change state as a group (i.e. when one S1 head binds to an actin site, the chances of 
S1 heads binding at adjacent actin sites within the tropomyosin unit is increased); and  
because of the interactions between adjacent Tm units. 
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Figure 1.5: The two-state model of the thin filament. The A7-Tm-Tn structural unit is shown as seven open circles 
connected by a linear tropomyosin. In the presence of Ca2+, this unit exists in a dynamic equilibrium between the 
open and closed states shown as two positions of the line representing Tm. Calcium binding alone is insufficient to 
activate the thin filament. S1 binding is required to switch the thin filament completely into the activated state. 
 
Further investigations brought to light an additional step of complexity, showing that S1 
binding to actin occurred in a 2-step process (Coates et al., 1985).  This was shown using 
pressure relaxation (Geeves and Gutfreund, 1982) to measure S1 binding to actin. This 
technique is based on the observation that increased pressure causes a small fraction of the 
bound S1 to dissociate from the actin-S1 complex, and the rapid release of pressure allows the 
reassociation reaction to be monitored. Pyrene-labelled actin was used to monitor this 
reassociation reaction, as S1 binding quenches pyrene fluorescence by 70 % (Kouyama and 
Mihashi, 1981).  
The results of this study showed that S1 binds actin in at least two steps: 
 
Where step 1 results in formation of relatively weakly bound actin. This complex isomerizes in 
step 2 to give strongly bound actin and weakly bound nucleotide (Coates et al., 1985). 
A steric blocking model of thin filament regulation with three biochemically distinct states was 
later proposed by McKillop and Geeves (McKillop and Geeves, 1993).  This model took into 
account the two steps of actin binding as shown by pressure relaxation studies, and also 
additional kinetic data for a third state. The three states are the “blocked” state in which S1 
does not bind actin (except for weak electrostatic interactions), and therefore the acto-myosin 
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ATPase is off;  Ca++ binding to Tn shifts equilibrium towards the “closed” state which allows 
weak binding and low ATPase activity; and the “open” state (or myosin-induced M-state) by 
myosin heads strongly binding to actin, which allows isomerisation of the S1 to the rigor-like 
state (McKillop and Geeves, 1993). 
 
Figure 1.6: McKillop and Geeves’ three-state steric blocking model. The A7·TmTn structural unit is shown as seven 
open circles representing the actins connected via a line representing the tropomyosin. In the blocked state, Tm 
prevents all binding of S1 to actin. In the closed state, Tn moves to uncover a binding site which allows S1 to form 
the relatively weakly bound A state. In the open state the full interaction of S1 with actin is possible and R state 
binding (McKillop and Geeves, 1993). 
 
In both these models the size of the apparent cooperative unit was assumed to be equivalent 
to the structural unit, which is defined as the average number of actin subunits trapped in the 
open state by one myosin head bound. However, this was found not to be compatible with 
experimental data. The work of Lehrer et al. (Lehrer et al., 1997) with pyrene-labelled Tms 
showed that the apparent cooperativity was not dependent upon the length of Tm but upon 
Tm-Tm interactions. The authors compared the cooperativities of the closed-to-open transition 
of actin complexed with three different Tm isoforms of the same length: gizzard Tm and 5aTm 
from fibroblasts, which differ at the N-terminus but share the same sequence of the 27 amino-
acid C-terminal segment; and striated Tm with a unique C-terminal sequence. The cooperative 
unit size, calculated from fluorescence changes of pyrene-labelled Tm on binding of S1 to actin, 
was similar for gizzard Tm and 5aTM. In the presence of striated muscle Tm the size of the 
cooperative unit was about 50 % smaller. This implied that the sequence of the C-terminus 
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influences the strength of Tm–Tm interactions, which in turn influences cooperativity: the 
stronger the Tm end-to-end interaction, the larger is the actin segment remaining under 
control of one tropomyosin molecule. This led to the proposal of Tm existing as a flexible 
filament which has an apparent cooperative unit size based upon the filament properties and 
not the size of the structural unit. Maytum et.  al showed that, in striated muscle filaments, the 
apparent cooperative unit size is dependent upon both the presence of TnC and of Ca2+ 
(Maytum et al., 1999). A later study studying the regulatory properties of naturally occurring 
tropomyosins (Tms) of differing lengths found that, apart from  skeletal Tm (skTm), where the 
apparent cooperative unit size (n) is the same as the structural size (n = 7 actin sites), the other 
vertebrate muscle and non-muscle Tms that were studied exhibited large n values (n = 12−14). 
The yeast Tms also exhibited large values of n (6−9) in comparison to their structural sizes (4−5 
actin sites) (Maytum et al., 2001). It was suggested the difference in cooperative unit size 
between yeast and vertebrate Tms was an indication of differences in  flexibility  caused by 
variationsbetween their sequences; or that alternatively, there may be some relationship with 
the length of the Tms as the Tm-Tm junctions could provide a point of greater flexibility and 
hence greatly influence the apparent cooperativity (Maytum et al., 2001).  
Additionally, although the yeast Tms were shown to have regulatory parameters similar to 
those of skTm, the effect of S1 upon their actin affinity differed significantly (Maytum et al., 
2001). Whereas the affinity of yeast Tms for actin remained largely unchanged in the presence 
of an excess of S1, the affinity of skTm under these conditions was greatly increased. It was 
suggested that an actin state with a high affinity for S1 and Tm is thus not necessary for 
regulation, and the higher affinity of S1 for actin in the presence of vertebrate Tms is probably 
the result of a direct interaction of S1 with Tm (Maytum et al., 2001). 
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1.1.2 Role of Tms in Non-Muscle Context 
There are over 40 known isoforms of mammalian and avian Tm, generated by the use of four 
genes (α,β,γ,δ) and alternative splicing within at least three genes (Pittenger et al., 1994) 
(Figure 1.7). Of these, only 5 Tms are involved in the well characterized contractile system 
described previously (Pittenger et al., 1994).  
 
Figure 1.7: Intron-exon organization of mammalian Tm genes. Horizontal lines represent introns; coding regions 
are represented by boxes. The empty boxes depict exons common to all Tm genes (Perry, 2001). 
 
 The role of the muscle isoforms has been discussed in detail in the sections above. The non-
muscle isoforms have recently been shown to play roles in the regulation of most actin-
cytoskeletal function (Gunning et al., 2005), although the details are currently only poorly 
understood.   
The Actin Cytoskeleton 
The actin cytoskeleton is responsible for a vast number of functions in eukaryotic cells. These 
include cytokinesis, cell motility, contractile force, intracellular transport, cell morphology and 
cell size . Important prerequisites for actin's functional diversity are its intrinsic ability to 
rapidly assemble and disassemble filaments and its spatially and temporally well-controlled 
supramolecular organization. A large number of proteins that interact with actin, collectively 
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referred to as actin-binding proteins (ABPs), influence the structure and organization of the 
actin cytoskeleton. 
Some examples of ABPs and their functions are illustrated in Figure 1.8 below. Capping 
proteins (for example, tropomodulin) bind to filament ends and can modify filament turnover 
to affect their length. Cross-linking proteins like α-actinin (Figure 1.8, B) and filamin (Figure 1.8, 
C) can arrange F-actin into distinct networks, such as actin bundles and gels respectively. The 
ABP known as ADF (Actin De-polymerizing Factor), affects actin filaments by promoting their 
de-polymerization or severing, whereas profilin promotes actin filament polymerisation (Figure 
1.8, A) (Cingolani and Goda, 2008).   
 
Figure 1.8: Action of various ABPs on actin filaments. (From Cingolani and Goda, 2008). 
 
The ABPs are targeted by a wide range of signal transduction cascades that regulate actin 
remodelling to meet the changing demands of cellular functions (Cingolani and Goda, 2008). It 
has become increasingly evident that different tropomyosin isoforms have a significant role to 
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play in the regulation of such actin remodelling and, hence, actin filament functions. Figure 1.9 
shows an example of this. 
 
Figure 1.9: Tropomyosin-directed regulation of actin filament function. Left- The binding of one isoform of Tm to 
actin filaments enhances its affinity for myosin II, and leads to myosin II recruitment to these filaments. 
Simultaneously, this isoform also eliminates ADF binding to the filaments, which results in more-stable filaments 
engaged in contractile activity. Right- By contrast, binding of a second isoform, increases the affinity of the filament 
to ADF. ADF binding promotes severing of the filaments and greater turnover. In parallel, myosin II interacts poorly, 
if at all, and the result is non-contractile, rapidly re-modelling filaments. In both cases, the different Tm isoforms 
influence the role of the actin filament (Gunning et al., 2005). 
 
However, although non-muscle tropomyosins have such putative roles in regulating a large 
array of very important processes with all eukaryotic cells, the exact mechanisms by which 
tropomyosins regulate these interactions is not well understood. This makes these non-muscle 
tropomyosin isoforms vital candidates for continued research. 
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Thus far, it is research in budding yeast that has contributed substantially to defining the 
universal mechanisms regulating actin dynamics in eukaryotes. 
The budding yeast actin cytoskeleton exists in two distinct types of structures: F-actin cables 
and cortical patches. The cortical patches are dense, membrane-associated structures that 
form a ring around the site of polarisation (Adams and Pringle, 1984), (Kilmartin and Adams, 
1984, Pruyne and Bretscher, 2000). Actin cables extend through the cell to sites of polarized 
growth. 
Yeast cells use actin-based transport along these cables to direct polarized cell growth and to 
segregate organelles prior to cell division (Bretscher, 2003). Early in the cycle, actin patches are 
localised at one cell tip; from this site, actin cable assembly is initiated, which leads to 
reorientation of actin cables and targeting of growth and secretion to the future bud tip. 
Polarized growth towards the bud isdependent on actin cables emanating from the bud tip and 
neck. These cables serve as polarized tracks for the delivery of constituents needed to build 
the daughter cell. Figure 1.10 shows the organisation of the actin cytoskeleton during the 
yeast cell cycle. 
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Figure 1.10: Cell cycle-regulated organization of the S. cerevisiae actin cytoskeleton. Yeast cells at different stages 
in the cell cycle contain. F-actin cortical patches, polarized actin cables, and a cytokinetic actin ring can be clearly 
seen. While patches and cables are visible throughout the cell cycle, the ring is visible shortly before and during 
cytokinesis. Shown here are actively growing cells from an asynchronous culture that were chemically fixed and 
stained with rhodamine phalloidin to visualize filamentous actin structures (Moseley and Goode, 2006) 
 
Virtually all animals and fungi utilize an actin-based contractile ring to physically separate the 
two daughter cells during cytokinesis. Although a cytokinetic actin ring had been observed in 
fission yeast as early as 1986 (Marks et al., 1986), the existence of such a division mechanism 
in budding yeast was realized only in recent years (Lippincott and Li, 1998). 
Yeast Tms 
Because Tms were first discovered as regulators of acto-myosin contractility in muscle cells 
(Bailey, 1948, Perry and Corsi, 1958), it was not expected that lower eukaryotes such as yeast 
would harbour these proteins. However, the discovery of myosin and actin in yeast (Pollard 
and Korn, 1973, Water et al., 1980) raised the possibility for a role for tropomyosin in 
regulating their interaction and stability. In spite of the small size of the yeast genome, and 
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great evolutionary distance when compared to multicellular eukaryotic organisms there are 
striking similarities in the organisation and function of the actin cytoskeleton in yeast and man. 
Yeast is thus an attractive system in which to undertake a molecular genetic approach to 
investigate the mechanism and regulation of contraction of the actin cytoskeleton. 
In 1989, Liu and Bretscher indentified and purified the first fungal tropomyosin (Liu and 
Bretscher, 1989b), which was later shown to be a 199 residue, 5 actin monomer-spanning 
product of the TPM1 gene and the major form of Tm in budding yeast S. cerevisiae (Liu and 
Bretscher, 1989a). A second S. cerevisiae Tm of 161 residues (large enough to span just 4 actin 
monomers), coded by the gene designated TPM2 was discovered in 1995 (Drees et al., 1995). 
This gene was found to share 64.5 % sequence identity with TPM1 and was expressed at 
approximately 20 % the level of TPM1. 
Both Tms displayed strong similarities to their animal counterparts in terms of α-helical coiled-
coil protein structure and physical properties, including heat stability, iso-electric point and 
cooperative, saturable cation-dependent binding to F-actin (Liu and Bretscher, 1989a). Tpm1p 
was shown by immunolocalization to selectively associate with actin cables in yeast cells using 
(Liu and Bretscher, 1989a).  Deletion of both genes was shown to be lethal (Drees et al., 1995), 
showing that Tms perform essential functions. Elimination of TPM1 alone resulted in reduced 
growth, disappearance of actin cables, heterogeneity of cell size, poor mating and defective 
vesicular transport (Liu and Bretscher, 1992). These results suggested that Tpm1p is important 
for the stability of actin cables. No detectable phenotype was observed on deletion of just 
TPM2 and over-expression of Tpm2p could not restore function to TPM1Δ deletion strains 
(Drees et al., 1995).  This suggests that the two isoforms are functionally distinct. The ratio of 
their levels is also an important factor for correct morphogenesis since over-expression of 
Tpm2p had no obvious effects on the actin cytoskeleton, but did affect cell polarity (Drees et 
al., 1995). 
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In 1992, Balasubramanian et al. discovered a 161-residue Tm coded by the CDC8 gene in the 
fission yeast Scizosaccharomyces pombe (Balasubramanian et al., 1992). This Tm was shown to 
be absolutely required for cytokinesis, and its deletion resulted in lethal arrest of the cells, 
suggesting an essential role for CDC8 Tm is to form part of the F-actin contractile ring during 
cytokinesis (Balasubramanian et al., 1992). Interestingly, the lethality of the cdc8 disruptant 
can be rescued by expression of a fibroblast tropomyosin cDNA, suggesting that S. pombe 
tropomyosin and vertebrate tropomyosin share at least some function (Balasubramanian et 
al., 1992). Cdc8p was later found to be essential for cell fusion during conjugation in S.pombe 
leading to the hypothesis that it may organize a small F-actin-containing organelle at the cell-
to-cell contact site in each mating cell, which plays a key role in cell fusion (Kurahashi et al., 
2002).  Figure 1.11 shows the size and sequence relationships between vertebrate and yeast 
tropomyosins. 
 
Figure 1.11 Size and amino acid sequence relationships between vertebrate and yeast Tms. There is 20 % 
sequence identity between muscle and platelet Tms amino acid sequence. S. cerevisiaeTpm1p contains an internal 
repeat (B and B’, which share 80 % sequence identity). In Tpm2p and cdc8p, one of these repeats is deleted 
resulting in Tms that span only 4 actins. 
 
As can be seen from Figure 1.11, larger multi-cellular organisms have a larger number of more 
complex Tm isoforms when compared with simpler organisms. The key questions that then 
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arise are:  why have Tms evolved to be larger and more complex in multi-cellular organisms? 
Do the sizes of different Tm isoforms ultimately influence their function? 
Why study Tms from N. crassa? 
Fungal Tms are the smallest known Tms, and on the basis of smallest is simplest they provide 
an attractive model for studying Tm function. The smallest Tm characterized to date was a 3-
actin-spanning Tm of 123 residues. This Tm, called Tm1d23p, was produced by the deletion of 
both of the internal repeats within S. cerevisiae Tpm1p (see Figure 1.11). It was found to bind 
to actin with very similar affinities as other Tms (Maytum et al., 2008a). However, while 
previously characterized yeast Tms have been shown to regulate S1 myosin and actin binding 
in a cooperative fashion (similar to skeletal Tms), Tm1d23p induced only a very significant 
inhibition of myosin-S1 binding to actin. In addition, the presence of S1 greatly reduced the 
affinity of Tm1d23 for actin. Tm1d23 and S1 appeared to be binding competitively to the same 
sites upon actin (Maytum et al., 2008a). This unusual behaviour was explained by considering 
the Tm molecules as interacting end to end to form a semi-flexible strand around the actin 
filament (as proposed by Lehrer et al (Lehrer et al., 1997). This Tm strand is usually constrained 
to one side on binding of either S1 or Tn to actin. However, it was suggested that because 
Tm1d23 is such a short molecule, it is in effect stretched more tightly along the actin filament 
than larger Tms (Maytum et al., 2008b). As a result, it cannot accommodate the binding of S1 
to actin and instead is forced to stretch, creating a strain and causing it to break at its weakest 
points: Tm-Tm interactions. Reduced Tm-Tm interactions greatly reduce the affinity of Tm for 
actin as discussed earlier, causing it to dissociate from the filament. The binding of S1 and 
Tm1d23 therefore becomes competitive.  This is illustrated in a simple schematic in Figure 
1.12. 
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Figure 1.12: Why S1 and Tm1d23 compete to bind to F-actin. (A) Flexible Tm strand moves azimuthally across the 
actin filament to allow S1 heads to bind to actin. (B) The ultra short Tm is stretched tightly across the actin filament, 
blocking the S1 binding sites. (C) At high S1 concentration, the Tm is pushed aside by S1, and the additional strain 
causes the Tm filament to break at its weakest point: Tm-Tm interaction. 
 
1.1.3 N-terminal Acetylation of Tropomyosins 
Both yeast and vertebrate Tms are subject to N-terminal acetylation co-translationally. This 
acetylation is essential for the function of α-Tm (Urbancikova and Hitchcock-DeGregori, 1994). 
Striated α-Tm expressed recombinantly in E. coli (where it is not acetylated) polymerises 
poorly and binds weakly to F-actin compared with Tm isolated from muscle (Cho et al., 1990, 
Heald and Hitchcock-DeGregori, 1988, Hitchcock-DeGregori and Heald, 1987, Willadsen et al., 
1992). This can be explained by understanding the sequence-structure relationships in Tm. 
Primary structure analysis reveals a heptad repeat, typical of α-helical coiled-coil proteins, that 
extends throughout protein sequence. In each successive group of seven residues, a -g, 
residues a and d (‘‘core’’ residues) are hydrophobic. This is illustrated in Figure 1.13.  
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Figure 1.13: The amino acids in a coiled-coil structure forming a heptad repeat a-g.  The first and fourth position (a 
and d) are generally apolar or hydrophobic amino acids. When the two strands coil around each other positions a 
and d are internalized, stabilizing the structure, while positions b, c, e, f, g are exposed on the surface of the protein 
(Lee et al., 2008). 
 
The coiled-coil structure of Tm is stabilized by hydrophobic interactions between parallel 
strands. The N-terminus of Tm lies in an a position, and N-terminal acetylation neutralizes the 
charge on the amino acid residue in this position. If the N-terminus remained unacetylated, 
the amino acids in position a would carry a +ve charge and repel each other, causing splaying 
at the N-terminus and preventing end-to-end interactions of Tm molecules. As they are unable 
to polymerise, the functionality of unacetylated Tms is greatly reduced. Acetylation, and the 
resultant removal of the charge, allows a folded N-terminus to “slot” inside the C-terminus, 
thus enabling the polymerisation of Tm into filaments (Greenfield et al., 2006).  
The use of an N-terminal peptide extension on unacetylated skeletal Tm was shown to restore 
actin binding. A variety of extensions ranging from 2 to 69 amino acids were shown to result in 
α-Tm that bound to F-actin (Heald and Hitchcock-DeGregori, 1988, Hitchcock-DeGregori and 
Heald, 1987, Monteiro et al., 1994, Urbancikova and Hitchcock-DeGregori, 1994). These 
additional N-terminal residues cause the shifting of the charged N-terminus from position a so 
they are no longer in close enough proximity to each other to repel and destabilize the Tm 
core. However, the differing lengths of the N-terminal extensions were seen to vary in their 
effects on actin-S1 binding. The addition of an Ala-Ser dipeptide was seen to restore the most 
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native-like functionality to unacetylated Tm (Monteiro et al., 1994). The dipeptide extension 
would cause the charged residue at position a in the core of the Tm molecule, to be shifted to 
position f on the outside of the molecule (Figure 1.13). 
The functioning of yeast Tpm1p was also found to be dependent upon N-terminal modification 
(Maytum et al., 2000). Tpm1p was produced in E. coli with an N-terminal Ala-Ser extension, or 
the natural extension found in fibroblast Tm 5a/b. In each case the Tms bound tightly to actin, 
and showed secondary structure and thermostability similar to native Tpm1p. However, this 
study also highlighted the importance of such N-terminal extensions as each different N-
terminal extension significantly altered the regulatory properties of the resultant Tm on S1 
binding to actin. 
The following section introduces in detail N-terminal N-acetyltranferases (NATs), and focuses 
on what is currently know about Nat3p, the NAT responsible for acetylatying Tms. 
 
1.2 N-terminal acetylation of proteins 
N-terminal acetylation is by far the most common covalent modification that occurs on 
eukaryotic proteins. It occurs on approximately 80 – 90 % of mammalian proteins (Persson et 
al., 1985) and on 50 % of yeast proteins (Lee et al., 1989). In contrast, it is very rare in 
prokaryotes, where 807 of 810 E. coli proteins examined were not acetylated at the N-
terminus (Polevoda and Sherman, 2003).  
N-terminal acetylation is a reaction in which the protein α-amino group is acetylated, with 
acetyl coenzyme A (ACoA) acting as the activated carrier of the acetyl group (See Figure 1.14). 
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Figure 1.14: Acetylation of the N-terminal amino groups of proteins. ACoA acts as the activated acetyl donor for 
protein N-acetylation. Transfer of the acetyl group to the N-terminus of the peptide results in neutralisation of its 
positive charge. 
 
The direct effect of N-terminal acetylation is the neutralization of the positive charge on the N-
terminus of the peptide chain.  This neutralization alters the electronic environment within the 
molecule and may as a result influence its stability, interactions with other molecules and 
subsequent modifications, thus having potential implications for its functionality.  
The process of N-acetylation of protein N-termini is catalyzed by a sub-group of the enzymes 
known as N-acetyl transferases (NATS). N-terminal NATs catalyse the addition of the acetyl 
group  either directly to  intact N-terminal methionine amino groups or, most often, after the 
hydrolytic clipping of the N-terminal methionine by one of two methionine aminopeptidases 
(MAPs), as seen in Figure 1.15, (Polevoda and Sherman, 2000, Polevoda and Sherman, 2003). 
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Figure 1.15: Action of MAP and  NAT at the amino termini of eukaryotic proteins.  The N-terminal methionine is 
cleaved off and the N-terminus of the subsequent amino acid in the peptide chain is acetylated (Adapted from 
Walsh C 2006). 
 
MAP catalyses the cleavage of the N-terminal methionine when the second amino acid residue 
on the growing peptide chain is small, for example Gly, Ala, Ser, Cys, Thr, Pro, and Val.  In turn, 
Ser, Ala, Gly and Thr are the major residues that get N-acetylated when they become the N-
terminus. In vitro studies indicate that N-terminal acetylation occurs when the emerging 
protein chain has grown to 20–50 residues and is still elongating on the ribosome (Driessen et 
al., 1985, Kendall et al., 1990). It is, strictly speaking, thus a co-translational rather than a post-
translational process. 
1.2.1 S. cerevisiae N-acetyl transferases 
NATs have been most widely studied in yeast where genetic investigations have provided 
evidence for the existence of three major NAT complexes: NatA, NatB and NatC. Each of these 
NATs is a complex comprising a catalytic core as well as auxiliary subunits as detailed in Table 
1.1 (Polevoda and Sherman, 2000).  Each NAT was found to act on different sets of proteins, 
each having different N-terminal regions (as listed in Table 1.1). Polevoda et al. (Polevoda et 
al., 1999) deduced the substrate specificity of the S. cerevisiae N-terminal NATs in vivo by 
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investigating the lack of acetylation of several subsets of yeast proteins from various NAT 
deletion mutants. NatB and NatC act as acetyltransferases for yeast proteins with the original 
N-terminal Met still in place: NatB recognizes Met-Glu, Met-Asp, Met-Gln, and Met-Met 
sequences, whereas NatC N-acetylates at Met-Ile, Met-Leu, Met-Trp, and Met-Phe, reflecting 
preferences for acidic or hydrophobic side chains at residue 2. NatA catalyzes acetyl transfer to 
the NH2 group of Ser, Ala, Gly, and Thr termini, the predominant side chains liberated from 
MAP action described above. 
Table 1.1: Details of the three major NATs in S. cerevisiae (Polevoda et al., 1999). 
N-terminal 
acetyltransferase 
 
Catalytic subunit Auxiliary subunit Substrate 
NatA Ard1p Nat5p, Nat1p Ser- 
Ala- 
Gly- 
Thr- 
 
NatB Nat3p Mdm20p Met-Glu- 
Met-Asp- 
Met-Asn- 
Met-Met- 
 
NatC Mak3p Mak10p, Mak31p Met-Ile- 
Met-Leu- 
Met-Trp- 
Met-Phe- 
 
1.2.2 Structure of the Yeast N-Terminal NATs 
Before protein structural data were available Mak3p was seen to share conserved sequence 
motifs with several N-acetyltransferases (Tercero and Wickner, 1992). The same motifs were 
later seen to be conserved in other N-acetyltransferases, and in 1997 Neuwald and Landsman 
(Neuwald and Landsman, 1997) designated these and over 140 other proteins with the same 
conserved motifs, the GCN5-related N-acetyltransferase (GNAT) superfamily based on the 
histone acetyltransferase GCN5 as the archetype of the group. At this time Ard1p was also 
included in this class of related proteins.  In 2000 Polevoda and Sherman (Polevoda and 
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Sherman, 2000) found the Nat3p sequence to be significantly similar to both Ard1p and 
Mak3p; making the catalytic subunits of all three major yeast NATs members of the GNAT 
family.  
NatA was shown to contain a previously unrecognized third subunit, the GNAT called Nat5p. 
However, while NAT1Δ or ARD1Δ deletion strains were temperature sensitive and showed 
derepression of silent mating type loci ΔNAT5 did not display any obvious phenotype, calling 
into question its actual role in the acetylation process (Gautschi et al., 2003). 
1.2.3 What are the GCN5-related N-acetyltransferases (GNATs)? 
The GNATs are now identified as an enormous superfamily of enzymes that are universally 
distributed in nature and that use acyl-CoAs to acylate their substrates. Some members of this 
family that have been structurally and mechanistically characterised include aminoglycoside N-
acetyltransferases, serotonin N-acetyltransferase, glucosamine-6-phosphate N-
acetyltransferase and the histone acetyltransferases (Vetting et al., 2005).  These enzymes 
cover a range of substrate specificities, but catalyse the same basic reaction. The members of 
the GNAT family share strikingly modest primary sequence identity (3 – 23 %). Despite this, all 
the GNATs whose structures have been successfully solved have been shown to possess a 
structurally conserved fold spanning over 100 residues and comprising four motifs (Dyda et al., 
2000). The topology and 3-D fold of the GNAT core structure is shown in Figure 1.16. The order 
in which the conserved motifs follow each other in the primary sequences is C, D, A, and B: (C) 
an N-terminal strand followed by two helices; (D) three antiparallel β strands; (A)  a 
‘‘signature’’ central helix followed by a fifth β  strand; (B) a fourth α helix and a final β strand 
(Neuwald and Landsman, 1997).  
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Figure 1.16 The (A) Topology of the core GNAT fold. From the N-terminus, secondary structural elements are 
coloured green (Motif C: β1,α1, α2), yellow (Motif D: β2–4), red Motif A:( α3, β5) and blue (Motif B: α4, β6). The 
dark green (b0) N-terminal strand is not completely conserved and the deep blue C-terminal strand maybe from the 
same monomer, or contributed by another. (B) Superposition of 15 GNAT structures. Residues aligned at 2.7 Å are 
coloured red (Vetting et al., 2004). 
 
Neuwald and Landsman  (Neuwald and Landsman, 1997) suggested that the conserved motifs 
would be involved in binding ACoA because the ability to bind and transfer the acetyl group is 
the only property that these diverse N-acetyltransferases have in common.  
Motif A is the longest and most conserved region of the GNAT fold. The solving of the 
structures of established N-acetyl transferases such as histone N-acetyltransferase, Hat1p 
(Dutnall et al., 1998a), aminoglycosidase 3-N-acetyltransferase (Wolf et al., 1998) and 
serotonin N-acetyltransferase (Hickman et al., 1999b) confirmed that motif A (the red region in 
Figure 1.16) comprising the central helix, α3, followed by a strand, β5) is indeed involved in 
CoA binding. The loop connecting β4 to α3, the so-called P-loop (Figure 1.16), is one of the 
most highly conserved structural features of the GNAT superfamily. The conformation of the P-
loop provides five amide backbone hydrogen bonds to the pyrophosphate group of bound  
38 
 
CoA, and thus has an important role to play in ACoA binding (Dyda et al., 2000). Shared 
between the P-loop and the α3 helix is a very highly conserved short amino acid sequence, 
Q/RxxGxG/A, which is of particular interest, as it was shown that point mutations in any of 
these residues lead to >90 % reduced activity of a number of GNATs, including Gcn5p, Hat1p, 
Mak3p, Esa1p, MOF and SSAT enzymes (Coleman et al., 1996, Dutnall et al., 1998a, Hilfiker et 
al., 1997, Kuo et al., 1998, Smith et al., 1998, Tercero and Wickner, 1992), as they provide the 
hydrogen bonds to bind to the phosphate in ACoA. 
Figure 1.17 shows the structure of human GCN5, a histone acetyltransferase which is the 
archetype of the GNAT family that illustrates the conserved motifs described above. 
Highlighted in this figure are the ACoA-binding site (with substrate bound), the P-loop and the 
highly conserved amino acid sequence therein. 
 
Figure 1.17: Structure of human GCN5 histone acetyltransferase (PDB: 1Z4R). ACoA is bound between β4 and β5. 
The conformation of P-loop, between β4 and α3, allows direct interaction with the ACoA phosphate. The highly 
conserved Q/R_ _G_G/A is highlighted in green. This model was created using Cn3D (NCBI). 
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More details about the mode of function of GNATs have been derived through a number of 
GNAT structures co-crystallized with ACoA. The mechanism appears to follow so-called 
ordered substrate binding: It has been shown that the donor-substrate, ACoA, first binds in the 
opening formed between the diverging strands β4 and β5, contacting protein atoms mainly 
from β4 and α3, predominantly through main-chain interactions. The binding of ACoA then 
introduces a conformational change which results in the formation of the acceptor-substrate 
binding site (Dyda et al., 2000).  
This mechanism illustrated in Figure 1.18 which shows the structure of the GNAT N-serotonin 
acetyltransferase with (Hickman et al., 1999b) and without (Hickman et al., 1999a) a 
bisubstrate-analog bound. The bisubstrate-analog used is believed to be a very close 
approximation of ACoA during acetyl transfer. 
 
Figure 1.18: (a) The structure of serotonin N-acetyltransferase (b) bound bisubstrate-analog. The region of 
conformational change on binding is highlighted in dark grey. (Adapted from (Dyda et al., 2000). 
 
There are two different ways in which ACoA-dependent acetyltransferases could catalyze the 
transfer of the acetyl group. Both are illustrated in Figure 1.19, along with the structure of 
ACoA. In the first possible mechanism, the acetyl group is transferred directly from ACoA to 
the acceptor via direct nucleophilic attack by the primary amine on the acyl-carbon. This 
40 
 
obviously requires the formation of a ternary complex between the enzyme, ACoA, and the 
acceptor substrate Figure 1.19. 
The second possible mechanism is a ‘ping-pong’ mechanism. In this, the acetyl group is 
transiently transferred to a suitably located Cys residue of the enzyme, forming a covalently 
bound acetylated enzyme intermediate. The enzyme subsequently catalyzes the transfer of the 
acetyl group from the Cys residue to the acceptor substrate. 
 
Figure 1.19 (Top The chemical structure of ACoA; (Bottom)  Acetylation of acceptor substrate: A ternary complex 
is formed between the enzyme (E), the target substrate (S) and a second substrate, the metabolic intermediate 
ACoA. The bound substrate is positioned for nucleophilic attack on ACoA; the acetylated substrate then leaves the 
complex, followed by CoA.; Acetylation by ping-pong mechanism. The enzyme (E) binds to ACoA and attacks via its 
catalytic cysteine, resulting in the formation of a covalent acetyl-enzyme intermediate and release of CoA. The 
substrate (S) binds to and attacks the covalent acetyl-enzyme intermediate, creating an acetylated substrate and 
free enzyme (Mukherjee et al., 2007). 
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The majority of biochemical data acquired indicate that the GNAT superfamily members use 
the direct acetyl transfer mechanism. These include kinetic experiments (De Angelis et al., 
1998, Tanner et al., 1999), the failure to identify covalently bound intermediates (Dutnall et al., 
1998b), and the inability to inactivate yGCN5 using reagents that block thiol groups (Tanner et 
al., 1999). In addition, most of the structural work failed to identify suitably located Cys 
residues near the acetyl group of ACoA, and the case for direct nucleophilic attack was further 
strengthened by the recent direct crystallographic evidence for the existence of ternary 
complexes (Hickman et al., 1999b, Rojas et al., 1999).  
However, studies on the NAT enzyme from Salmonella typhimurium, which was initially 
identified as also carrying out the O-acetylation of hydroxylamines, showed the presence of a 
cysteine reside in the enzyme active site (Watanabe et al., 1992). The active-site cysteine was 
also found to be essential by site-directed mutagenesis of the human NAT2 isoform (Butcher et 
al., 2004, Dupret and Grant, 1992), and by chemical modification of the cysteine residue in 
NATs from S. typhimurium (Sinclair et al., 2000) and hamster (Wang et al., 2004).  
The final step in the catalytic cycle is product release. The environment around the primary 
amine is polar, and upon formation of acetylated substrate, the dramatic increase in 
hydrophobicity may serve to eject the acetylated product from the protein (Dyda et al., 2000). 
However, the accuracy of this hypothesis is yet to be verified.  
1.2.4 Biological Significance of N-terminal N-acetylation 
Orthologues of Ard1p, Nat3p and Mak3p have been identified within the eukaryotic genomes 
of model organisms, including Caenorhabditis elegans, Drosophila melanogaster, Arabidopsis 
thaliana, Mus musculus and Homo sapiens (Polevoda and Sherman, 2003). The overall pattern 
of N-terminally acetylated proteins in both yeast NATs and higher orthologues have been 
found to be very similar. This suggests that the system of N-terminal acetylation is conserved 
from lower to higher eukaryotes. N-terminal acetylation is more frequent in mammals 
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compared to yeast, which may point to some form of selection for this modification during 
evolution. 
Although the majority of eukaryotic proteins are N-acetylated at the N-terminus, the biological 
significance of these N-terminal modifications varies with the particular protein. The 
assessment of the general importance of N-terminal acetylation has thus far come primarily 
from studying phenotypic defects in mutants lacking specific NATs. Some proteins which are 
natively acetylated, such as alcohol dehydrogenase (Hoog et al., 1987) and the chaperonin 
Hsp10 protein (Ryan et al., 1995), appear to be functional without acetylation. In contrast, 
others have been shown to require acetylation to be fully functional. For example, the lack of 
N-terminal acetylation of the viral major coat protein, gag, in MAK3Δ strains was shown to 
prevent assembly or maintenance of the viral particle (Tercero and Wickner, 1992). More 
recently AMAK3, a homologue of yeast MAK3 in A. thaliana, was found to acetylate core 
proteins of photosystem II, which was necessary for the formation of thylacoid complexes and 
plant growth (Pesaresi et al., 2003).  
1.2.5  The NatB Complex and Tropomyosin 
Among the three NATs, deletion mutants of the NatB subunits have the most severe 
phenotypes. Severe defects in NAT3∆ strains have been consistently reported. These include 
the following: slow growth; temperature and osmotic sensitivity; deficiency in utilization of 
non-fermentable carbon sources; reduced mating efficiency; inability to form functional actin 
cables; defects in mitochondrial and vacuolar inheritance; random polarity in budding; 
sensitivity to antimitotic drugs; and susceptibility to a number of DNA-damaging agents 
(Polevoda et al., 2003). However, the reported phenotypes of strains lacking Mdm20p vary 
from severe and numerous defects (Polevoda et al., 2003), to no observable effects (Caesar et 
al., 2006). These differences remain to be resolved. This implies that Nat3p and Mdm20p may 
have certain independent functions. In addition, the average cellular concentration of Nat3p is 
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639 molecules, whereas that of Mdm20p is 5800 molecules per cell (Ghaemmaghami et al., 
2003). Since NatB is a 1:1 complex of Nat3p and Mdm20p, the vast differences in their cellular 
concentrations also indicates that they may have functions outside the NatB complex. 
These deletion mutant phenotypes were compared with the phenotypes displayed by strains 
containing unacetylated tropomyosin and actin (Polevoda et al., 2003). The similarities in 
phenotypes observed in each case was strongly indicative that NAT3Δ phenotypes are due 
primarily, if not entirely, to the lack of actin and tropomyosin acetylation. This is based on 
knowing that in NAT3Δ, Tm is unacetylated, and that unacetylated Tm is not functional as 
explained below. 
As discussed in detail in Chapter 3, Urbancikova and Hitchcock-DeGregori (Urbancikova and 
Hitchcock-DeGregori, 1994) previously established the importance of N-terminal acetylation 
for function of tropomyosin in vitro. Unacetylated striated muscle tropomyosin expressed in E. 
coli was shown to polymerize poorly and bind weakly to F-actin (Hitchcock-DeGregori and 
Heald, 1987). The N-terminal tail of yeast tropomyosin and its state of acetylation were also 
shown to be critical for protein function, and unacetylated Tpm1p expressed in E. coli was 
shown to have a much lower affinity for actin compared with native protein (Maytum et al., 
2000). Thus, acetylation of tropomyosin is important for tropomyosin–F-actin interactions, 
which are required to stabilize actin filaments that are bundled together to form actin cables 
(Hermann et al., 1997). In summary, the above findings strongly indicate that the phenotypes 
observed in NAT3Δ strains are due primarily, if not completely, to defects in the function of 
tropomyosin and actin. 
1.3 The role of tropomyosins and Nat3p in the actin cytoskeleton 
As described in Section 1.1.2, budding yeast express two tropomyosin isoforms, TPM1 and 
TPM2, which function primarily to stabilize actin filaments. Intriguingly, they are the only 
proteins known to localize exclusively to cables, i.e., not also label patches.  
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As actin cables are highly dynamic structures that undergo rapid filament turnover (Ayscough et 
al., 1997), (Yang and Pon, 2002), it is important to determine how tropomyosin acts to regulate 
actin structure and function, and also whether tropomyosin-actin interactions themselves are 
regulated. As has also been discussed in some detail in previous chapters, Nat3p is responsible 
for the acetylation of the N-terminus of tropomyosins. This acetylation is essential for 
tropomyosin function. One question then raised is whether this N-terminal acetylation can act 
as a mechanism of regulating the interaction of tropomyosin with the actin filament, which can 
then in turn regulate actin filament stability and turnover.  
1.3.1 Tpm1p 
As detailed in Section 1.1.2, through gene knockout and cell biology investigations, Tms have 
been shown to be essential in yeast and higher eukaryotes alike. The Bretscher lab was the 
first to demonstrate that the disruption of the budding yeast Tm gene TPM1 in budding yeast 
results in the apparent loss of actin cables from the cytoskeleton (Liu and Bretscher, 1989a). 
Over-expression of Tpm1p was shown to restore the actin cables, inferring a role for Tpm1p in 
the assembly and stabilisation of actin filaments. Further phenotypic characterisation of 
TPM1Δ mutants (Liu and Bretscher, 1992) showed slow growth, heterogeneity in cell size, 
delocalized deposition of chitin, and poor mating because of defects in both shmooing and cell 
fusion. These phenotypes corroborated the involvement of Tpm1p with the actin cytoskeleton, 
and also pointed to the potential role of Tpm1p in the directed transport of components to 
their correct destination on the cell surface. For instance, in exponentially growing wild-type 
cells, all the growth is directed to the bud and the mother cell maintains a constant size during 
the cell cycle. In TPM1Δ cells, the growth is less directed and both the mother and daughter 
cells grow. This results in smaller than normal daughter cells and larger than normal mother 
cells and overall heterogeneity in cell size and morphology. Similarly when wild-type cells of 
opposite mating types are mixed, cells grow towards each other forming shmoo projections. 
Agglutinin is targeted to the shmooing tip that sticks cells of opposite mating types together 
45 
 
via actin cables. In the case of TPM1Δ cells, actin cables are not correctly assembled and 
directed to the tip, and this morphological change does not occur. As a result, the cells cannot 
conjugate efficiently (Liu and Bretscher, 1992). 
The deletion of the second Tm isoform in budding yeast, TPM2, did not show any phenotype at 
all (Drees et al., 1995). However, TPM1 expression levels were ~6 times higher than TPM2 
levels in exponentially growing cells (Drees et al., 1995), which correlates with the relative 
severity of their phenotypes.  Although it has been shown that elevated expression of TPM2 
was unable to compensate for TPM1 deletion (Drees et al., 1995), Bretscher (personal 
communication) stated that this may have been due to poor expression of the TPM2 construct. 
The ability of TPM2 to rescue TPM1Δ phenotypes thus remains unclear. However, when both 
TPM1 and TPM2 genes were deleted, S. cerevisiae cells did not survive (Drees et al., 1995). 
These findings indicate some overlapping function between Tpm1p and Tpm2p.  
1.3.2 Nat3p 
The importance of the N-terminal acetylation of Tm is detailed in Chapter 3.  In S. cerevisiae, 
this is known to be carried out by the NatB complex, which comprises the catalytic core Nat3p 
and auxiliary subunit Mdm20p, as discussed in depth in Chapter 4.  
Studies of genetic knockouts have given some insight into the roles of these two subunits. 
Initial investigations showed that NAT3Δ and MDM20Δ deletion mutants had similar 
phenotypes (Polevoda et al., 2003). These included diminished growth at elevated 
temperatures and on hyper-osmotic and non-fermentable media; diminished mating; 
defective actin cable formation; abnormal mitochondrial and vacuolar inheritance; inhibition 
of growth by DNA-damaging agents and inhibition of growth by anti-mitotic drugs. The 
similarity of these phenotypes to the phenotypes of certain actΔ and TPM1Δ knockouts 
suggested that such multiple defects were caused by the lack of acetylation of actin and 
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tropomyosins. However, the lack of acetylation of other unidentified proteins conceivably 
could cause the same phenotypes.   
A later study claimed, conversely, that NAT3Δ and MDM20Δ mutants display different growth 
rates and morphologies in specific conditions, with MDM20Δ exhibiting unperturbed growth 
indistinguishable from the reference strain. These data implied that the two subunits of the 
NatB complex also have individual functions (Caesar et al., 2006). 
In both the above studies, the defective phenotypes of NAT3Δ were comparable. However, 
while Polevoda et. al showed that these defects could be suppressed by an induced mutant 
TPM1-5 (Polevoda et al., 2003), Caesar et. al showed while the expression of TPM1-5 
suppressed the actin cable defect, other defective phenotypes were not suppressed (Caesar et 
al., 2006). These findings were used to suggest that different NAT3Δ  phenotypes are caused 
by defects in the acetylation pattern of a number of different substrates and not primarily Tm 
(Caesar et al., 2006). 
It is, however, important to note that TPM1-5  is a random MDM20Δ suppressing mutant of 
yeast TPM1 (Singer et al., 2000). The TPM1-5 mutation adds seven amino acids (MHTKKAT) to 
the N terminus of Tpm1p.  As described in Chapter 3, Maytum et al. showed that any 
alterations in the N-terminal region of Tms results in changes in their regulation of S1 binding 
to actin (Maytum et al., 2000). This opens up the question of whether TPM1-5 is not able to 
fully rescue NAT3Δ mutant phenotypes because its seven residue N-terminal extension does 
not restore native-like functionality to the Tpm1p. Whether unacetylated Tpm1p is the primary 
source of the main phenotypic defects of NAT3Δ mutants therefore remains unresolved. 
The aim of the work in this thesis is to characterize novel Tms from N. crassa, and Nat3p using 
an interdisciplinary approach: combining biochemistry, molecular biology, biophysics, and 
genetics will lead to a comprehensive understanding of their roles in the actin cytoskeleton. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
All chemicals were sourced from Sigma-Aldrich® unless otherwise stated. Reagents for 
molecular biology were sourced from New England Biolabs® unless otherwise stated. 
2.1.2 Bacterial and Yeast Strains and Cell Lines 
2.1.2.1 E. coli strains 
All E. coli strains used in this study and their genotypes can be found in Table 2.1. 
Table 2.1: List of bacterial strains and genotypes used in this study 
E. Coli Strain Genotype 
XL1-Blue 
(Stratagene) 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac *F´ proAB lacIqZΔM15 Tn10 
(Tetr)] 
BL21(DE3)pLysS 
(Promega) 
F
-
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) λ(DE3) pLysS(cm
R
) 
Rosetta(DE3)pLysS 
F
-
 ompT hsdSB(rB
-
 mB
-
) gal dcm λ(DE3 *lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
pLysSRARE (Cam
R
) 
C43(DE3) F-ompT gal hsdSB (rB
-
 mB
-
) dcm lon λ DE3 and two uncharacterised mutations. 
C41(DE3) F-ompT gal hsdSB (rB
-
 mB
-
) dcm lon λ DE3 pLysS and an uncharacterised 
mutation. 
 
2.1.2.2 Yeast strains 
Yeast strains used in this study and their genotypes can be found in Table 2.2. 
Table 2.2: List of yeast strains and genotypes used in this study 
Yeast Strain Genotype 
Wild Type BY4741; MAT a; his3A1; leu2AO; metl5A0 
NAT3Δ BY4741; MAT a; his3Al; leu2A0; metl5A0; ura3A0; YPRI 3lc::kanMX4 
TPM1Δ BY4741; MAT a; his3A1; leu2AO; metl5A0; ura3A0; YNL079c::kanMX4 
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2.1.3 Plasmids 
A list of all plasmids used in this study, commercial and cloned derivatives, is shown in Table 
2.3. 
Table 2.3: List of plasmids used in this study 
 Plasmid Description Source 
1 pJC20 T7 promoter Clos J and Brandau S, 1994 
2 pJC20-HisN T7 promoter, N-terminal His-tag Kindly donated by M Konrad 
3 pET14b T7 promoter, N-terminal His-tag Novagen 
4 pET14b-SUMO T7 promoter, N-terminal His-tag Kindly donated by M Konrad 
5 pET14b-MBP T7 promoter, N-terminal His-tag Kindly donated by M Konrad 
6 pET14b-GST T7 promoter, N-terminal His-tag Kindly donated by M Konrad 
7 pET14b-NusA T7 promoter, N-terminal His-tag Kindly donated by M Konrad 
8 YEp512N Yeast Episomal Plasmid, LEU2-GAL10-GUK1 Konrad M, 1992 
9 
YEp512N* 
Modified to include Nde1 –BamH1 cloning 
site 
This Study 
 
A list of all constructs, with details of the original vector and cloned insert in each case, is given 
in Table 2.4. 
Table 2.4: List of constructs used. All were produced in this study unless otherwise stated 
 
Construct 
Original vector Insert (cloned Nde1-BamH1 unless stated 
otherwise) 
1 pJC20-S.cerevisiaeNAT3 pJC20 NAT3  
2 pJC20-HisN-S.cerevisiaeNAT3 pJC20-HisN NAT3  
3 pJC20-N.crassaTm123 pJC20 crTm123  
4 pJC20-N.crassaTm161 pJC20 crTm161  
5 pJC20-N.crassaASTm123 pJC20 crTm123 with N-terminal Ala-Ser   
6 pJC20-N.crassaASTm161 pJC20 crTm161 with N-terminal Ala-Ser   
7 pET-14b- S.cerevisiaeNAT3 pET-14b NAT3  
8 pET-14b- S.cerevisiaeNAT3W39G pET-14b NAT3 with W39G mutation (GGC- GCC)  
9 pET-14b- S.cerevisiaeNAT3W39F pET-14b NAT3 with W39F mutation (TTT – AAA)  
10 pET-14b- S.cerevisiaeNAT3W74G pET-14b NAT3 with W74G mutation (GGC- GCC)  
11 pET-14b- S.cerevisiaeNAT3W74F pET-14b NAT3 with W74F mutation (TTT – AAA)  
12 pET-14b-NusA- S.cerevisiaeNAT3 pET-14b-NusA NAT3  
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13 pET-14b-MBP- S.cerevisiaeNAT3 pET-14b-MBP NAT3  
14 pET-14b-GST- S.cerevisiaeNAT3 pET-14b-GST NAT3  
15 pET-14b-SUMO- S.cerevisiaeNAT3 pET-14b-SUMO NAT3  
16 pET-14b-S.cerevisiaeMAK10 pET-14b MAK10  
17 pET-14b-S.cerevisiaeMAK3 pET-14b MAK3  
18 pET-14b-S.cerevisiaeMAK31 pET-14b MAK31  
19 pET-14b-S.cerevisiaeARD1 pET-14b ARD1  
20 pET-14b-S.cerevisiaeARD5 pET-14b ARD5  
21 pET-14b-S.cerevisiaeNAT1 pET-14b NAT1  
22 pET-21d- S.cerevisiaeMDM20† pET-21d MDM20  
23 pET-14b- S.cerevisiaeMDM20* pET-14b MDM20 (internal Nde1 sites removed) 
24 pRSF-Duet- S.cerevisiaeNAT3-MDM20† pRSF-Duet NAT3 and MDM20  
25 pCDF-Duet- S.cerevisiaeNAT3-MDM20† pCDF-Duet NAT3 and MDM20  
26 YEp512N* - S.cerevisiaeNAT3 YEp512N NAT3  
27 YEp512N -S.cerevisiaeNAT3W39G YEp512N NAT3 with W39G mutation (GGC- GCC)  
28 YEp512N - S.cerevisiaeNAT3W39F YEp512N NAT3 with W39F mutation (TTT – AAA)  
29 YEp512N - S.cerevisiaeNAT3W74G YEp512N NAT3 with W74G mutation (GGC- GCC)  
30 YEp512N -S.cerevisiaeNAT3W74F YEp512N NAT3 with W74F mutation (TTT – AAA)  
31 YEp512N -S.cerevisiaeTPM1 YEp512N TPM1  
32 YEp512N -N.crassaTm123 YEp512N crTm123  
33 YEp512N - N.crassaTm161 YEp512N crTm161  
34 YEp512N *-S.cerevisiaeNAT3His YEp512N* His-tagged NAT3  
† Made by R.Maytum 
 
An example construct is illustrated in Figure 2.1. Here the NAT3 gene is seen cloned in E. coli 
expression vector pET14b. 
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Figure 2.1: Vector map for pET-14b-NAT3. The NAT3 gene was cloned into E. Coli expression vector pET-14b using 
the restriction enzymes Nde1 and BamH1. 
 
2.1.4 Primers 
A list of all the primers used in this study can be found in Table 2.5.  
Table 2.5: List of primers used in this study. Nucleotide bases in uppercase bold refer to the enzyme restriction site 
with the restriction enzyme indicated in brackets, whereas nucleotide bases in lower case bold refer to the base 
change for site directed mutagenesis and (I) indicates an internal primer. 
 
Primer name 
 
Sequence 
 
N.N  crassa Tm forward 
 
G GAA TTC CAT ATG GAC CGC ATC AAG GAG AAA ATG (Nde1) 
1 N. crassa Tm reverse CGC GGA TCC TTA GAT GTT GGC AAT ATC AGC (BamH1) 
 
2 
 
 
N. crassa ASTm forward 
N. crassa ASTm reverse 
 
G GAA TTC CAT ATG GCG UCU GAC CGC ATC AAG GAG AAA ATG (Nde1) 
CGC GGA TCC TTA GAT GTT GGC AAT ATC AGC (BamH1) 
 
 
3 N. crassa 5’ splice site 
 
GTGCTAGAAAAGGAGGCCGAGGAG 
  
yEP512N Nco1/BamH1/Sal1 forward TGG TCG ACG CTC Ccc ATG gGA CTC GGA TCC AC  
4 yEP512N Nco1/BamH1/Sal1 reverse GT GGA TCC GAG TCc CAT ggG GAG CGT CGA CCA           (l) 
 
   S. cerevisiae NatA-ARD1 forward G GAA TTC CAT ATG CCT ATT AAT ATT CGC AGA GCG (Nde1) 
5 S. cerevisiae NatA-ARD1 reverse CGC GGA TCC TTA TAC AAT GAT ATC ATT TAC GCC (BamH1) 
 
   S. cerevisiae NatA-ARD1-BamH1 forward AAG TTt GAT  CCA ACA TAC TTG GCT CCG GGC 
6 S. cerevisiae NatA-ARD1-BamH1 reverse GTA TGT TGG ATC aAA CTT GAT TGT CCT GCC (I) 
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 S. cerevisiae NatA-NAT5 forward G GAA TTC CAT ATG GGC CGT GAT ATA TGC ACA TTA (Nde1) 
7 S. cerevisiae NatA-NAT5 reverse CGC GGA TCC TTA AGA AAT GTG TTT TTT CAA TAA GA (BamH1) 
 
   S. cerevisiae NatA-NAT 1 forward G GAA TTC CAT ATG TCT AGG AAA AGA AGT ACT AAG (Nde1) 
8 S. cerevisiae NatA-NAT 1 reverse CGC GGA TCC CTA CAA GTA ATA CTG TAG AAT TTC GTT C (BamH1) 
 
   S. cerevisiae NatA-NAT1-BamH1 forward ACG CAG GAc  CCA ATT CCT TTT ATT TGG ACC 
9 S. cerevisiae NatA-NAT1-BamH1 reverse AGG AAT TGG gTC CTG CGT AGG ATC TAA TCC (I) 
 
   S. cerevisiae NatC-MAK31 forward G GAA TTC CAT ATG GAC ATC TTG AAA CTG TCA GA (Nde1) 
10 S. cerevisiae NatC-MAK31 reverse CGC GGA TCC CTA AAC AAT ATT AGC CAT CAA TTC (BamH1) 
 
   S. cerevisiae NatC-MAK3 forward G GAA TTC CAT ATG GAA ATA GTG TAC AAG CCA TTG (Nde1) 
11 S. cerevisiae NatC-MAK3 reverse CGC GGA TCC TTA TGT GGC CAG CCG GCC ATG CA (BamH1) 
 
   S. cerevisiae NatC-MAK10 forward G GAA TTC CAT ATG GAA GTA GAC AGT ATA TTA GG (Nde1) 
12 S. cerevisiae NatC-MAK10 reverse CGC GGA TCC TTA TTT ATA GCG GTC TTG CTT TAT TC (BamH1) 
  
 
S. cerevisiae NatC-MAK10-Kpn1 forward 
 
 
GCT TTT AGA ATG GTA CCA AAA CTG C  
13 S. cerevisiae NatC-MAK10-Kpn1 reverse GCA GTT TTG GTA CCA TTC TAA AAG C (l) 
 
   S. cerevisiae NatB-MDM20 forward G GAA TTC CAT ATG TCC GAC AAG ATA CAG GAG GAG (Nde1) 
14 S. cerevisiae NatB-MDM20 reverse CGC GGA TCC TCA TAA ATT TCT TAC ACT TTT TTG (BamH1) 
 
   S. cerevisiae NatB-MDM20-Nde1 forward GAA CCg TAT GGG CTG AAA GGG ACA ACG 
15 S. cerevisiae NatB-MDM20-Nde1 reverse CAG CCC ATA cGG TTC TTC TAG CAG TTT A (I) 
 
   S. cerevisiae NatB-MDM20-Nde2 forward GTA CAA GCg TAT GAA GAA TTA AAA AAA 
16 S. cerevisiae NatB-MDM20-Nde2 reverse TTC TTC ATA cGC TTG TAC TAA AGC TTT AGA (I) 
 
  17 S. cerevisiae NatB-Nat3 forward 
  S. cerevisiae NatB-Nat3 reverse 
  
   S. cerevisiae NAT3 W39G forward GAA TAC ATG ATA ATA ggc CCA GAC C 
18 S. cerevisiae NAT3 W39G reverse AAA AAG GTC TGG gcc TAT TAT CAT GTA (I) 
 
   S. cerevisiae NAT3 W39F forward TAC ATG ATA ATA ttt CCA GAC CTT TTT 
19 S. cerevisiae NAT3 W39F reverse AAA AAG GTC TGG aaa TAT TAT CAT GTA (I) 
 
   S. cerevisiae NAT3 W74G forward G ACC ACG GAG ggc CAC ACT CAT ATA ac 
20 S. cerevisiae NAT3 W74G reverse TAT ATG AGT GTG gcc CTC CGT GGT CTT (I) 
  
S. cerevisiae NAT3 W74F forward AAG ACC ACG GAG ttt CAC ACT CAT ATA 
21 S. cerevisiae NAT3 W74F reverse TAT ATG AGT GTG aaa CTC CGT GGT CTT (I) 
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2.1.5 Media and Solutions for Bacterial Work 
2.1.5.1 Luria-Bertani (LB) broth 
Per  Litre: 
Peptone (DIFCO) 10 g 
Yeast Extract   5 g 
NaCl    5 g 
This was made up to 1 litre with distilled water, the pH set to 7.5 with 1 M NaOH, and then 
sterilised by autoclaving. 
2.1.5.2  LB agar 
1.5 % w/v bacteriological agar was added to LB, and the mixture sterilised by autoclaving. The 
agar was allowed to cool to around 40 °C before the addition of appropriate antibiotics for 
selection, and then plates were poured using aseptic technique. 
2.1.5.3  Antibiotic Stocks 
Ampicillin (100 mg ml-1) 
 
Ampicillin sodium salt was dissolved in MilliQ purified water and sterilised by filtration.  
The final concentration used was 100 mg L-1. 
Chloramphenicol (34 mg ml-1) 
Chloramphenicol was dissolved in AnalaR ethanol.  
The final concentration used was 34 mg L-1. 
Streptomycin (50 mg ml-1) 
Streptomycin was dissolved in AnalaR water and sterilised by filtration.  
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The final concentration used was 50 mg L-1. 
Kanamycin (30 mg ml-1) 
Kanamycin salt was dissolved in AnalaR water and sterilised by filtration.  
The final concentration used was 30 mg L-1. 
2.1.6 Media and Solutions for Yeast work 
2.1.6.1  YP Medium 
For 1 litre: 
Bacto Peptone 20 g 
Yeast Extract 10 g 
This was made up to 1 litre with distilled water and then sterilised by autoclaving. 
2.1.6.2  YPD Medium 
1/10 volume of a sterile filtered 30 % glucose stock (2.1.6.4) was added to autoclaved YP to 
give a final concentration of 3 %. 
2.1.6.3  SD Medium (x10 Stock) 
6.7 g of Nitrogen Base without amino acids (Difco) was dissolved in 100 ml distilled water and 
sterile filtered. The stock was diluted to 1x SD media with sterilised distilled water as required. 
2.1.6.4  YP/SD Agar 
1.5 % w/v bacteriological agar was added to YP/SD before the addition of any carbon source or 
amino acids. The solution was autoclaved to sterilise. Once cooled to around 40 °C, and before 
pouring plates, carbon source and amino acids supplements were added as appropriate. 
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2.1.6.5 Carbon Source and Amino Acid Stocks 
30 % solutions of glucose and galactose were prepared and filter sterilised to be used as 
carbon source for yeast media. The final concentration of carbon source in the media was 3 %. 
Uracil and lysine were required to supplement the SD media. 10x stock solutions of 300 mg/ml 
and 200 mg/ml respectively were prepared, and filter sterilised prior to storage at room 
temperature. An appropriate dilution of the stocks was added to the SD media as required. 
2.1.7 Solutions for DNA Work 
TAE buffer 10 x 
For 1 litre 
Tris Base  48.4 g 
Glacial Acetic acid 10 ml 
EDTA   3 g 
DNA loading Buffer 6 x 
Xylene Cyanol  0.025 g 
Bromophenol Blue 0.025 g 
Glycerol  12.5 ml 
10 % SDS  1.25 ml 
H2O   6.25 ml 
2.1.8 Solutions for Protein Work 
2.1.8.1 Lysis Buffer 
Tris pH 7.5  20 mM 
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NaCl   150 mM 
MgCl2   5 mM 
2.1.9 Buffers for Polyacrylamide Gel Electrophoresis  
SDS- gel (13.5 %) 
Table 2.6 lists the recipes for stacking and resolving SDS-gels. 
Table 2.6: Recipes for SDS stacking and resolving gels. 
Gel Water 
Acrylamide 
40 % 
Stacking/Resolving 
Buffer 4x (below) 
Ammonium 
persulphate 
10 % 
TEMED 
Resolving 3.05 ml 2.4 ml 1.85 ml 50 µl 15 µl 
Stacking  2.5 ml 0.6 ml 1 ml 35 µl 8 µl 
 
Stacking Buffer 4x 
Tris pH 8.8  0.5 M 
SDS   0.1 % 
 
Resolving Buffer 4x 
Tris pH 6.8  1 M 
SDS   0.1 % 
(Native gel recipe same as above but without SDS) 
SDS running buffer 10 x 
For 1 litre: 
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Tris Base   30.2 g 
Glycine    144 g 
SDS    10 g 
Sample denaturing buffer 4 x 
For 7.5 ml 
1 M Tris-HCl (pH 6.8)  1.5 ml 
1 M DTT   3 ml  
Bromophenol Blue  0.03 g 
Glycerol   3 ml  
Stain 
Methanol   30 % 
Acetic acid   10 % 
Coomassie Brilliant Blue 0.025 % 
Destain 
Methanol   30 % 
Acetic acid   10 % 
2.1.9.1 Buffers for Anion Exchange Chromatography 
Buffer A 
NaPO4  (pH 7.4)  5 mM 
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NaCl    100 mM 
Buffer B 
NaPO4  (pH 7.4)  5 mM 
NaCl    1 M 
2.1.9.2 Buffers for Ni-IDA Column Chromatography 
LEW buffer (Lysis-Equilibration-Wash buffer) 
NaH2PO4    50 mM 
NaCl     300 mM 
 Adjust pH to 8.0 using NaOH 
Elution buffer  
NaH2PO4    50 mM 
NaCl    300 mM 
Imidazole    250 mM 
Adjust pH to 8.0 using NaOH 
 
Denaturing Solubilisation buffer 
NaH2PO4    50 mM 
 NaCl     300 mM 
Urea      6 M 
Adjust pH to 8.0 using NaOH 
Denaturing Elution buffer 
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NaH2PO4    50 mM 
NaCl     300 mM 
Urea     6 M  
Imidazole    250 mM 
 Adjust pH to 8.0 using NaOH 
2.1.9.3 Buffers for Western Blotting  
Transfer Buffer 
For 1 litre: 
Tris HCl    3.03 g 
Glycine    14.4 g 
Methanol   200 ml 
SDS 10%   1 ml 
Wash Buffer 
For 1 litre: 
Tris Base   24.2 g 
NaCl    84 9 g 
Tween-20   2.5 ml 
Adjusted pH to 7.6 with HCl 
Blocking Solution 
5 % solution of dried skimmed milk powder in Wash Buffer 
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2.1.9.4 Buffer for G-Actin Polymerisation 
Tris pH 8    5 mM 
KCl     50 mM 
ATP     0.2 mM 
MgCl2     5 mM 
2.1.9.5 S1 Buffer 
MOPS pH 7.0     20 mM 
NaCl      50 mM 
NaN3      1 mM 
MgCl2     5 mM 
 DDT     0.1 mM 
2.1.9.6 Buffer for Cosedimentation Assays 
MOPS    20 mM 
KCl    100 or 200 mM as stated in text 
MgCl2    5 mM 
 Adjust to pH 7.0 with 1 M NaOH 
2.1.9.7 Buffers for Circular Dichroism (CD) 
NaPO4    5 mM 
 
2.1.9.8 Buffers for Inorganic Phosphate Assays 
Solution A1 
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12 % w/v L-ascorbic acid in 1N HCl 
Solution A2 
 2 % w/v ammonium molybdate tetrahydrate in MilliQ purified water 
Solution B 
 2 % sodium citrate tribasic dihydrate 
 2 % acetic acid in MilliQ purified water 
Assay Buffer 
MOPS pH 7.9  20 mM 
NaCl   50 mM 
MgCl2   5 mM 
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2.2 DNA Methods 
2.2.1 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) is a molecular biology technique that occurs invitro to 
allow the enzymatic amplification of specific DNA fragments of certain sequence and length. 
PCR uses a template of DNA, oligonucleotide primers and a thermostable polymerase, to 
reproduce many copies of the initial molecule (Saiki et al., 1988). 
2.2.1.1  Standard PCR 
The genes for all proteins recombinantly expressed in this study were initially amplified from 
genomic DNA using PCR.  
For a standard PCR reaction, the components used in a 50 µl reaction are listed below in Table 
2.7. 
Table 2.7: Pipetting instructions for standard PCR amplification of gene from template DNA 
 Volume (µl) Final 
Concentration 
5x Phusion™ HF Buffer 10 x 1 
10mM dNTPs 1 200 µM 
25 µM 5’ Primer 1 0.5 µM 
25 µM 3’ Primer 1 0.5 µM 
DNA template 0.5  
Phusion™ High-Fidelity DNA 
Polymerase 
0.5 0.01 U 
H2O 36  
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The cycling conditions used for standard PCR amplifications were as described in Table 2.8. 
Table 2.8: Cycle conditions for standard PCR using Phusion™ High-Fidelity DNA Polymerase. 
Cycle Step Temperature (°C) Time No. of Cycles 
Initial Denaturation 98 30 s 1 
Denaturation 
Annealing 
Extension 
98 
55 
72 
10 s 
30 s 
30 s / kb 
25 
Final Extension 72 5 min 1 
 
Post-PCR, samples were separated by agarose gel electrophoresis as described in Section 2.2.2.  
2.2.1.2  Colony PCR 
Colony PCR was used in this study for rapid screening for plasmid inserts directly from E. coli 
and S. cerevisiae colonies. For a typical colony PCR reaction, the components listed in Table 2.9 
were mixed on ice (a large master mix was prepared and aliquoted for multiple samples). 
Table 2.9: Pipetting instructions for typical colony PCR with a total reaction volume of 20 µl. 
 Volume (µl) Final Concentration 
10 x ThermoPol Buffer (NEB) 2 x 1 
10 mM dNTPs 0.5 250 µM 
25 µM 5’ Primer 0.5 0.6 µM 
25 µM 3’ Primer 0.5 0.6 µM 
Taq DNA Polymerase (NEB) 0.5 1.25 
H2O 16  
 
A small amount of colony was added to each cold PCR tube containing the PCR reaction. To do 
this, a fine yellow pipette tip attached to a pipette (set at 15 μl to avoid addition of air into the 
PCR reaction) was used. The colony was mixed into the PCR mix by pipetting up and down as 
sufficient mixing results in a homogenous cell suspension which encourages complete cell lysis 
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on heating. The cycling conditions for a typical colony PCR using Taq polymerase is described in 
Table 2.10. 
Table 2.10: conditions for standard colony PCR using NEB Taq Polymerase. 
Cycle Step Temperature (°C) Time No. of Cycles 
Initial Denaturation 95 5 min 1 
Denaturation 
Annealing 
Extension 
95 
55 
72 
1 min 
30 s 
1 min / kb 
35 
Final Extension 72 5 min 1 
 
The PCR products were the analysed using agarose gel electrophoresis, as described in Section 
2.2.2.  
2.2.1.3  Site-Directed Mutagenesis 
Site-directed mutagenesis was used to introduce or remove restriction enzyme sites within 
genes or plasmids to facilitate cloning, or introduce nucleotide base changes which result in 
amino acid residue changes in the protein product. Three different methods were used 
depending on each different case, and each is described briefly below: 
2.2.1.3.1 PCR-Fusion 
This method was used to introduce a nucleotide base substitution in a DNA sequence, either to 
remove a restriction enzyme site from within a gene prior to cloning into a specific plasmid; 
and also to introduce an amino acid change in a protein sequence. In this study, most of the 
expression plasmids used were designed with and Nde1/ BamH1 cloning site. Therefore, if the 
gene of interest contained any internal Nde1 or BamH1 sites, these were removed prior to 
cloning. 
In this technique, two pairs of oligonucleotide  primers are designed. The first is a pair of 
external primers, and the second is a pair of internal primers designed to contain the desired 
base-substitution mutation. Two specific fragments of the target DNA sequence are then 
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amplified in separate PCRs: one fragment using the 5’ external and 3’ internal, and the second 
using 3’ external and 5’ internal primers respectively.  This concept is illustrated clearly in 
Figure 2.2 below.   
 
Figure 2.2: PCR-Fusion to introduce a site-directed base substitution within a DNA sequence. 
 
The internal primers introduce the mutation in the template DNA, by engineering a mis-match 
during the first cycle of PCR. Because PCR employs exponential growth, after a sufficient 
number of cycles the mutated fragments will be amplified sufficiently to replace the original 
templates. Both amplified fragments are then mixed together, denatured, annealed, and the 
resultant single mutation-containing DNA sequence amplified by the external primers. Reagent 
concentrations and cycling conditions used were as in Table 2.7 and Table 2.8 respectively. 
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2.2.1.3.2 Site-directed mutagenesis based on QuikChange® method by Stratagene  
The protocol was based on the QuikChange® method by Stratagene, however Phusion™ High-
Fidelity DNA polymerase was used. In this method, two synthetic oligonucleotide primers 
containing the desired mutation are mixed with a super-coiled double-stranded DNA vector 
with the insert of interest (Figure 2.3). The oligonucleotide primers, each complementary to 
opposite strands of the vector, were extended during temperature cycling by Phusion™ High-
Fidelity DNA polymerase (reagent concentrations and thermo cycler conditions used were as in 
Table 2.7 and Table 2.8 respectively).   Incorporation of the oligonucleotide primers generates 
a mutated plasmid containing staggered nicks. Following temperature cycling, the product is 
treated with Dpn1, a restriction endonuclease that is specific for methylated and 
hemimethylated DNA. DNA isolated from almost all E. coli strains is methylated by DAM (DNA 
adenine methylase), an enzyme that adds a methyl group to the adenine of the sequence 5'-
GATC-3' in newly synthesized DNA to help the cell differentiate between the template strand 
and the newly synthesized strand. Therefore, Dpn1 digests the parental DNA template, and 
leaves behind the mutation-containing synthesized DNA.  XL1-Blue supercompetent cells  are 
then transformed with the nicked vector DNA containing the desired mutations. This protocol 
is outline in Figure 2.3. 
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Figure 2.3: The 4-step QuikChange site-directed mutagenesis protocol by Stratagene 
 
2.2.1.3.3 Cassette mutagenesis 
Cassette mutagenesis involves cleavage by restriction enzymes at selected sites in the plasmid 
and subsequent ligation, in the same site, of an oligonucleotide containing the desired 
mutation. A simplified illustration is presented in Figure 2.4. 
 
Figure 2.4: Simplified overview of cassette-mutagenesis. The production of mutant within a region bounded by 
unique restriction sites (blue) by the use of synthetic oligonucleotides that fill the gap with mutants designed into 
the synthetic genetic material (red). 
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Table 2.11 lists the constructs produced via the various site-directed mutagenesis protocols 
used during this study. 
Table 2.11: Constructs produced by site-directed mutagenesis. 
 Construct Created Using Site-
Directed Mutagenesis 
Site-Directed 
Mutagenesis 
technique used 
Primer Pair 
1 pET-14b-S.cerevisiaeNat1 
To remove BamH1 site in Nat1 
 
 
 
 pET-14b-S.cerevisiaeNat1 
To remove BamH1 site in Nat1 
PCR-Fusion ACG CAG GAc  CCA ATT CCT TTT ATT TGG ACC 
AGG AAT TGG gTC CTG CGT AGG ATC TAA TCC 
 
2 pET-14b- S.cerevisiaeNat3W39G 
 
QuikChange 
GAA TAC ATG ATA ATA ggc CCA GAC C 
AAA AAG GTC TGG gcc TAT TAT CAT GTA 
3 pET-14b- S.cerevisiaeNat3W39F 
 
QuikChange 
TAC ATG ATA ATA ttt CCA GAC CTT TTT 
AAA AAG GTC TGG aaa TAT TAT CAT GTA 
4 pET-14b- S.cerevisiaeNat3W74G 
 
QuikChange 
G ACC ACG GAG ggc CAC ACT CAT ATA ac 
TAT ATG AGT GTG gcc CTC CGT GGT CTT 
5 pET-14b- S.cerevisiaeNat3W74F 
 
QuikChange 
AAG ACC ACG GAG ttt CAC ACT CAT ATA 
TAT ATG AGT GTG aaa CTC CGT GGT CTT 
6 pET-21d- S.cerevisiaeMdm20* 
To remove two Nde1 sites to enable 
cloning into pET14b.  
QuikChange GAA CCg TAT GGG CTG AAA GGG ACA ACG 
CAG CCC ATA cGG TTC TTC TAG CAG TTT A 
 
GTA CAA GCg TAT GAA GAA TTA AAA AAA 
TTC TTC ATA cGC TTG TAC TAA AGC TTT AGA 
 
7 yEP512N* 
To alter the MCS and introduce an 
Nco1 site. 
Cassette 
mutagenesis 
GT GGA TCC GAG TCc CAT ggG GAG CGT CGA CCA  
TGG TCG ACG CTC Ccc ATG gGA CTC GGA TCC AC  
      
 
 
 
2.2.2 Agarose Gel Electrophoresis 
The agarose gel percentage was chosen according to the size of the DNA fragments to be 
separated. A 1 % agarose gel was routinely used. A 1% solution of agarose in 1 x TAE was 
heated in a microwave to dissolve the agarose. Once dissolved, the solution was poured into a 
gel cast, with an appropriate comb, and allowed to set at room temperature. 
Electrophoresis was carried out at 100 V for approximately 40 minutes. The gel was then 
removed from the gel tank and soaked in a 10 µM ethidium bromide bath for 10 minutes 
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before direct visualisation under UV. Ethidium bromide is a fluorescent dye that intercalates 
between base pairs, allowing visualisation of the DNA when viewed under UV light. 
2.2.2.1 Visualisation of DNA under UV 
UV radiation (312 nm) is absorbed by the ethidium bromide that is bound to DNA and re-
emitted at 590 nm in the red-orange wavelength range. Therefore, the DNA was visualised by 
placing the gel onto an UV transilluminator. The gel was then photographed by a camera 
through a red filter. 
In the case of analytical gels, a photograph of the gel under UV light was taken as a record. For 
preparative gels, where the separated DNA was to be used for downstream applications such 
as cloning, the DNA was excised from the agarose gel as described in Section 2.2.3. 
2.2.3 DNA purification from Agarose Gels 
The DNA band of interest was carefully excised from an agarose gel using a scalpel blade and 
subsequently purified using Eppendorf PerfectPrep® Gel Cleanup Kit. Refer to the Eppendorf 
PerfectPrep® Gel Cleanup Kit handbook for details of the protocol using a micro-centrifuge. 
Once purified, the PCR product was usually prepared for cloning into a suitable expression 
vector by treating with the appropriate restriction endonucleases, as described in Section 
2.2.4. 
2.2.4 Restriction Endonuclease Digestion of DNA 
Restriction endonuclease digests were used to prepare amplified PCR products and plasmids 
for cloning, as well for sub-cloning inserts from one plasmid to another. In each case, the DNA 
was digested using the relevant enzymes and the optimal buffer according to the New England 
Biolabs data sheet. The reaction mixtures were incubated for 2 hours at the temperature 
required by the restriction enzyme before being subjected to agarose gel electrophoresis 
(Section 2.2.3). 
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2.2.5 Ligation of DNA insert and plasmid 
The vector and insert were digested with the relevant restriction enzymes, isolated by agarose 
gel electrophoresis, and purified. The DNA fragments were ligated together in a 4:1 molar ratio 
of vector to insert with T4 DNA ligase obtained from New England Biolabs, and the supplied 
buffer. The ligations were incubated at a temperature of 16 °C for 30 minutes before being 
subsequently used to transform competent cells. 
2.2.6 Preparation of Competent E. coliCells 
A glycerol stock scraping or single colony of the E. colistrain was grown overnight in 5 ml LB. 
This overnight culture was diluted 1/100 in 25 ml LB in a sterile 250 ml flask. The cells were 
allowed to grow for 2 – 3 hours (depending on the strain) until they reached early log phase 
(OD600 of 0.2 – 0.4). At this point the cells were harvested by centrifugation at 4500 rpm for 5 
min at 4 °C, and kept on ice. The cells were resuspended in ½ culture volume of 0.1 M ice-cold 
sterile CaCl2, and incubated on ice for an hour. After incubation, the cells were harvested as 
before, and resuspended in 1/10 culture volume of 0.1 M ice-cold sterile CaCl2 with 10 % (v/v) 
ice-cold, sterile glycerol. The competent cells were then stored as 100 µl aliquots at -70 °C, and 
used as required. 
2.2.7 Transformation with plasmid DNA 
2.2.7.1 Transformations in E. coli 
Competent cells were defrosted on ice before addition of 1 ng of plasmid DNA, or up to 10 µl 
ligation mix (Section 2.2.5) to be transformed. The mixture was incubated on ice for 15 
minutes and then heat-shocked at 42 °C for 55 sec before the addition of 200 µl of sterile LB. 
The cells were then incubated at 37 °C for 20 to 60 minutes to allow antibiotic resistance 
expression. This mixture was then spread onto an LB agar plate containing the appropriate 
antibiotics and incubated at 37 °C overnight 
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2.2.7.2 Transformations  in  S. cerevisiae 
A single yeast colony or scraping from a glycerol stock was grown overnight in YPE medium at 
30 °C. 500 µl of the overnight culture was used to inoculate 10 ml fresh YPE medium, and 
allowed to grow at 30 °C until mid-log phase (approx. 4 hours). For each transformation 
required, 1.2 ml of the mid-log culture was aliquoted into a 1.5 ml Eppendorf tube, and the 
cells pelleted by centrifugation at 10, 000 x g for 30 seconds. All but 50 µl of the supernatant 
was removed, and the pellet resuspended by vortexing. 0.5 – 5 µg of the plasmid DNA to be 
transformed was added to the cells. This was followed by 20 µl of carrier DNA (boiled salmon 
sperm DNA), 25 µl of 1 M DTT, and finally 500 µl of Yeast Transformation buffer. The mixture 
was vortexed, and placed on ice for 1 hour, after which time they were heat-shocked by 
placing in a 42 °C heat block for 15 minutes. The cells were once again pelleted by 
centrifugation at 13,000 x rpm for 1 minute. The pellets were resuspended in 100 µl sterile 
water, and then spread on SD agar with the appropriate amino acid for auxotrophic selection. 
2.2.8 Preparation of Plasmid DNA from E. coli 
Plasmid DNA was extracted from E. colicells using the Eppendorf PerfectPrep® Mini Kit (Midi 
Kit for larger preps) according to the manufacturers’ directions. The DNA was sequenced to 
confirm the presence of the correct cloned gene sequence within the plasmid vector, and 
subsequently transformed into an expression strain of bacteria or yeasts (Section 2.2.8) for 
expression of recombinant protein. 
2.3 RNA Methods 
2.3.1 RNA Extraction from N. crassa 
Invitrogen’s TRIzol® reagent was used to extract total RNA from N. crassa. 500 mg of fungal 
hyphae was snap frozen in liquid nitrogen, and homogenised after the addition of  1 ml  
TRIzol® Reagent.  
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 Following homogenization insoluble material was removed from the homogenate by 
centrifugation at 12,000 × g for 10 minutes at 4 °C. The resulting pellet contained extracellular 
membranes, polysaccharides, and high molecular weight DNA, while the supernatant 
contained RNA.   
The homogenised sample was then incubated at room temperature for 5 minutes to allow the 
dissociation of the nucleoprotein complexes.  0.2 ml of chloroform was then added to the 
tube.  The tube was shaken vigorously by hand for 15 seconds and then incubated at room 
temperature for 3 minutes. The sample was once again centrifuged at 12,000 ×  g for 15 
minutes at 4 °C. Following centrifugation, the mixture separated into a lower red, phenol-
chloroform phase, an interphase, and a colourless upper aqueous phase. RNA remains 
exclusively in the aqueous phase.   
The aqueous phase was transferred to a fresh tube and the RNA precipitated by the addition of 
0.5 ml isopropyl alcohol. The sample was incubated at room temperature for 10 minutes, and 
centrifuged at 12,000 ×  g for 10 minutes at 4 °C.  After decanting the supernatant, the RNA 
pellet was washed once with 75% ethanol, vortexed and once again centrifuged at 12,000 x g 
for 5 minutes at 4 °C.  
At the end of the procedure the RNA pellet was briefly air-dried, and the RNA dissolved in 
RNase-free water by passing the solution a few times through a pipette tip, and incubating for 
10 minutes at 55 to 60 °C.  
2.3.2 Reverse Transcription PCR (RT-PCR) to amplify a specific gene 
In  RT PCR,  total RNA is first reverse transcribed into its DNA complement using the enzyme 
reverse transcriptase, and then specific genes amplified by PCR as described in Section 2.2.1.1. 
This is illustrated in Figure 2.5. 
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Figure 2.5: Schematic representation of RT-PCR using the TaqMan EZRT-PCR Kit. 
 
The total RNA isolated from N. crassa was first reverse transcribed using oligo-dT primers and 
the TaqMan® reverse transcriptase. The reagent concentrations and thermo cycler conditions 
are detailed in Table 2.7 and Table 2.8 respectively. 
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Table 2.12: Reverse transcriptase reagent mix 
Component 
Volume for one 
Sample (total 10 µl) 
Final Concentration 
RNase-free water 1 µl  
5 x TaqMan® EZ Buffer (10x) 1 µl 1 x 
Oligo dT primer (50 µM) 0.5 µl 2.5 µM 
dNTPs Mix (10 mM) 2 µl 500 µM 
25 mM MgCl2 2.2 µl 5.5 mM 
Total RNA 2 µl 1 µg 
TaqMan® EZ reverse transcriptase 0.25 µl 1.25 U/µl 
 
Table 2.13: Thermo cycler conditions for DNA synthesis 
Cycle Step Temperature (°C) Time (min) 
 25 10 
Reverse Transcription 48 45 
Inactivate Enzyme 95 5 
 4 Hold 
 
The RT-PCR products were analysed by agarose gel electrophoresis (Section 2.2.2). 
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2.4 Protein Methods 
2.4.1 Expression of Recombinant Proteins in E.coli 
The following protocol was followed for the expression of recombinant proteins from E. coli 
BL21 cells unless stated otherwise: 
A single colony, or scraping of a glycerol stock, of E. coli BL21 cells transformed with the 
plasmid containing the cDNA of interest was grown shaking overnight at 37 °C in 5 ml LB 
medium containing the appropriate antibiotic for selection. 1 ml of the overnight culture was 
then used to inoculate 1 L of LB (supplemented with the appropriate antibiotics), and allowed 
to grow shaking at 37 °C until an OD of around 0.6 was reached. IPTG was then added to a final 
concentration of 0.4 mM to induce expression of the protein overnight at 30 °C. 
The cells, containing expressed recombinant protein, were then harvested by centrifugation at 
6,000 x g for 10 minutes.  
2.4.2 Protein Purification 
2.4.2.1 Tropomyosin Purification 
The purification of tropomyosin is a multi-step process. Because this protein is highly 
thermostable, the initial purification step involves boiling the cell lysate containing over-
expressed tropomyosin. This denatures the majority of other proteins within the lysate. The 
tropomyosin is separated from the denatured protein by centrifugation, as it remains soluble. 
The second purification step involves iso-electric point precipitation, and finally anion 
exchange chromatography is used to remove residual, mainly nucleotide, contamination.  
Details of each step are detailed: 
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2.4.2.1.1 Isolating thermostable tropomyosins by boiling  
After induction of recombinant tropomyosin expression in E.coli, the cells were harvested and 
the pellet resuspended in 30 ml lysis buffer per litre of original culture and briefly sonicated to 
lyse cells and break up DNA. The sonicated cells were then placed in boiling water for 10 
minutes. This ensures the denaturation of all proteins that are not thermostable, and hence 
acts as a primary purification step for thermostable tropomyosins. After boiling, the cells were 
placed on ice to cool, and centrifuged at 10,000 x g for 20 minutes to separate the 
tropomyosins (supernatant) from other denatured proteins and remaining cell debris. 
2.4.2.1.2 Iso-electric Point Precipitation 
The second step in the purification of tropomyosins was iso-electric point precipitation. The 
iso-electric point of the tropomyosins in this study was around pH 4.5. The boiled tropomyosin 
was placed on ice, and the pH reduced to 4.5 with 1 M HCl, resulting in the formation of a 
‘snowy’ white precipitate. The precipitated tropomyosin was then separated by centrifugation 
at 10,000 x g for 10 minutes. The protein pellet was resuspended in 5 ml of 5 mM phosphate 
buffer (Buffer A), and the pH adjusted to 7 to re-dissolve the tropomyosins. 
2.4.2.1.3 Anion Exchange Chromatography 
The final step in the purification was anion exchange chromatography to separate the mainly 
charged, poly-nucleic acids from tropomyosins. The re-suspended protein, post iso-electric 
precipitation, was loaded on to a pre-equilibrated 1 ml Resource-Q (Pharmacia) column.  The 
column was connected to an ÄKTA™fplc™. The FPLC was programmed to start by washing the 
loaded column with 5 column volumes (CV) of Buffer A. This was followed by a gradient of 
Buffer B from 0 % - 40 % over the course of 20 CV, and finally a step up to 100 % B to remove 
tightly bound contaminants from the column. A fraction collector connected to the FPLC was 
programmed to collect 1 ml fractions throughout the 0 % - 40 % gradient. The column was 
subsequently washed by alternating 2 CV 0 % and 100 % buffer B multiple times. 
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2.4.2.2 His-Nat3p Purification  
2.4.2.2.1 Separating Soluble and Insoluble Fractions 
After protein expression (2.2.4.1), the harvested cells were resuspended in 30 ml LEW buffer. 
The cell suspension was then placed in an ice-water slurry to keep cool, and the cells lysed by 
sonication. The sonicator probe was placed in the tube containing the cell suspension, with 
care being taken that no part of the probe was in contact with the tube. The sonicator was set 
to 100 W and programmed to sonicate in 20 sec pulses, at 30 sec intervals.  
The lysed cells were then centrifuged at 10,000 x g for 20 minutes to separate all soluble 
protein from insoluble inclusion bodies in the pellet.  
2.4.2.2.2 Solubilisation of Inclusion Bodies 
The pellet containing inclusion bodies was resuspended in denaturing LEW (containing 6 M 
urea), in the presence of 100 mM DTT and 1 mM EDTA, and incubated for 2 hours at room 
temperature. Insoluble cell debris was removed by centrifugation (10, 000 g), and the DTT was 
removed by dialysis against 500 ml denaturing LEW at 4 °C overnight.  The solubilised His-
tagged Nat3p inclusion bodies were then ready for purification by affinity chromatography 
(below). 
2.4.2.2.3 Immobilised Metal Ion Chromatography (IMAC) 
The His-tagged Nat3p was purified from total urea-soluble extract on a pre-packed Protino® 
mini gravity flow Ni-IDA 1000 column (Macherey-Nagel GmbH & Co. KG, Germany). IDA is a tri-
dentate chelator, which occupies three of the six binding sites in the coordination sphere of 
the Ni2+ ion. The remaining three coordination sites are usually occupied by water molecules 
and can be exchanged with histidine residues of the recombinant protein (Figure 2.6). 
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Figure 2.6: Schematic representation of IDA conjugated with a silica bead. A tri-dentate chelator, it occupies three 
of the six binding sites in the coordination sphere of the Ni2+ ion. The remaining three coordination sites are usually 
occupied by water molecules and can be exchanged with histidine residues of the recombinant protein (Taken from 
Macherey-Nagel GmbH & Co. KG, Germany) 
 
The column was pre-equilibrated with 2 ml of 1 x LEW (or 1 X denaturing LEW, as appropriate) 
buffer, before loading with concentrated lysate. The column was then washed with 5 ml LEW, 
and finally eluted, using elution buffer (LEW containing 250 mM imidazole) in three 1.5-ml 
fractions. 
2.4.3 Actin Polymerisation 
Frozen G-actin stocks (prepared by R. Bailey and R. Maytum) were polymerised to produce F-
actin as follows: 
10 ml of a frozen stock of G-actin was allowed to thaw at room temperature. Once thawed, 
ATP was added drop-wise, while stirring, to a final concentration of 5 µM. This was followed by 
the addition of MgCl2 to a final concentration of 2 mM, and KCl to a final concentration of 100 
mM. The G-actin was then left to stir for 1 hour at room temperature for the polymerisation to 
occur. Following the incubation, the samples were divided between 4 x 4-ml tubes and spun at 
100,000 x g at 4 °C in an Optima™ TLX Personal Benchtop Ultracentrifuge. The rotor was 
carefully removed so as not to disturb the pellets. The supernatant was carefully pipetted off, 
and the pellets resuspended in 1 ml actin buffer. The resuspended polymerised actin (F-actin) 
was then dialysed against 1 L actin buffer at 4 °C overnight. The molar concentration of the F-
actin was determined from its absorbance at 280 nm using an E1% of 1.104 cm-1 and a 
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molecular mass of 42, 000 Da as determined from ProtParam (Jack et al., 2008) (Section 
2.5.7.1). 
2.4.4 Preparation of Myosin S1 stock 
Freeze-dried S1 stocks (R. Maytum) were used to prepare S1 solution. Approximately 50 mg of 
freeze-dried S1 was dissolved in 1 ml of S1 buffer. The final concentration was determined 
from its absorbance at 280 nm using an E1% of 7.5 cm-1 and a molecular mass of 50,000 Da as 
determined from ProtParam (Jack et al., 2008) (Section 2.5.7.1). 
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2.5 Protein Analysis Techniques 
2.5.1 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
The protein sample to be analysed was mixed with 4 x sample denaturing buffer in a 4 : 1 ratio. 
Samples were then heated at 94 °C for 4 min.  SDS gels were placed into the Protean II tanks 
and covered with 1x SDS running buffer. Denatured protein samples were loaded into wells 
using a 50-μl Hamilton syringe.  5 μl NEB Pre-stained Molecular Weight Marker was loaded in 
one well. Gels were run by applying a voltage of 180 V for about 45 minutes or until the 
bromophenol blue dye front had run off the bottom of the gel. 
Once run, gels were removed from the glass plates and placed into a container with 50 ml 
Coomassie stain. To accelerate staining, gels were microwaved for 30 sec on full power (800 
W) and agitated slowly on a rocker for 30 minutes. Once stained, gels were rinsed with water 
and transferred to a container with 50 ml destain. Slow heating in the microwave on low 
power (100 W) for five minutes was followed by agitation on the rocker for 1 hr or until the gel 
was sufficiently destained. Gels were transferred to water for a minimum of 6 hours before 
scanning/drying. 
2.5.2 Native Gel Electrophoresis 
This technique is used to separate proteins without denaturing them. In this study this 
technique was used to obtain information on the extent of protein aggregation. The method is 
identical to that of SDS-PAGE (2.4.5.1), except for the absence of any denaturants or reducing 
agents (i.e SDS and -mercaptoethanol) in the sample loading dye, polyacrylamide gel or 
running buffer. 
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2.5.2.1  Drying Polyacrylamide Gels 
Following staining and destaining, the polyacrylamide gel was allowed to soak in water for a 
minimum of 30 minutes. A sheet of gel-drying film (VWR) of appropriate size was soaked in 
water and placed on the back of the gel-drying frame. Care was taken to remove any wrinkles 
and air bubbles forming between the frame and the film. The gel was then placed on the wet 
film in the centre of the gel-drying frame, again taking care to remove any air bubbles. A 
second sheet of gel-drying film was carefully placed on the gel, covering both the first 
membrane and the gel. Care was taken to exclude any air bubbles from between the sheets. 
The second frame was placed upon the first, and the frames held together with binder clips. 
Gels thus sandwiched in gel-drying film were air dried at room temperature for 24 hours. 
2.5.3 Western Blotting 
Protein blotting is an analytical method that involves the immobilization of proteins on 
membranes before detection using monoclonal or polyclonal antibodies. In this study anti-His 
Western blotting was used to confirm the presence of His-tagged recombinantly expressed 
protein in cell lysate.  
The samples to be tested were run on an SDS-polyacrylamide gel, as described in Section 
2.4.5.1. Once the gel was run, the proteins separated on the gels were transferred to an 
Amersham Hybond™-P, Hydrophobic polyvinylidene difluoride (PVDF) membrane. In order to 
do this, the gel was first placed in a container with 50 ml Transfer Buffer, along with blotting 
paper and the membrane both cut to the same dimensions as the polyacrylamide gel. After 10 
minutes, a so-called ‘transfer sandwich’ was assembled on the surface of a Bio-Rad Trans-Blot 
SD Semi-Dry Electrophoretic Transfer Cell in the following order: 1. blotting paper, 2. 
membrane, 3. polyacrylamide gel. A roller was used to roll over the sandwich and remove any 
trapped air bubbles. A few mls of Transfer Buffer was applied to the top of the sandwich to 
avoid drying out during the transfer. The Transfer Cell was set to 14 V for 60 minutes to 
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complete the blotting of proteins onto the membrane. After the transfer, the membrane was 
placed in a small container with 50 ml blocking solution, and left at ambient temperature with 
gentle shaking overnight.  
The solution was decanted and discarded, and replaced with blocking solution containing a 1: 
3000 dilution of rabbit anti-His antibody. This was left for 1 hour at room temperature with 
gentle shaking.  The antibody/buffer was decanted and discarded.  The membrane was washed 
with 20-30 ml of wash buffer for 5 minutes at ambient temperature with gentle mixing. The 
wash buffer was discarded, and the wash step repeated two additional times. 
The secondary antibody, mouse anti-rabbit IgG, conjugated with alkaline phosphatiae was 
diluted in blocking solution according to the manufacturer’s recommendation. This 
antibody/buffer mixture was poured into the container with the membrane and incubated for 
1 hour at ambient temperature with gentle mixing. 
The membrane was once again washed as described above, and finally developed with 3 x 
SigmaFast  (B5655)  tablets  dissolved  in  25  ml  H2O  and incubated at room temperature for 
30 minutes. These tablets comprise a precipitating substrate for the detection of alkaline 
phosphatase activity. 
2.5.4 Electrospray Mass Spectrometry 
This technique allows for large, non-volatile molecules to be analyzed directly from the liquid 
phase. It was used in this study to determine the molecular mass of protein molecules. 
In electrospray mass spectrometry, the sample is dissolved in a polar, volatile solvent and 
pumped through a narrow, stainless steel capillary (diameter 75 - 150 µm) at a flow rate of 
between 1 µL/min and 1 ml/min (Yamashita and Fenn, 1984). The capillary sits within the 
ionisation source of the mass spectrometer. A voltage of 3 or 4 kV is applied to the tip of the 
capillary and as a consequence of this strong electric field, the sample emerging from the tip is 
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dispersed into an aerosol of highly charged droplets, a process that is aided by nebulising gas 
flowing around the outside of the capillary. This gas, usually nitrogen, helps to direct the spray 
emerging from the capillary tip towards the mass spectrometer and diminish the size of the 
charged droplets by evaporation. In this case an ion trap system was used, where eventually 
charged sample ions, free from solvent, are released from the droplets and separated 
according to their mass (m) -to-charge (z) ratios (m/z) . The separated ions are detected and 
this signal sent to a data system where the m/z ratios are stored together with their relative 
abundance, and presented as a m/z spectrum.  The analyser and detector of the mass 
spectrometer are maintained under high vacuum to allow the ions to travel across the 
instrument without any hindrance from air molecules.  
2.5.4.1 Analysis of Mass Spectra 
The molecular mass of the sample can be deciphered from the m/z peaks on the spectrum, 
using the following relationship: 
m/z = (MW + nH+)/n 
where m/z = the mass-to-charge ratio marked on the abscissa of the spectrum; 
MW = the molecular mass of the sample 
n = the integer number of charges on the ions 
H = the mass of a proton = 1.008 Da. 
 Proteins and peptides were analysed under positive ionisation mode, where 0.1 % formic acid 
was added to aid protonation of the sample molecules. 
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2.5.4.2 Experimental Setup 
Protein samples to be analysed were first dialysed against 0.5 mM ammonium bicarbonate 
solution, and subsequently diluted to 10 µM.  These samples were then acidified by addition of 
formic acid to 0.1 % v/v and methanol to 10% v/v. Samples were applied at flow rates of 3–5 
µl/minute to a Agilent MSD ion-trap mass spectrometer. Mass accuracy was expected to be 2–
3 Da (1/10,000). Predicted molecular weights for proteins were calculated using ProtParam 
(EBI).  
 
2.5.5 Circular Dichroism (CD) 
Light in the form of waves in space is said to be linearly polarised because the electric field 
vector oscillates only in one plane, similar to a sine wave. If light is composed of two plane 
waves of equal amplitude differing in phase by 90°, then the light is said to be circularly 
polarized. The electric field vector rotates about the direction of propagation, forming a helix. 
The differences are illustrated in Figure 2.7. 
 
 
Figure 2.7: Linear and ‘circular’ polarised light (Fick et al., 2008).  Left: Linear polarised light- the electric field 
oscillates only in one plane. Right: Circular polarised light- the light is composed of two plane waves that differ in 
phase by 90 °. 
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If the circularly polarised light propagates forming a left-handed helix, it is known as left-
handed circularly polarised light and conversely for a right-handed helix. 
CD is the differential absorption of left- and right-handed circularly polarized light. The 
difference in absorbance of the left-handed (EL) and right-handed (ER) circularly polarized light 
is defined as:  
DE = EL – ER.  
In this equation, EL and ER are the molecular extinction coefficients for the right and left 
circularly polarized beams of light. 
To show CD, a molecule must be chiral and contain a chromophore. Such molecules, proteins 
for example, interact differently with left- and right-handed circularly polarized light. It has 
been shown that CD spectra between 260 and approximately 180 nm can be analyzed to 
detect different protein secondary structures: α- helix, parallel and anti-parallel β- sheet, turn, 
and other, each having a characteristic CD spectrum, illustrated in Figure 2.8. 
3  
Figure 2.8: Characteristic CD spectra for different protein secondary structures  (Fasman, 1996, C and J, 2001) .  
The red spectrum represents alpha helical secondary structure, The green spectrum is typical for that expected 
from beta-sheet. The blue spectrum is characteristic for unordered secondary structure. 
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The amount of the different secondary structure elements present in a protein of interest can 
be obtained by fitting its CD spectrum to a set of known reference spectra. Some 
deconvolution programs used to do this, such as the one used in this investigation, are 
available on the web.  
2.5.5.1 Determination of Protein Secondary Structure Using CD 
A Chirascan™ Circular Dichroism (CD) Spectrometer (Applied Photophysics) was used to obtain 
CD spectra for the proteins of interest in this investigation. The spectrometer was connected 
to a personal computer running Chirascan™ Windows software. A Peltier unit was used to 
control sample temperature during CD scans. 
The protein samples under investigation were dialysed overnight at 4 °C against 5 mM sodium 
phosphate buffer at pH 7.4. For tropomyosins, each sample was also dialysed against 5 mM 
phosphate buffer with 500 mM NaCl.  After dialysis, the concentration of each sample was 
adjusted to 0.5 mg/ml.  The CD spectrometer was programmed to measure CD at 0.5 nm 
intervals from 200 nm to 270 nm in samples containing 500 mM NaCl, and from 180 nm to 270 
nm in samples without salt, for 3 seconds per point. Initial temperature was set to 10 °C. Each 
scan was repeated in triplicate to be averaged for increased accuracy. Before measuring the 
CD of the samples, the CD of the buffer was measured, and subsequently used as a baseline. A 
quartz cuvette with 1 mm path-length was used.  
2.5.5.2 Determining Thermal Stability of Proteins using CD 
The thermostability of the protein of interest was determined by constantly increasing the 
temperature of the sample and measuring the change in CD at 222 nm.  The change in CD at 
222 nm specifically reflects change in the alpha helical content of the protein being heated. 
The Peltier was programmed to ramp the temperature from 10 °C to 60 °C at 5 °C intervals, 
with a 2 minute hold at each temperature before the CD measurement was taken (this was to 
allow the temperature of the sample to equilibrate).  
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2.5.5.3 Deconvoluting CD Data  
Direct CD measurements ( , in mdeg) were converted to molar ellipticity, (M-1 cm-1) using 
the relationship  =  / (33,000 × c × l), where c is the concentration in M and l is the path 
length in cm. Data were averaged, smoothed and baseline corrected using Chirascan software.  
Raw data were also uploaded to DICHROWEB (Whitmore and Wallace, 2008, Whitmore and 
Wallace, 2004b) for analysis. DICHROWEB is an internet-based deconvolution programme (K et 
al., 2005), which interprets CD spectra, providing predictions of proportions of each secondary 
structure characteristic present.  
2.5.6  UV/Vis 
2.5.6.1 Protein Concentration Determination 
Proteins absorb light at 280 nm, primarily due to constituent aromatic amino acids. The 
theoretical extinction coefficient of the protein can be determined from its sequence. The 
concentration of a protein sample of known absorbance and extinction coefficient can be 
determined by exploiting the relationship between these parameters, described by Equation 
2.1. 
 A = .c.l 
Where A = Absorbance at 280 nm,  = extinction coefficient, l = path length, and c = molar 
concentration. In this study, the ProtParam tool (Jack et al., 2008) on the ExPaSy server was 
used to calculate extinction coefficients. 
2.5.7 Dynamic Light Scattering 
Particles, emulsions and molecules in suspension undergo Brownian motion. This motion is 
induced by the collision of solvent molecules that themselves are moving due to their thermal 
energy. 
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If the particles or molecules are illuminated with a laser, the intensity of the scattered light 
fluctuates at a rate that is dependent upon the size of the particles. This is because smaller 
particles travel further on collision by solvent molecules, and thus move more rapidly. Analysis 
of these intensity fluctuations yields the velocity of the Brownian motion and hence the 
particle size using the Stokes-Einstein relationship. 
The diameter that is measured in Dynamic Light Scattering is called the hydrodynamic 
diameter and refers to how a particle diffuses within a fluid. The diameter obtained by this 
technique is that of a sphere that has the same translational diffusion coefficient as the 
particle being measured.  
The translational diffusion coefficient will depend not only on the size of the particle “core”, 
but also on any surface structure. DLS can thus be used to determine the size distribution 
profile, and hence stability and aggregation state of macromolecules in solution (Baldwin et 
al., 2002). A modern DLS setup is illustrated in Figure 2.9 below. 
 
Figure 2.9: Schematic DLS setup (Dresing and B, 2001).  The particles in solution are illuminated by laser light. Light 
scattered by the particles is detected, and the information converted to particle size distribution using the Stokes-
Einstein relationship. 
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In this investigation DLS was one of the techniques used to determine the aggregation state 
of the protein Nat3p in solution, and to monitor the effects of varying experimental 
conditions in order to enhance its solubility. 
2.5.7.1 Experimental Setup 
The method of using the DLS was described in the User Manual for the DynaPro Molecular 
Sizing Instrument and DYNAMICS V6 Software. 
DLS is quite sensitive to large particles such as dust, therefore everything was cleaned so that 
dust particles were removed. The protein sample was also filtered using a 0.02-μm filter 
membrane. A cuvette with volume ~45 μl was used. It was washed with 1 % (v/v) Triton X100 
(detergent) and the surface wiped using lens tissue. Protein samples at concentrations of  
2 mg/ml were used for analysis. Results were collected over a number of 10-second exposures 
and the overall data analysed using the DYNAMICS V6 Software.   
2.5.8 Protein Crystallisation 
The function of a protein is highly related to its three-dimensional structure. The structure-
based study of proteins is therefore an important approach in the investigation of protein 
function.  X-ray crystallography is the most powerful method to obtain a 3-D structure of a 
protein, as it allows visualisation of molecular structures at atomic resolution. 
The first step in X-ray crystallography is the generation of a protein crystal. To achieve this, a 
supersaturated protein solution is used and the solubility of the protein in that solution 
gradually lowered using a precipitant. In most cases this will result in aggregation of the 
protein. In a few cases, however, a small number of molecules will form a regular 
arrangement. This is known as a nucleation event. Following nucleation, the effective 
concentration of protein in solution falls and, if conditions are favourable, further molecules 
will join this arrangement in three dimensions. This step is known as crystal growth. Figure 
2.10 illustrates the relationship between protein concentration, solubility and nucleation 
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Figure 2.10: Crystallisation phase diagram. As precipitant concentration increases, protein enters the nucleation 
zone. Once nucleation occurs, soluble protein concentration lowers and the system therefore enters the crystal 
growth zone (Giege and Ducruix, 1999). 
  
Once crystals have been obtained, in order to achieve atomic resolution of around 1 to 1.5 Å, 
X-rays- with a wavelength of 1 Å- are used. However, since there is no way to focus X-rays, 
direct visualisation of an X-ray image is not possible. To circumvent this problem information is 
obtained through the diffraction pattern of X-rays. It is possible to translate the information 
from a diffraction pattern into atomic structure using Bragg’s Law, which predicts the angle of 
reflection of any diffracted beam from specific atomic planes. 
 X-ray diffraction from a single protein molecule would be indistinguishable from background 
noise, and indeed a single molecule of protein would incur vast amounts of damage from an X-
ray beam. However, by measuring diffraction from an ordered crystal of protein molecules, 
sufficient detectable diffraction can be observed, and damage to a small population of 
molecules can be tolerated.  
As only crystal trials were reached in this study, further detail regarding solving of the protein 
structure from diffraction data is beyond the scope of this study. 
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2.5.8.1 Experimental Setup 
The most common setup to grow protein crystals, and the method used in this study, is the so 
called ‘hanging drop technique’. Crystal Screen and Crystal Screen 2 from Hampton Research 
were used for initial screening with a wide range of precipitants.  Two microlitres of protein 
solution (of 2 - 6 mg ml-1 concentration) were mixed with an equal volume of precipitant, on a 
siliconised glass cover-slip. The cover-slip was then inverted over a well in a 24-well crystal 
tray, containing 500 μl of the precipitant solution. This set up is illustrated in  
Figure 2.11 below. 
 
Figure 2.11: The Hanging Drop method. 500μl of a precipitant reservoir solution is added to a crystal tray well. 2 μl 
of concentrated protein solution is mixed with 2 μl of the reservoir solution in a drop on a glass cover-slip. The 
cover-slip is then inverted over the reservoir solution and the tray incubated at 19°C. (Adapted from Schneider et 
al., 2008). 
 
Silicon vacuum grease was applied to the edge of the reservoir well to ensure sufficient 
sealing. As discussed, since the protein/precipitant mixture in the drop is less concentrated 
than the reservoir solution, water evaporates from the drop into the reservoir. The 
concentration of both protein and precipitant in the drop slowly increases, and crystals may 
form.  It is important to ensure all vibrations are kept to a minimum and temperature 
fluctuations are avoided during crystal growth, therefore a dedicated constant temperature 
crystal room at 19 °C was used for incubations. 
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2.6  Biophysical Methods 
2.6.1 Actin Co-sedimentation Assay 
The actin co-sedimentation assay is an in vitro assay routinely used to analyze the binding of 
specific proteins or protein domains with F-actin. The basic principles of the assay involve 
incubation of the protein of interest (full length or domain of) with F-actin and an 
ultracentrifugation step to pellet F-actin. Finally the pellet is analysed for the protein co-
sedimenting with F-actin, and the supernatant for unbound protein by SDS-PAGE. Actin co-
sedimentation assays can be designed accordingly to directly measure actin binding affinities 
and also in competition assays against a known binding protein. In this investigation the 
affinities of N.crassa Tms for actin were determined using co-sedimentation assays. 
2.6.1.1 Experimental Setup 
In a final volume of 100 µL, 10 µM actin was mixed with increasing concentrations of Tm (0.5 
µM, 1.0 µM, 1.5 µM, 2.0 µM, 3.0 µM, 4.0 µM and 5.0 µM) in cosedimentation buffer. The 
mixture was allowed to incubate at room temperature for 20 minutes, and the actin, along 
with any bound Tm, was pelleted by ultracentrifugation at 100,000 x g  for 20 min (Beckman 
Instruments TLA-100.1). Equivalent samples of pellet and supernatant were then separated by 
SDS-PAGE (2.4.5).  
2.6.1.2 Quantification of protein bands 
For quantification of the protein in each band, the absorbance of the bands needed to be 
measured. This was done by first scanning the gel (using an Epson Perfection 4990 Photo 
scanner). The scanned image measures the transmittance of the gel. In order to convert this 
transmittance to absorbance, a calibrated optical density step tablet (Agfatrans neutral density 
step tablet by Agfa) was also scanned alongside the gel, as shown in Figure 2.12. The scanned 
image was saved as a TIFF file.  
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Figure 2.12: A scanned image of an SDS gel to be quantified Above the gel is a calibrated neutral density step 
tablet. The known absorbances of each step in the tablet were used to calculate the absorbance values for each 
protein band 
 
The scanned image was opened using the program ImageJ. The steps taken to calibrate the 
image are illustrated in Figure 2.13: The mean transmittance of each step was first measured 
(A); these values were listed alongside the known absorbance values for each step in a results 
box (B); these data were used to generate a calibration curve based on the ‘Rodbard’ function 
(C). The Rodbard function is an exponential function with an additional slope to correct for 
background errors. 
Once the images were calibrated, and transmittance converted to absorbance, the absorbance 
values of the actin and Tm bands in both the pellets and the supernatants were measured. 
These data were fitted to the Hill equation using Origin® 7 (MicroCal), to determine the affinity 
of crTms for actin. 
The Hill equation is used to describe cooperativity.  
 
(1) 
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where [TM] is the concentration of free tropomyosin in the sample, ν is the observed TM/actin 
density ratio at [TM], n is the maximal TM/actin density ratio, Kdapp (apparent equilibrium 
constant), at which concentration 50 % of TM is bound to actin, and H is the Hill coefficient. It 
is used to describe Tm binding to actin as this is a polymerization reaction, which is 
cooperative in nature. 
 
Figure 2.13: Calibration of a scanned image of an SDS-gel with an optical density step tablet. A: measuring the 
grey value of each step; B: results showing measured grey values of each step and corresponding ODs; C: calibration 
curve using the data in B fit using the Rodbard function 
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 was carried out using an Epson 4990 Photo scanner with a transparency adaptor attached to a 
PC. Scanned images were analyzed using ImageJ, a Java-based image processing program 
developed at the National Institute of Health (Rasband, 1997 - 2009). 
2.6.2 Inorganic Phosphate Assay 
Phosphate assays are important for assaying a number of biochemical reactions involving both 
inorganic phosphate, as well as organic phosphoesters. In this investigation, this assay was 
used to determine the rate of ATP turnover by acto-myosin ATPase, and to determine the 
regulatory effects on this rate of tropomyosins isolated from N. crassa.  
The colorimetric determination of phosphate typically involves the interaction between 
phosphate and molybdate, with reducing agents and/or dyes to produce a coloured complex 
that can be easily monitored (Cogan et al., 1999). In this investigation the phosphate reacts 
with an acid solution of ammonium molybdate, to produce an anion, which is then reduced by 
ascorbic acid to form the bluecoloured product. The amount of the blue-coloured ion 
produced is proportional to the amount of phosphate present. The colour development is then 
stopped by the introduction of citrate to complex excess molybdate, and the absorbance can 
be determined (Gawronski and Benson, 2004). 
2.6.2.1  Experimental Setup 
The experimental setup utilised 96-well micro-titre plates to allow for increased speed, 
accuracy and reproducibility of the assay. The system was first optimised for reproducibility 
and tolerance to ATP by using standard solutions in the presence and absence of ATP. A 100 
mM stock solution of potassium phosphate, standard solutions of 50 µM, 100 µM, 200 µM, 
500 µM, 1 mM, 2 mM and 10 mM were prepared by serial dilution. 
Using a multi-channel pipette (Eppendorf), 150 µl Solution A was aliquoted into the wells of 
the micro-titre plate. Solution A contains molybdate in a highly acidic solution. The molybdate 
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complexes inorganic phosphate causing a colour change and the acidic solution ensures the 
termination of any enzymic reaction by inactivating the enzyme. 
50 µl of each standard, and water as a ‘zero phosphate’ sample, was added to a well 
containing the Solution A. The colour was allowed to develop for exactly five minutes, after 
which time 100 µl of Solution B was added to the wells to stop the colour development. The 
samples were then stable for up to 3 hours, and the absorbance at 610 nm was measured 
within this time period using a plate reader (Tecan Sunrise). The data were used to produce a 
standard curve of absorbance at 610 nm. 
Once the assay was seen to be successful using phosphate standard solutions, and to be 
accurate even in the presence of ATP, it was used to assay the phosphate turnover rate of 
myosin S1 ATPase, and its regulation by N. crassa Tms. 50-µl volumes of each reaction solution 
were added to the appropriate wells on the micro-titre plate (containing Solution A) at suitable 
time intervals to stop the reaction, and allow the colour to develop.  As with the standards, the 
colour development was stopped after exactly 5 minutes by the addition of 100 µl Solution B. 
The amount of phosphate present at each time point for each reaction was then quantified by 
measuring absorbance at 610 nm, and using the standard curve to convert absorbance to 
concentration.  
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2.7 Cell Biology Methods 
2.7.1 Growth of S. cerevisiae 
In this study WT, NAT3Δ and TPM1Δ S. cerevisiae, were transformed with yeast episomal 
plasmid Yep-512N. Under the control of the inducible yeast GAL10 promoter, the cells 
expressed the respective proteins during growth on galactose. The consequences of 
complementation on cell growth, size and morphology were then monitored to determine the 
effects of these genes on the deletion mutants. Between 85 – 90 % of Yep plasmids will still 
contain the plasmid when grown for 15 – 20 generations in non-selective media. All yeast work 
was thus carried out in complete medium supplemented with 3 % galactose. 
Yeast cells were routinely grown in a shaker incubated at 30 °C in YP medium supplemented 
with 3 % galactose as a carbon source. Cells from a single colony or glycerol stock scraping 
were allowed to grow overnight in 5 ml of medium. This resulted in a culture with an OD600 of 
about 1.0 – 1.2. 100 µl of this overnight culture was used to inoculate 5 ml of fresh medium 
(resulting in a culture of OD600 of about 0.1), and the cells allowed to grow for 3 to 4 hours until 
they reached log phase, determined by an OD600 of 0.4 - 0.6. At this stage, the cells were either 
stained for subsequent microscopy analysis (Sections 2.7.3 and 2.7.4), or used in growth assays 
(Section 2.7.2). 
2.7.2 Temperature Sensitivity Dot Blots 
NAT3Δ and TPM1Δ cells have been previously shown to be temperature sensitive, exhibiting 
slower growth at 37 °C than at 30 °C. In order to test whether the over-expression of certain 
genes can correct for this defective phenotype, the difference in growth rate between each of 
the strains at 37 °C over time was assayed. Cells were grown on medium containing glucose as 
a carbon source when over-expression was to be repressed, and  galactose to induce over-
expression of cloned genes. Once in log phase, each yeast culture was diluted to an OD600 of 
0.1.  The cultures were further diluted 10-, 100,- 1000- and 10, 000- fold. 2 µl of the serial 
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dilution of each yeast culture was dropped on the solid medium. The plate was produced in 
duplicate, with one being incubated at 30 °C and the second at 37 °C for 3 – 6 days.  
2.7.3 Staining Actin within S. cerevisiae with Rhodamine-Phalloidin 
To visualize actin cortical patches and actin fibres within S. cerevisiae, the cells were harvested 
in log phase, fixed and stained with rhodamine-phalloidin. Phalloidin is a heptapeptide toxin 
from the poisonous mushroom Amanita phalloides. It binds tightly and specifically to 
polymerized actin, stabilizing the filaments from a variety of depolymerizing agents and 
conditions (Wieland and Faulstich, 1978). In rhodamine-pPhalloidin,phalloidin is conjugated to 
tetramethylrhodamine (TRITC), an orange-fluorescent dye with excitation/emission 554/573 
nm to enable visualisation in the fluorescence microscope. 
0.5 – 1 ml of yeast cells in log phase were centrifuged for 30 seconds at 10,000 x g The 
supernatants were decanted, and the pellets resuspended in 50 µl sterile PBS, and 50 µl 4% 
paraforamldehyde (PFA). The cells were left shaking at room temperature for 45 minutes. The 
fixed cells were then centrifuged once more at 10, 000 x g for 30 seconds, and the supernatant 
discarded. The pellets were washed in 200 µl sterile PBS x 3, and then resuspended in 25 µl 
sterile PBS with 1% Triton x 100 to permeabilise the cells. Finally, rhodamine-phalloidin, 
dissolved in methanol, was added to a final concentration of 3.3 µM. The cells were left 
shaking at room temperature, in the dark, for 1 hour. Subsequently, the cells were harvested, 
and the pellets washed in sterile PBS x 3 as before. The washed pellets were resuspended in 25 
µl sterile PBS.  
To mount on slides, 2 µl of fixed, stained cells were placed on a microscope slide. A drop of 
VECTASHIELD® Mounting Medium with DAPI from Vector Laboratories was added to prevent 
photo-bleaching of rhodamine, and counter-stain with DAPI.  DAPI or 4',6-diamidino-2-
phenylindole is a fluorescent stain that binds strongly to DNA, with excitation/emission 
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353/475 nm for visualisation  in a fluorescence microscope. A cover-slip was placed over the 
drop, and the edges sealed with nail varnish.   
2.7.4 Cellular Imaging  
Once each S. cerevisiae strain under investigation was grown under appropriate conditions to 
the desired growth phase, and fixed and stained, various phenotypes were analysed. 
Fluorescence microscopy was used to analyse the actin cytoskeleton and nuclear material 
within the cells (stained with rhodamine-lphalloidin and DAPI respectively). Optical microscopy 
was used to analyse the size and morphology of the cells. 
2.7.4.1  Fluorescence Microscopy 
2.7.4.1.1 Experimental setup 
A Leica TCS 4D fluorescence microscope was used to view the stained yeast cells. The filters 
used to observe the red fluorescence emitted by rhodamine-phalloidin and the blue 
fluorescence emitted by DAPI, were Cy3 and DAPI filters respectively. The yeast cells were 
observed at a magnification of 1000 x (100 x NA 1.4 oil immersion), and images captured using 
an Orca (Hamamtsu, Japan) digital camera which was integrated within the system. 
2.7.4.2  Optical Microscopy 
To analyse cell size and morphology, cells were observed under 500 x magnification using an 
Olympus BX51 Research Microscope. Cell images were captured using a JVC digital camera 
integrated with the microscope. These images were saved in .TIFF format and analysed 
subsequently using the program ImageJ, as described in detail in Chapter 5. 
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3 N. crassa Tropomyosin: Isolation, Expression, 
Purification and Characterisation  
3.1 Introduction 
This chapter deals with the identification, isolation and characterization of novel tropomyosins 
from N. crassa. Originally identified from a database search, EST sequences of these Tms 
revealed that they were the result of alternative splicing from a single gene- a phenomenon 
that has not previously been reported for yeast Tms.  In addition to this, the sizes of the two N. 
crassa Tms (henceforth referred to as crTms) are 161 and 123 residues (crTm161 and crTm123 
respectively), making the latter the smallest naturally occurring Tm to date, and similar in size 
to Tm1d23, which has been shown to display anomalous regulation of S1-actin binding.  
This chapter focuses first on the isolation of the N. crassa Tm cDNA, and the expression and 
purification of crTm123p and crTm161p. This is followed by biochemical and biophysical 
characterization of the novel crTms in terms of actin-binding affinity and S1 regulation. Finally 
preliminary crystallization data for both crTms are described as a step towards acquiring 
structural information. In light of the overview given, by characterizing these novel Tms at a 
molecular level, this chapter adds to existing knowledge on non-muscle Tms. In addition, the 
study of the smallest naturally occurring Tm will give insight into potential connections 
between Tm size and function.  Understanding the roles of Tm in simple model organisms and 
how it has evolved may also aid us in understanding the evolution of cytoskeletal function in 
higher eukaryotes.  
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3.2 Results 
3.2.1 Identification of N. crassa Tms 
In order to learn more about the role of Tms in regulation of the cytoskeleton, it was decided 
to investigate and biochemically characterize as simple a Tm as possible. In order to do this, a 
BLAST search was conducted for regions of similarity between the S. cerevisiae Tpm1p and 
other fungal protein sequences. What resulted was a large number of hits, the majority of 
which were 161 amino acid residues in length. This length corresponds to the length of yeast 
Tpm2p, which spans 4 actin monomers and was, until this point, the smallest naturally 
occurring Tm that had been characterized. The BLAST search showed that like many other 
fungi, the orange bread mould N. crassa too had a 161-residue putative Tm (henceforth 
referred to as crTm161p). However, an additional N.crassa hit was a 123-residue Tm-related 
protein- potentially. This was an exciting discovery as a Tm of this size would be exactly the 
right length to span 3 actin monomers , making it potentially the smallest naturally occurring 
Tm identified to date. This protein will be referred to as crTm123p.   
As this phenomenon has not previously been reported in fungal Tms, to make sure that the 
smaller protein was not a truncation of the 161 residue Tm, it was decided to search for 
Expressed Sequence Tag (EST) of N. crassa Tms from Cogeme (Gabel et al., 2008), a database 
containing ESTs from eighteen species of plant pathogenic fungi, two species of 
phytopathogenic oomycete and three species of saprophytic fungi.) ESTs are short (200–800 
nucleotide bases in length), unedited, randomly selected sequence reads derived from cDNA 
libraries of organisms. The EST search resulted in two hits for N.crassa Tms. The cDNA 
sequences corresponded to the 123-residue and the 161-residue Tms found during the BLAST 
search. An alignment of the two cDNA sequences showed that they were indeed alternately 
spliced from a single gene. Figure 3.1 shows an amino acid sequence of these Tms.  
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Figure 3.1: cDNA (A) and protein (B) sequence alignment of both putative N. crassa Tms. The sequences for both, 
align perfectly aside from the region within the yellow box which is completely deleted in crTm123p. 
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3.2.1.1 RNA extraction, cDNA library construction and amplification of crTm123 and 
crTm161 
 
Once the potential Tms had been identified, primers were designed to amplify both cDNA 
transcripts from a cDNA library (primer pair 1,Table 2.5). As both transcripts were predicted to 
be spliced from a single gene, one pair or external primers would in theory amplify both 
transcripts. 
To create the cDNA library, total RNA was first isolated from N.crassa as described in Section 
2.3.1. This was then reverse transcribed (Section 2.3.2.1) to construct a cDNA library. Using 
primer pair 1 from Table 2.5, a PCR (Section 2.3.2.2) was used to amplify crTm cDNA from the 
cDNA library. Analytical agarose gel electrophoresis (section 2.2.2) of the PCR products 
confirmed the presence of two DNA bands, of approximate size 370 bp and 500 bp (Figure 
3.2). 
 
Figure 3.2: Products from a PCR of N.crassa cDNA using primers common for both crTms. This shows that the small 
isoforms is the minor isoform. 
 
These corresponded well with the predicted size of 123 and 161 amino acid residues 
respectively, for the two N. crassa Tm splice variants. The difference in intensities between the 
bands on the gel is an indication that the relative quantities of each isoform present in the 
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total RNA of N. crassa differ substantially. The smaller isoform is present in much lower 
concentrations. This may have some implications regarding the function of the two isoforms., 
similar to TPM1 and TPM2 in S. cerevisiae. 
3.2.1.2 Cloning crTm123 and crTm161 in pJC20 
 
To separate the two gene transcripts from each other, each DNA band was carefully excised 
from the gel and the DNA purified (Section 2.2.3). The purified DNA was digested with 
restriction enzymes Nde1 and BamH1 as described in Section 2.2.4, and ligated into E. 
coliexpression vector pJC20, which had also been treated with restriction endonucleases Nde1 
and BamH1 (Section 2.2.5). The ligation mixture was then used to transform E. coliXL1-Blue 
competent cells (Section 2.2.8.1), and a number of resultant colonies screened for presence of 
the insert using colony PCR (Section 2.2.1.2). Plasmid DNA was extracted from one or two 
colonies that screened positively (Section 2.2.9), and sequenced to confirm the successful 
cloning of pJC20-N. crassaTm123 and pJC20-N. crassaTm161.  
3.2.2 PCR to produce N-terminally modified crTm123 and crTm161 
Tms are unable to bind to actin without an essential acetylation at their N-terminus as detailed 
in the introduction to this chapter (Section 3.1). Since Tms produced recombinantly in E. 
coliare not post-translationally modified in this prokaryotic system, such Tms remain 
unacetylated, and non-functional. However, as also discussed in Section 3.1, it has been shown 
that a (Met)-Ala-Ser addition (where the Met is removed post-translationally leaving a 
dipeptide) at the N-terminus of unacetylated Tms mimics the effect of acetylation and restores 
function to levels comparable with native acetylated Tms (Monteiro et al., 1994).   
For this reason, additional crTm primers with the sequence coding for an Ala-Ser extension at 
the N-terminus of the crTms were also designed (primer pair 2,Table 2.5). crTm transcripts 
amplified using these primers would express protein that should have properties similar to the 
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presumably acetylated wild-type crTms. The AS-crTms should therefore bind to actin and could 
thus be further characterised. 
 The amplification from the cDNA library, subsequent DNA purification and cloning as 
described in sections 3.2.1 and 3.2.2 above was thus repeated, but using primer pair 2 
fromTable 2.5. The resulting clones, pJC20-N.crassaASTm123 and pJC20-N.crassaASTm161, 
were sequenced and found to contain the complete crTm123 and crTm161 cDNA sequence, 
respectively, in frame and with the addition of N-terminal codons for Met-Ala-Ser in each case. 
A gel of digested clones, both with and without the N-terminal modification, is below (Figure 
3.3) 
 
Figure 3.3: Clones of the two N.crassa Tm gene products showing their differing sizes. Clones were produced both 
with (Lanes 1 and 2) and without (Lanes 4 and 5) an N-terminal tripeptide extension ((Lander et al.){Met}-Ala-Ser) 
shown to mimic acetylation (post-translational cleavage of Met leaves Ala-Ser-). 
 
3.2.3 Recombinant Expression of crTm123, crASTm123, crTm161 and 
crASTm161 
The cloning of the N. crassa Tms (with and without Ala-Ser extensions) in pJC20 resulted in the 
creation of four new constructs (constructs 12, 13, 14 and 15, Table 2.2). E.coli-BL21-pLysS cells 
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were transformed with each new construct as detailed in Section 2.2.8.1. The cells were then 
grown and induced as detailed in Section 2.4.1.  
A 250 µl aliquot of cells was taken both pre- and post-induction in every case. These were 
subsequently analysed by SDS-gel electrophoresis (Section 2.5.1) to estimate the yield of 
recombinant protein expressed post-induction, compared with the pre-induction sample.   
Each aliquot was centrifuged, and the resulting pellet resuspended in 30 µl of water and 10 µl 
of sample denaturing buffer 4x. The samples were then heated at 95 °C for 4 minutes prior to 
loading and running the gel. The SDS-gel (shown in Figure 3.4) confirmed the presence of 
significant amounts of recombinantly expressed N.crassa Tms in the induced cells (Lanes 2 and 
4) when compared to the uninduced cells (Lanes 1 and 3). 
 
Figure 3.4: An SDS-PAGE gel showing protein expression of the crTms. Lanes 1 and 3 show proteins expressed from 
BL21 pLysS(DE3) cells harbouring the pJC20-crASTm161 and pJC20-crASTm123 constructs respectively prior to 
induction. Post-induction expression of crTm161p and crTm123p is represented in Lanes 2 and 4 respectively. All 
cultures with induced with 0.4 mM IPTG and left shaking overnight at 30 °C, prior to harvesting. 
 
3.2.4 Purification of N.crassa Tms 
The harvested cells were resuspended in Lysis Buffer and sonicated as described in Section 
2.4.2.1 to lyse the cells and release the cytosolic contents. Because Tms are known to be 
extremely thermostable, the lysed cells were then boiled for 10 minutes as an initial 
purification step in order to denature the majority of native E. coliproteins, leaving 
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recombinant Tms in solution. The boiled cells were allowed to cool on ice prior to 
centrifugation to separate soluble from insoluble components of the cells. Tm, in the soluble 
fraction, was further purified by iso-electric precipitation as detailed in section (2.4.2.1.2). SDS-
gel electrophoresis of the Tm at this stage showed almost completely pure Tm. However, A280 
and A260 measurements revealed the presence of large amounts of nucleic acid contamination 
(data not shown). This is likely the consequence of the high charge of Tm molecules in low salt 
conditions, causing them to attract charged nucleic acids, which also co- precipitate at pH 4.6 
along with the Tms in the second purification step. 
This nucleic acid contamination was removed by anion exchange chromatography using a 
Resource Q column, as described in Section 2.4.2.1.3. A280 traces, used to assess protein purity 
and nucleic acid contamination, were very similar for all N. crassa Tms and ASTms. An example 
trace is illustrated in Figure 3.5.  
 
Figure 3.5: A typical trace from an anion-exchange purification of N. crassa Tm. The green line represents the 
gradient of NaCl applied to the column. The gradient goes from 0 – 40 % NaCl over 50 ml, and then up to 100 % 
NaCl for the final wash. The blue line represents A280, and therefore Tm concentration. The Tm is seen to elute at 
around 20 – 30 % NaCl. Fractions beneath the peak were pooled and analysed via SDS-PAGE. 
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Very high A280 during loading of the column is due to flow through of mainly nucleic acid 
contamination. Very high A280 was also observed at 100 % B, at the end of the FPLC program. 
This was as a result of further nucleic acid contamination, which had been separated from the 
Tm by anion exchange.  All fractions corresponding to the peak at ~20 % B were analysed for 
protein content using SDS-gel electrophoresis, and found to contain purified Tm as illustrated 
in Figure 3.6. Lanes 1 and 2 in this Figure contain bands for crASTm161p and crTm161p, 
respectively. Lanes 3 and 4 contain bands for crASTm123p and crTm123p respectively.   
 
Figure 3.6: SDS-PAGE gels showing N.crassa Tms after purification. Lanes 1 to 4 respectively: Purified crASTm161p, 
crTm161p, crASTm123p and crTm123p 
 
In some cases, one cycle of anion exchange chromatography was insufficient to remove all 
nucleic acid contamination as measured by the UV-absorbance spectrum. In such cases, eluted 
fractions containing Tm from the first round of anion exchange chromatography were pooled, 
diluted x3 in 5 mM phosphate buffer, pH 7.4, and reloaded on to the Resource Q column to be 
purified as before. Once again, fractions corresponding to the ~20% B peak were pooled. The 
A260 and A280 were measured to ensure the removal of nucleic acid contamination, and SDS-
PAGE was used to ensure the absence of protein contaminants.  The purified protein was 
pooled and protein concentration determined from the A280 using an extinction coefficient for 
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crTms, which was calculated to be 8480 M-1 cm-1 (Section 2.5.7).  In each case the concentration 
was found to be in the range of 150 µM giving an approximate yield of over 10 mg of protein 
per litre of culture. The yield of protein in each case was similar and approximately 5 – 10 ml of 
Tm at 70 – 150 µM per litre of culture was obtained. The purified protein was then divided into 
200 µL aliquots and stored at -20 °C. The frozen Tms were quick-thawed under running tap 
water when required. 
3.2.4.1 Mass Spectrometry to verify purified Tms 
 
Electrospray mass spectrometry (Described in Section 2.5.5) was used to confirm, by 
determining their molecular mass, the identity of the purified crTms (data not shown). Prior to 
being loaded onto the mass spectrometer, each protein was diluted to a concentration of 10 
µM. These samples were then acidified by addition of formic acid to 1 % v/v and methanol to 
10 % v/v.  
3.2.5 Characterisation of N.crassa Tms 
Once the crTms had been successfully expressed and purified, they were characterised in 
terms of binding to actin, interaction with myosin S1, and their regulation of S1 ATPase. 
 
3.2.5.1 Actin-Binding Affinity Using Cosedimentation Assays 
 
The actin-binding affinity of Tms is measured using cosedimentation assays. In these assays 
actin and Tm in solution are mixed together and allowed to interact. After a period of time 
(usually 20 to 30 min), the protein mixture is centrifuged in an ultracentrifuge at 100, 000 x g 
for 20 min. At the speed, F-actin is pelleted, along with any bound Tm. Tm that is not bound to 
actin remains in solution, therefore allowing a simple quantification of bound versus free Tm.  
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Initial qualitative binding studies of the constructs were carried out by adding an excess of 
each of the crTms (~4 µM) to 10 µM F-actin, and visualising bound and free Tm on an SDS gel 
as described in Section 2.6.1.  
Once it was confirmed that the N. crassa ASTms bound to actin, the affinity of the binding in 
each case was quantified. This was done by repeating cosedimentations, but with varying 
concentrations of crTms in order to acquire a binding curve.  crTm concentrations used for 
these cosedimentations were: 0.2, 0.5, 0.1, 1.5, 2, 3, 4 µM. Actin concentration used was 10 
µM. Once again, equivalent samples of supernatant and pellet were separated by SDS-PAGE. 
The gels were run at least in duplicate, for increased statistical accuracy. Example gels are 
shown in Figure 3.7. 
 
Figure 3.7: SDS-PAGE gels showing cosedimentation of crTm 123 and crTm161 with actin. The gel shows 
supernatants and pellets from cosedimentations containing 10 µM actin and 0.2, 0.5, 1, 2, 3, 4 and 5 µM Tm, from 
right to left as shown by the arrows. 
 
The protein in each band was quanitifed as described in Section 2.6.1.2. Binding curves for 
both crASTm161p and crASTm123p were obtained using the cosedimentation data (Figure 
3.8). 
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Figure 3.8: Binding curves of crTm123 and crTm161 to actin. Determined by cosedimentation of increasing 
concentrations of Tm (0.25, 0.5, 1, 2, 3, 4, 5 µM) with 10 µM actin. The y-axis is plotted as ratio of the absorbance of 
the Tm/actin bands in the pellet. Curve fits using the Hill equation are shown as solid lines 
 
Both curves show that the binding of the Tms to actin is cooperative, as would be expected. 
Additional binding data for both crTms are listed in Table 3.1, which also lists binding data 
from other previously characterized Tms for comparison. 
Table 3.1: Binding data of Tms to actin 
 K50 (actin) Hill coeff Residues Stoichiometry 
skTm* 0.34 ± 0.02 3.24 ± 1.0 284 7 
yTpm1* 0.95 ± 0.02 4.8 ± 1.0 201 5 
crTm161 0.39 ± 0.05 3.0 ± 1.2 163 4 
crTm123 0.35 ± 0.02 3.9 ± 0.6 125 3 
   *(data for skTm and yTpm1 from Maytum R, Konrad M, Lehrer SS and Geeves, 
MA, 2001 (Maytum et al . ,  2001)) 
Half-saturation points (K50%) for crASTm161 and crASTm123 were determined as 0.39 and 0.35 
μM respectively (Table 3.1). Previous studies characterizing Tms have shown the affinity for 
actin to be within a similar range (～ 0.5 µM) for the majority of all functional Tms from yeast 
to man (Lees-Miller and Helfman, 1991, Liu and Bretscher, 1989b). Quantification shows the 
crTms also saturate at the same Tm/actin mass ratio seen for other Tms, confirming the 
111 
 
expected 1:4 and 1:3 Tm:actin binding stoichiometry for crASTm161p and crASTm123p 
respectively.  
3.2.5.2 Effect of Myosin S1 on N. crassa ASTm Affinity for Actin 
 
The regulatory properties of the N. crassa Tms were first investigated by observing the effects 
of S1 on the crTm affinity for actin. The binding affinity of Tm in the presence of increasing 
concentrations of S1 was analysed using cosedimentation assays. To do this, varying 
concentrations of S1 (1, 2, 4, 6, 8, 10 µM) were added to a constant concentration of actin (10 
µM) and crTm (5 µM), to a final volume of 200 µl. After incubating for 20 min, the reactions 
were centrifuged at 100, 000 x g for 20 min. and the supernatants and pellets analyzed by SDS-
PAGE (Figure 3.9). The gel was quantified as detailed previously.  
 
Figure 3.9: Cosedimentation of crTm161 and crTm123 with actin and excess of myosin S1. The gels show 
supernatants and pellets from cosedimentations containing 10 µM actin, 4 µM Tms and myosin S1 (1, 2, 4, 6, 8, 10 
µM, right to left, labelled: S1). Buffer conditions are the same as for Figure 3.7 
 
The gel shows that the intensity of the crTm bands in the pellets remains largely unchanged as 
the concentration of S1 is increased. This indicates that increasing the concentration if S1 has 
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little effect on the affinity of the crTms for actin.  Plotting staining ratio of the Tm and actin 
bands shows that in the presence of high concentrations of S1, the affinity is very slightly 
decreased (Figure 3.9). 
This result is comparable to that seen for other fungal Tms, where the presence of S1 resulted 
in a slight decrease in the affinity of yeast Tms for actin (Landis et al., 1999, Moraczewska et 
al., 1999).  
The behaviour of crTm123p in this respect does not agree with the behaviour of the other 
previously characterized ultra short Tm (Tm1d23p), whose affinity for actin was greatly 
diminished in the presence of S1 (as described in Section 3.1). Therefore, despite both Tms 
being identical in length, their regulatory properties differ significantly.  While Tm1d23p does 
not appear to be able to bind actin simultaneously with S1 (as explained in the Introduction), 
the shorter isoform of the N. crassa Tm appears to bind with almost unchanged affinity. If the 
explanation for Tm1d23p behaviours as described in Figure 1.12 is used, the difference in the 
behaviour of both ultra short Tms should be caused by differences in the Tm end-to-end 
interactions. As both these Tms have an Ala-Ser addition at their N-termini, sequence and 
structural differences at the C-terminus may have some role to play. Alternatively, more 
complex interactions than solely Tm end-to-end contacts may be involved in the regulation of 
these Tms.    
3.2.5.3 Tm crassa competitive binding to actin 
 
As N. crassa has two isoforms of Tm, it was of interest to characterise their interactions with 
each other in terms of actin binding to try and better understand whether, for instance, they 
are able to co-habit a single actin filament. This would give some insights into whether they 
potentially share the same function, or have individual roles within the cytoskeleton. 
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To determine if crTm123p and crTm161p could influence each other's F-actin-binding 
behaviour, cosedimentation assays were carried out using both proteins. In these experiments, 
the amount of one protein was held constant, and increasing amounts of the other protein 
were added. All reactions were carried out at identical buffer concentrations as with previous 
cosedimentations, and gels were also analysed as described previously. Figure 3.10 shows that 
the addition of increasing concentrations of crTm161p had little effect on the ability of 
crTm123p to bind F-actin, and that crASTm161p is unable to bind at the same time as 
crASTm123p, until its concentration reaches 4 µM. The concentration of crTm123p bound to 
actin (in the pellets) remains constant until this point, where it is slightly decreased. 
 
Figure 3.10: Cosedimentation of constant crTm123 in the presence of increasing crTm161.  The cosedimentation 
was carried out with 10 µM actin, 4 µM crTm123p and crTm161p at concentrations: 0.1, 0.25, 0.5, 1, 2, 3, and 4 
increasing from left to right as labelled by the arrows. The concentration of crTm161p in each lane is labelled at the 
top of each gel. 
 
In contrast, Figure 3.11 shows that the addition of increasing amounts of crTm123 to reactions 
containing crTm161 and F-actin showed that crTm123 had a negative effect on crTm161 
binding to F-actin.  
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Figure 3.11: Cosedimentation of constant crTm161 in the presence of increasing crTm123. The cosedimentation 
was carried out with 10 µM actin, 4 µM crTm161p and crTm123 at concentrations: 0.1, 0.25, 0.5, 1, 1.5, 2, 3, 4 and 5 
across both gels, increasing from left to right as labelled by the arrows. The concentration of crTm123p in each lane 
is labelled at the top of each gel. 
 
The molar ratio of crTm161p bound to actin appears to remain constant until the 
concentration of crTm123p reaches a critical point (2 µM in Figure 3.11), after which the 
crTm161p becomes displaced by the crTm123p. At this point crTm123p appears to compete 
with crTm161p binding to F-actin, suggesting that its interaction with the actin filament is 
stronger. 
The binding affinities of both crTms for actin are very similar (Table 3.1) suggesting that in a 
mixture of the two isoforms, the probability for either to bind to actin should be proportional 
to its relative concentration. This scenario is represented by the black line in Figure 3.12, 
where in a mixture of both crTms, crAStm161p binding to actin is simulated by: (crASTm161)= 
[crASTm161p]/([crTm161p + [crTm123p]. Actual experimental concentrations were used for 
this simulation. 
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Figure 3.12: Ratio of actin-bound to free Tm when crTm123 and crTm161 are both present. The black line 
represents what would be expected if both crTm isoforms bound to actin with equal probability. The red line 
represents the actual ratio of bound : free crTm123p in the presence of increasing concentrations of crTm161p, and 
the green line represents the measured ration of bound : free crTm161p, in the presence of increasing 
concentrations of crTm123p. Increasing concentrations are represented on the x-axis. The constant concentrations 
in both cases was 4 µM 
 
Also in Figure 3.12 is the actual measured experimental data, which does not at all agree with 
the simulation. Rather, the data indicate the presence of competition between the two crTms 
to bind to actin.  The green line represents the binding of crASTm161p in the presence of a 
constant concentration of crAStm123p. Conversely, the red line depicts the binding to actin of 
crASTm123p in the presence of a constant concentration of crASTm161p. In both cases, 
binding of the crTm appeared inhibited until a critical concentration is reached, after which 
point binding occurs when the competing crTm is displaced from the actin filament. This 
critical concentration is almost twice as high for crASTm161p (4 µM, Figure 3.12) as it is for 
crASTm123p (around 2 µM, Figure 3.12).  
Since, as previously mentioned, this apparent competition cannot be attributed to differences 
in actin binding affinity, a potential explanation is that the differences in size of the two Tms 
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somehow prevents them from inhabiting the same actin filament. A potential explanation is 
that any gaps in a Tm strand comprising one crTm isoform cannot be filled by the other crTm 
isoform.  That is to say, for instance, that crTm161p would be too long to fit in a gap left by a 
crTm123 molecule. While crTm123p would be able to fill a gap left by a crTm161p molecule, it 
would be too short to form Tm-Tm end-to-end interactions with both adjacent crTm161p 
molecules, greatly reducing the stability of the resultant strand (Figure 3.13). 
 
Figure 3.13: A proposal for why both crTm isoforms may not habitate a single actin filament. Due to the difference 
in size of the two isoforms, gaps in the crTm filament of one isoforms cannot be filled by the second isoform. 
 
However, details regarding the nature of polymerisation of Tm on actin filaments remain 
limited, and it is not know whether the presence of such ‘gaps’ in the filament occur. Further 
experiments with different isoforms of the same length would be required to test the 
soundness of this theory.  
If the two crTm isoforms cannot indeed coexist on a single actin filament, this would indicate a 
level of independence in their functions.  
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3.2.5.4 Inorganic Phosphate Assay to Measure the Regulation of the Myosin ATPase 
 
To investigate the regulatory effects of the N. crassa Tms on the acto-myosin subfragment 1 
(S1) Mg2+, its ATPase activity was measured in the presence of these Tms. To measure ATPase 
activity, it was decided to monitor moles of inorganic phosphate released. It was also decided 
to carry out the assay in 96-well micro-titre plates. Benefits of this format include: smaller 
reagent volumes and the ability to perform multiple sets of kinetic experiments in parallel 
resulting in shorter assay times and increased accuracy. 
 Most assays that have been developed to measure inorganic phosphate are typically 
colorimetric reactions, involving the interaction of phosphate, molybdate and reducing agents 
or dyes to produce a coloured complex (Cogan et al., 1999).  
The reduction of the phosphomolybdate complex in a strong acid solution results in a 
formation of “molybdenum blue.” Numerous assays for quantifying phosphate based on this 
reaction have been developed with varying sensitivities and applications, mainly by altering 
the nature of reducing agents. However, initial testing of some of these assays showed that in 
the presence of strong acids, the excess ATP required for the acto-S1 ATPase reaction, was 
hydrolysed, resulting in false results. Alternative assay conditions were thus needed. 
Through a further literature search, it was discovered that the use of ascorbic acid as the 
reducing agent resulted in a more sensitive assay (Lowry, 1981, Taussky and Shorr, 1953). 
Sensitivity was of great importance when developing an appropriate assay due to the small 
reaction volumes used in a micro-titre plate based assay.  In addition, the addition of citrate 
was seen to complex excess molybdate, this halting continued colour development from 
potential ATP hydrolysis (Baginski et al., 1967, Black and Jones, 1983). These findings had 
recently been integrated into an assay for detecting Pi in the presence of high ATP 
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concentrations (Gawronski and Benson, 2004). A minor adaptation of this assay (detailed in 
Section 2.6.2) was used in this study to monitor the activity of the acto-S1-ATPase.  
Each well in the micro-titre plate contained an independent reaction mixture of actin, Tm, S1 
and ATP as the substrate. The concentration of S1 was increased across wells, and any change 
in rate of the acto-S1 ATPase in each well could be observed by change in colour of the 
reaction mixture: the more intense the colour, the more phosphate was being released by the 
ATPase. This change in colour was quantified by measuring absorbance at a set wavelength in 
a plate reader. The results from the assay are shown graphically in Figure 3.14, which 
illustrates the dependence of the Mg2+ATPase on the concentration of S1 in the presence of 
tropomyosin at saturating concentrations of ATP. 
 
Figure 3.14: The effect of various Tms on the acto-S1 ATPase. The activity was monitored by measuring inorganic 
phosphate turnover. The reaction was carried out in assay buffer with 4 µM actin and increasing quantities of added 
S1 in the presence of:  F-actin (red line); F-actin +  2 µM skTm (green line);  F-actin + 2 µM crTm123p (aqua line);  F-
actin +2 µM crTm161p (blue line). Basal S1 ATPase rate is represented by the black line. 
 
 
The results for basal S1 ATPase rates, actin-activated S1 ATPase rates, and rates regulated by 
skTm were found to be comparable with previous data from literature ( 
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Figure 3.15) (Lehrer and Morris, 1982). 
 
Figure 3.15: Dual effect of skTm on the acto-S1 ATPase (Adapted from (Lehrer and Morris, 1982).  Open squares 
represent basal acto-S1 ATPase rate. Open circles represent the actin-activated acto-S1 ATPase rate, and closed 
squares represent the acto-S1 ATPase rate in the presence of skTm. 
Lehrer and Morris studied the effects of regulatory tropomyosin on the (S1) Mg2+-ATPase 
activity over a range of S1 concentrations (Lehrer and Morris, 1982). They found that at low 
actin concentration the specific activity was constant in the absence of tropomyosin. When 
tropomyosin was present, however, it was found to inhibit the ATPase activity at low [S1] and 
activate it at higher [S1], ( 
Figure 3.15). The inhibition increased toward 100 % when the [S1] approached zero (the green 
line in Figure 3.14 shows data generated in this study, which is in agreement with these 
previous results).   
According to Figure 3.14, the N. crassa Tms appear to have an inhibitory effect on the S1 
ATPase. However, unlike skTm, neither of the crTms appears to activate the S1 ATPase at the 
higher concentrations of S1 assayed in this study.  
A possible explanation for this is that vertebrate Tms bind cooperatively with S1, showing a 4 – 
7 fold increase in affinity. However, when yeast Tms are used in the same assays, measuring 
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regulation of skeletal myosin binding to skeletal actin, they show good regulation without this 
huge increase in Tm affinity to acto-S1 (Maytum et al., 2000, Maytum et al., 2001).  This 
explains why the ATPase rate in the presence of actin and skTm crosses the line representing 
actin-activated rate (Figure 3.14: The green line crosses the red line).  It can therefore be 
expected that a four-fold higher concentration of S1 would be required to activate the system 
in the presence of these fungal Tms.  
Figure 3.15, the cooperative switch is seen to take place at around 4 µM S1 for skTm. It then 
follows that a concentration in the region of 16 µM S1 would be required for the crTms to 
activate the system and it can thus be expected that at the S1 concentrations measured, their 
effect remains solely inhibitory. 
The level of inhibition of both crTms appears to differ, once again pointing to potentially 
independent roles for each protein. 
3.2.5.5 Circular Dichroism to Determine Secondary Structure 
 
The structure of a protein can give interesting insights into its roles. Circular dichroism 
provides an effective measure of the folding of proteins (See Section 2.5.6 for details).  CD 
spectra of the crTms at 20 °C are shown in Figure 3.16. Studies were performed in a high salt 
buffer (10 mM NaPO4 pH 7.0, 0.5 M NaCl) to prevent self-association of Tms. The spectra are 
virtually identical, showing the222 and 208 nm peaks characteristic of tropomyosins. This 
shows they have the same ellipticity with identical secondary structures and are all fully folded 
α-helical coiled-coils.  
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Figure 3.16: CD spectra of crTm123, crTm161, and  Ala-Ser crTm123 and c. Spectra were measured from 200 – 270 
nm in 10 mM phosphate, pH 7.0, 500mM NaCl. 
 
3.2.5.6 Circular Dichroism to Determine Thermostability 
Figure 3.17 shows the thermal dependence of the CD ellipticity at 222 nm.  
 
Figure 3.17: CD melting curves for the crTm constructs measured at 222 nm. Melting curves are plotted as fraction 
of the total change in CD at 222 nm versus temperature. 
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These melting plots (Figure 3.2.16) were obtained from a cross-section through the spectra at 
222 nm (Details in 2.5.6.2). Repeated melting curves were identical to the initial ones, showing 
melting was fully reversible, as found for other Tms (Kremneva et al., 2006).  It can be seen 
that crTm123p is more thermostable than crTm161. Table 3.2 below lists the mid-point of the 
melting curves for all the crTm constructs, as well as that of S. cerevisiae Tpm1p, obtained 
from literature (Maytum et al., 2000) as a point of comparison. 
Table 3.2: Mid-point temperatures of CD melting curves for various Tms. 
Protein Length in amino acid residues Mid-point Temperature in 5 
mM Phosphate + 500 mM 
NaCl (°C) 
Tm1p* 199 38* 
Tm1d23** 125 32 
crTm161 161 43 
crASTm161 163 43 
crTm123 123 45 
crASTm123 125 47 
yTpm1p* (Maytum et al. ,  2000), and y1d23**(Maytum et al .,  2008b)  
The midpoints of the melting curves for crTms are unaffected by the Ala-Ser extension. As can 
be seen in table 3.2.2 the midpoints of all the crTms are higher than those observed in other 
yeast Tms. Particularly striking is the difference between the crTm123 melting point, and that 
of the deletion mutant of the same size and with the same dipeptide N-terminal extension, 
Tm1d23. The reduction in CD signal represents a loss of tertiary and secondary structure of the 
protein. The fact that crTm123 is significantly more thermostable than Tm1d23 once again 
points to differences in sequence, other than at the N-terminus, as having a strong influence 
on the structure and stability of the Tm. The loss in tertiary structure is caused as a result of 
the breakdown of Tm-Tm interactions between helices. The explanation is therefore that some 
property of the sequence of crTm123p confers additional stability when compared to Tm1d23. 
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3.2.5.7  N. crassa Tm crystallization 
It is widely believed that tropomyosin adopts a flexible rod-like structure and that this 
flexibility plays a crucial role in its functions. This high flexibility also makes crystallization of 
full-length tropomyosins an extremely difficult task. Additionally, because Tm exists in the 
form of long, thin polymers, the diffraction of resulting crystals is highly anisotropic. The 
structure of full-length tropomyosin (Phillips et al., 1986, Whitby et al., 1992) has only been 
obtained at 7 Å resolution at best (Whitby and Phillips, 2000). High-resolution structures have 
only been obtained for isolated fragments of muscle tropomyosin stabilized either by a GCN4 
leucine-zipper extension or by disulfide bonds between cysteine residues introduced at the 
end of the coiled coil (Brown et al., 2001, Greenfield et al., 2006, Greenfield et al., 1998, 
Greenfield et al., 2003, Li et al., 2002, Nitanai et al., 2007).  
To date, only the structure of muscle tropomyosin has been investigated intensively. Structural 
information on non-muscle tropomyosin still remains relatively unknown. Most recently, the 
full-length Tpm2p from S. cerevisiae was crystallised and diffracted to 3.5 Å .  
Based on the above information the newly discovered N. crassa Tms were prime candidates 
for crystallographic studies. In particular crTm123p, as CD data suggested this short Tm is 
stiffer than larger isoforms and may crystallise more easily. In addition, its small size may 
potentially mean that it can form crystals that are less anisotropic than seen with larger Tms. 
crTm123  and crTm161 were expressed and purified (as described in Section 2.4.1 and 2.4.2.1), 
and subsequently concentrated to 6 mg/ml using Centricon YM-10 (Millipore Corporation). 
 Initial crystallization experiments were performed using the hanging-drop vapour-diffusion 
method VDX plates (Hampton Research). The crystallization screening kits Crystal Screen and 
Crystal Screen 2 (Hampton Research) were used as initial screening conditions. One µl protein 
solution was mixed with an equal volume of precipitant solution and equilibrated against a 0.5 
ml reservoir.   
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Due to the almost instant precipitation of the Tms in a large proportion of precipitating 
solutions, the concentration was reduced to 2 mg/ml, and new screens set up. Crystals of 
crTm123 were obtained in Crystal Screen 2 Condition No. 1 (2.0 M sodium chloride, 10% w/v 
polyethylene glycol 6,000)(Figure 3.18), and crystals of crTm161 were obtained in Crystal 
Screen  condition No. 12 (0.2 M magnesium chloride hexahydrate, 0.1 M HEPES sodium pH 7.5, 
30% v/v 2-propanol)(Figure 3.18). 
    
Figure 3.18: Preliminary crystals of crTm123 (a) and crTm161 (b).  Conditions for crystallization of both proteins 
were screened using Hampton Crystal Screen, and Hampton Crystal Screen 2. The crTm123 crystal was formed 
under Condition 1 of Crystal Screen 2 and the crTm161 crystal under Condition 12 of Crystal Screen, both after one 
week. 
 
These preliminary crystals were birefringent under polarised light; a strong indication that they 
are crystals of protein and not salt. Although the dimensions of these crystals were not yet 
substantial enough for X-ray diffraction, there is significant potential to obtain larger crystals 
following optimisation of the initial crystallisation conditions. Of particular interest is the shape 
of the crystals as they differ from the plate-like crystals commonly obtained with Tms. This 
may be indicative that the anisotropy of diffraction, and therefore structural data, obtained 
from these crystals may differ from what has been previously observed. There is therefore 
some potential for novel structural information to be acquired. 
  
A B 
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3.3 Discussion 
Two ultra-short isoforms of Tm were identified in N. crassa through a search of an EST 
database. These isoforms, designated crTm123 and crTm161, were seen to be products of 
alternative splicing from a single gene. To our knowledge, these are the first fungal Tm 
isoforms to be products of alternative splicing. 
Alternative splicing is thought to be a major source of functional diversity in animal proteins. 
Between a third and a half of all human genes appear to undergo alternative splicing (Brett et 
al., 2000, Lander et al., 2001, Mironov et al., 1999, Modrek and Lee, 2002). Recent studies 
have shown that the amount of alternative splicing that occurs in the genomes of the fly and 
nematode are comparable to this,  emphasizing its major role in the biology of all animals 
(Brett et al., 2002). Conversely, prokaryotes have no introns in protein-coding genes and yeast 
S. cerevisiae has introns in only 3% of its genes (Spingola et al., 1999).  Very little is currently 
known about the evolution of alternative splicing.  The analysis of the evolutionary 
conservation of proteins encoded by alternatively spliced genes showed that alternative 
splicing often creates novel isoforms by the insertion of new, functional protein sequences 
that probably originated from noncoding sequences of introns (Kondrashov and Koonin, 2003). 
The shorter Tm isoform of N. crassa discovered in this study is the shortest known native Tm, 
making it possibly one of the earliest ancestors of this protein. Deciphering the role of this Tm 
is certainly an ideal starting point in understanding the roles of non-muscle Tm isoforms in 
higher eukaryotes. 
Preliminary studies have also suggested that the expression levels of both isoforms differ. This 
is similar to the difference in TPM1 and TPM2 expression levels in S. cerevisiae, and as such 
may be an indication that both isoforms potentially have some roles within the cell that are 
independent of each other.  This may mean that each isoform is expressed at different levels 
depending on the stage of cell development and the cell cycle.  
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Interestingly, the two isoforms of crTm were observed to compete with each other to bind to 
actin. It was proposed (Figure 3.13) that this may mean that both Tm isoforms cannot inhabit 
the same actin filament simultaneously, and once again points to the probability that they 
have some roles within the cell independent of each other. Alternatively, their different 
properties may mean that the isoforms differ in their regulation of the same function. For 
instance, each isoform may be able to regulate the speed of vesicular transport across the 
actin cytoskeleton to different degrees.  
Further genetic studies can be used to elucidate the level of independence/overlap in the 
function of the two crTms in vivo. Deletion mutants of both isoforms will have to be generated 
and the phenotypes of crTm123Δ, crTm161Δ and a double deletion mutant strain analysed and 
compared. Also the ability of over-expressing one isoform to rescue phenotypes caused by 
deletion of the second isoform should also be investigated.  
Both isoforms were characterised and required an Ala-Ser extension at the N-terminus to bind 
to actin. This suggests that the native forms of crTms in vivo are acetylated at the N-terminus, 
as is the case with other fungal Tms that have previously been characterized. 
Both isoforms have binding affinities for actin in the range seen for previously characterised 
isoforms. However, crTm123p did exhibit a slightly higher affinity than crTm161p (0.35 and 
0.39 µM for crTm123p and crTm161p respectively). 
The impact of both isoforms on the acto-myosin ATPase was also investigated by measuring 
ATP turnover in their presence. Both isoforms inhibited the acto-myosin ATPase. A dual 
regulatory effect, as that observed in the case of Tpm1p, was not observed. A possible 
explanation for this is that the crTms, like other fungal Tms, do not confer an increased S1-
actin affinity as seen with skTm. The source of this increased affinity in the case of skTm is not 
clear, and may be a result of the electrostatic properties of skTm. 
127 
 
Circular dichroism analysis showed that while both isoforms have the alpha helical component 
typical for Tms, they were both more thermostable than other Tms of similar size that have 
been characterized, and significantly more so than Tm1d23. This suggests these novel Tms are 
less flexible than other Tms of similar size, and this may have some influence on their roles in 
the cytoskeleton. The Ala-Ser dipeptide at the N-termini of the Tms conferred additional 
thermostability to both isoforms. It can be inferred from this information, that Tm-Tm 
interactions play a significant role in the stability of the crTm filament. Once these interactions 
are broken, the coiled-coil helix starts to fall apart resulting in a sudden loss in secondary 
structure. Compared with the only other ultra-short Tm, 1d23, crTm123p had a mid-point 
temperature 15 °C higher; an enormous difference. Since both proteins had an Ala-Ser N-
terminus extension, this finding indicates that sequence differences in other regions of the 
molecule strongly influence the stability and flexibility of the filament, and hence its function. 
Finally, both crTms were crystallised using different buffer conditions. The form of these 
crystals was dissimilar to the platelet-like crystals that are generally formed by Tms, and 
different from eachother. This may suggest that these crystals may diffract with anisotropy 
that differs from that reported for longer Tm isoforms. There is thus potential that further 
development of the crystal trials may result in high resolution structural data for these novel 
Tms 
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4 Expression, Purification and Characterization of Nat3p 
4.1 Introduction 
As discussed in detail in Chapter 1, interest in deciphering the precise function of tropomyosins 
in non-muscle cells, and their roles in the regulation of the cytoskeleton continues to grow. 
What is known is that the N-terminal acetylation of tropomyosins is essential for their stability 
and function. The NatB complex is responsible for the N-terminal acetylation of tropomyosin in 
yeast. However information regarding the mechanism of N-terminal acetylation of 
tropomyosins is extremely limited. At present, only the broad cell biology studies described in 
Chapter 1 have provided the basis of all we know about the NATs. Given these reasons, Nat3p, 
the catalytic core of NatB is the target of immense interest and the focus of this chapter.  The 
work presented here aims to provide some insights into its structure and function at a 
molecular level. 
 In addition, that orthologues of Nat3p have been identified across a number of eukaryotic 
species implies that any information acquired about this protein may potentially be applied to 
higher eukaryotic orthologues.  
Work on Nat3p presented in this chapter includes protein expression, purification and 
characterization studies. 
In addition, NatA and NatC genes (also discussed in Chapter 1) were also amplified from yeast 
genomic DNA, and cloned as targets for future investigations. Preliminary investigations into 
Nat5p included expression and successful crystallisation of this NatA component.  
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4.2 Results 
4.2.1 Recombinant Expression of Nat3p 
The NAT3 coding sequence was already available in expression plasmid pJC20-HisN 
(R.Maytum), carrying an ampicillin resistance marker.   E. coliBL21 (DE3) pLysS cells were 
transformed with this construct (Section 2.2.8.1). Nat3p was then expressed as detailed in 
Section 2.4.1. An SDS-gel showing a typical expression is shown in Figure 4.1. 
 
Figure 4.1: SDS-PAGE gel showing over-expression of Nat3p. Lanes from left to right, marker (M), total cell 
lysate(T), soluble fraction (S) and insoluble fraction (IS). 
  
The large band dominating Lane T (total lysate) of the gel in Figure 4.1 represents over-
expressed His-tagged Nat3p, which makes up a significant percentage of total expressed 
protein. However, as can be seen in lane S very little, if any, Nat3p was seen to be soluble. The 
majority of the over-expressed Nat3p was observed to remain insoluble (Lane IS), presumably 
in inclusion bodies. The yield of soluble eukaryotic proteins expressed in a prokaryotic system 
is often seen to be very low. This can be explained by the occurrence of mis-folding and 
aggregation as prokaryotic systems lack the protein-folding and modification machinery often 
required by eukaryotic proteins (Hannig and Makrides, 1998). This mis-folding and aggregation 
results in the formation of so-called insoluble inclusion bodies (IBs). The formation of IBs in 
prokaryotic systems can be influenced by a number of factors including the rate of protein 
expression, the cellular concentrations of protein-folding intermediates, the viscosity, and of 
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course the structure of the recombinant protein. The causes and potential solutions of this 
phenomenon are further detailed in Section 4.2.5. 
4.2.2 Molecular Modelling of Nat3p 
The structure of a protein directly influences its solubility by virtue of the extent and 
positioning of its constituent hydrophobic residues. It was therefore a logical step to explore 
the 3-D structure of Nat3p and to help understand its potential contribution to the lack of 
solubility of this protein. While its structure is not known Nat3p is, as described in Section 4.1, 
a known member of the GNAT superfamily of acetyltransferases. Also as detailed in Section 
4.1, all characterized members of this family share a structurally conserved GNAT fold in spite 
of very low structure-based sequence alignments. By this logic, using known GNAT structures 
should allow an accurate prediction of the molecular structure of Nat3p. In order to compare 
protein structures, the VAST (Vector Alignment Search Tool) algorithm was used. This 
algorithm uses vectors to represent secondary structure elements (SSEs) in protein structures 
and the structural comparison step relies on the relative orientation, length and alignment of 
those vectors. Comparisons that align only one or two vectors between two proteins are never 
considered significant to predict the structure of Nat3p based on the structures of its 
homologues (Whitmore and Wallace, 2004a).  
VAST was used for the superposition of sequences of 25 GNATs based on their known 3D 
structures. The Cn3D tool from NCBI (Lobley et al., 2002) was used to view the alignment 
generated of three-dimensional structures of the proteins. The results of the 
sequence/structural alignment are shown in Figure 4.2. 
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Figure 4.2a: Sequence alignment of 23 GNATs from a low redundancy dataset. VAST (Whitmore and Wallace, 
2004a) was used for the alignment. The colours in the sequence alignment correspond to the colours in the 
structural alignment in Figure 4.2b (Red to purple, N- to C-terminus). The regions in the sequence alignment in 
uppercase represent the highly conserved regions, and are the only regions represented in the structural alignment 
(Figure 4.2b). The boxed region in the sequence alignment corresponds to helices 1 and 2 (Refer to Section 4.1 for 
details). While these helices are present in virtually all GNATs, their conformations vary to a large extent, and they 
are thus missing from the structural alignment.  
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Figure 4.3b: Sructural alignment of 25 GNATs from a low redundancy dataset. The corresponding sequence 
alignment is in Figure 4.2a. Cn3D (Lobley et al., 2002) used for the visulaisation of the molecular structures. The 
colours in the sequence alignment correspond to the colours in the structural alignment (Red to purple, N- to C-
terminus). The The highly conserved GNAT Q/R_ _G_G/A sequence is highlighted in yellow. 
 
Human GCN5p (1Z4R) was used as the first sequence in the VAST sequence alignment. This is 
because it is the archetype of the GNAT family, and also one of the short GNATs, lacking 
extensions seen at either end on some other sequences. The alignment results show that all 25 
GNAT structures contain the conserved GNAT structural elements described in Section 4.2.1. 
These are represented in Figure 4.2 as follows: Motif C in orange/red, [N-terminal beta strand 
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(β1) followed by two helices (α1 and α2)];  Motif D in yellow/green, [three antiparallel beta 
strands (β2 ,  β3 and β4)]; Motif A in blue, [a ‘‘signature’’ central helix (α3) and a fifth beta strand 
(β5)] ; Motif B in blue/purple, [a fourth helix (α4) and a final b strand (β6)].  The highly 
conserved Q/R_ _G_G/A sequence that spans the P-Loop and α3 is highlighted in yellow.  It 
should be noted that motifs B, C and D aligned very strongly across all structures analysed, 
while motif A did not. While all structures are seen to contain α1 and α2, the orientation of 
these helices is so variable in every case that this region (represented by the box in Figure 4.2) 
does not align and is not represented in the structural alignment.  
The Nat3p structure was modelled on this core GNAT fold by threading the Nat3p sequence 
through this alignment i.e. aligned using the homology blocks identified in the initial VAST 
alignment (Figure 4.4).  
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Figure 4.4: VAST output of 25 GNATs based on human GCN5 (Whitmore and Wallace, 2004a). A structure-based 
alignment is needed as the sequences have a low (~20%) identityy. The Nat3p sequence was then aligned using the 
homology blocks identified in the initial VAST alignment (red box). The core aligned residues are shown in capitals, 
with non-aligned residues in lower case. Highlighted in yellow is the region present in all GNATs aligned, but deleted 
in Nat3p (also see Figure 4.2.4). Colour coding matches the domains shown in Fig 4.2b above. 
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It can be seen here that the structure based sequence alignment of Nat3p aligns strongly with 
all other GNAT structures, with one notable exception: The helix-loop-helix in motif C, present 
to some extent in all other GNAT structures, is deleted in Nat3p. This region (highlighted in 
yellow in Figure 4.4) shows that around 15 residues are deleted in the sequence of Nat3p. For 
the sake of clarity, Figure 4.5 shows the structure of human GCN5p, a Nat3p structural 
analogue, rotated and with the protein backbone of the deleted region highlighted in yellow.  
 
 
 
Figure 4.5: Human GCN5 (IZ4R) structure. Highlighted in yellow (corresponding to the yellow highlighted region in 
Figure 4.2.3) is the protein backbone of the helix-loop-helix, present in virtually all GNAT structures, but deleted in 
Nat3p. The green arrow represents the regions that would be joined in Nat3p in the absence of the helix-loop-helix. 
This would result in a short loop and an exposed beta sheet (red). 
 
According to this predicted structure, this helix-loop-helix deletion would leave exposed the 
entire core β- sheet (Motif D comprising 3 anti-parallel β-strands, coloured green in Figure 4.2). 
By virtue of its secondary structure, this β-sheet is likely to be hydrophobic in nature. Given the 
low likelihood of such a hydrophobic region being exposed on the surface of a protein, it is 
proposed that the deletion of the helix-loop-helix in Nat3p provides a docking site for 
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Mdm20p, the auxiliary subunit of the NatB complex. In addition to shielding the hydrophobic 
β-sheet, positioning Mdm20p in this region would potentially allow it access to the acetyl 
group of ACoA, allowing transfer to a substrate protein bound by Mdm20p. This would 
propose Nat3p as catalyst and Mdm20p as protein substrate carrier. While further 
investigation would be required to validate this theory, this putative structural feature of 
Nat3p is important in this chapter as it also provides some explanation for the low solubility of 
this protein. In the case of most GNATs there are a large number of primarily hydrophobic 
interactions between helices α1 and α2 and the β-strands below, which very likely confer some 
rigidity to the β sheet (Dyda et al., 2000). The absence of α1 and α2 helix-loop-helix thus 
renders this hydrophobic core exposed and destabilised, greatly reducing the solubility of the 
protein. Further investigations into obtaining soluble Nat3p, as described in the sections 
below, shed more light on the properties of this protein. 
4.2.3 Strategy for Obtaining Soluble Nat3p 
Based on the preliminary data from Sections 4.2.1 and 4.2.2, a few strategies for obtaining 
soluble Nat3p were simultaneously considered:  
1. Co-expression of Nat3p with Mdm20p. If the site of α1 and α2 deletion is indeed the docking 
site for Mdm20p, co-expression (Section 2.4.5) may result in the formation of a complex, 
stabilizing both proteins, and potentially yield soluble protein. Results are detailed below in 
Section 4.2.4. 
2. Non-native recombinant proteins in IBs are highly concentrated and therefore nearly pure 
(Middelberg, 2002, Speed et al., 1996). Chemical solubilisation and subsequent refolding of IBs 
has the potential for producing large amounts of soluble protein. Since the yield of 
recombinant Nat3p in the form of insoluble inclusion bodies (Fig 4.2.1) was substantial, it was 
decided to purify this protein under denaturing conditions, and subsequently attempt to refold 
Nat3p. Results are detailed below in Section 4.2.5. 
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3. While the information acquired from the molecular model of Nat3p provided insights into a 
potential explanation for its lack of solubility, there are a number of other factors that may 
have a contributory role to play in the formation of the insoluble aggregates in vivo, as detailed 
in Section 4.2.5. Therefore, a number of strategies to improve the expression of soluble Nat3p 
in vivo were employed, the results of which are described in Section 4.2.6. 
4.2.4 Nat3p and Mdm20p do not co-express from pET-Duet™ vectors 
The NAT3 and MDM20 genes had been previously cloned by R. Maytum in co-expression 
plasmids  pCDF-Duet™ and pRSF-Duet™ .  The Duet vectors are T7 promoter expression 
vectors, which are each designed to co-express two target proteins in E. coli. Each vector 
encodes two multiple cloning sites (MCS), each of which is preceded by a T7 
promoter, lac operator, and ribosome-binding site (rbs) (Figure 4.6). pCDF-Duet is a low copy 
number plasmid (20 – 40) and carries a spectinomycin/streptomycin resistance marker; pRSF-
Duet is a high copy number plasmid (>100) and carries a kanamycin resistance marker. 
 
Figure 4.6: Maps of E. Coli expression vectors pCDF-Duet™ and pRSF-Duet™. Shown are MCS 1 and 2 for each 
vector, with all the restriction enzyme sites contained therein. Expression in both vectors I under the control of the 
lacI gene (pink). pCDF-Duet™ carries a spectinomycin/streptomycin resistance marker (green) while pRSF-Duet™ 
carries a kanamycin resistance marker (blue). 
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In both vectors, NAT3 was cloned in MCS2 using the Nde1 and Xho1 sites. MDM20 was cloned 
in MCS1 using Nco1 and BamH1 cloning sites. NAT3 had to be cloned prior to MDM20 in each 
case as the MDM20 sequence contains two Nde1 sites. 
BL21-pLysS(DE3) cells were transformed with either  pCDF-Duet™  or pRSF-Duet™. Trials of 
Nat3p and Mdm20p expression from both vectors were undertaken, as detailed in Section 
2.4.1.  The expression of Nat3p was carried out as described in Section 2.4.1. Medium was 
supplemented with appropriate antibiotics for selection. Nat3p was expressed as seen 
previously; however, Mdm20p did not appear to be expressed- at least not at a level high 
enough to be visualised on an SDS gel. The analysis of the solubility of the expressed protein 
unfortunately showed that the Nat3p that was expressed in the case of both co-expression 
vectors, remained insoluble. Without Mdm20p co-expression, the conditions of Nat3p 
expression in this experiment remain very similar to the expression conditions in the initial 
expression trials (Section 4.2.1).  
The lack of Mdm20p expression may be due to the large size of the protein. With a molecular 
weight of almost 93 kDa, Mdm20p may be too large a protein for the prokaryotic expression 
system used to cope with. 
4.2.5 Purification of Nat3p from inclusion bodies 
Section 4.2.1 showed that almost all Nat3p expressed in E. coli was in the form of insoluble 
inclusion bodies (IBs). As mentioned earlier, although insoluble, IBs are known to contain 
nearly pure protein (Middelberg, 2002; Speed et al., 1996). In addition, IB formation is now 
known to be a reversible process (Carrio and Villaverde, 2001). For these reasons it was 
decided to attempt the chemical solubilisation and refolding of Nat3p in order to obtain 
correctly folded, soluble protein. 
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4.2.5.1 Purification of Nat3p from inclusion bodies 
 
His-tagged Nat3p in insoluble IBs, produced as a result of recombinant over-expression from 
expression vector pJC20, was solubilised in denaturing LEW buffer containing 6 M urea, and 
purified by IMAC under these denaturing conditions (Section 2.4.2.2). The purification process 
was monitored by SDS-PAGE. Figure 4.7 below shows an acrylamide gel from such an SDS-
PAGE (Section 2.5.1). 
 
Figure 4.7: SDS-PAGE showing IMAC of His-Nat3p under denaturing conditions. Urea-solubilised His-Nat3p was 
purified on a nickel-chelating column: (L= load of total solubilised IBs, FT = flow through, E1 – E4 = eluted fractions 1 
– 4 of 1.5 ml each). 
 
Figure 4.7, lane FT shows that all chemically unfolded His-Nat3p loaded on to nickel-chelating 
column (lane L) bound to the resin as no detectable Nat3p flowed through. Lanes E1 – E4 are 
each 1.5 ml elutions of the bound His-Nat3p using imidazole. It can clearly be seen that four x 
1.5 ml fractions of highly pure, urea-solubilised His-Nat3p were obtained from this purification. 
The concentration of this chemically unfolded protein was determined, using an A280 
measurement (Section 2.5.7.1) to be in the range of 2 mg/ml, which translates to a yield of 12 
mg of His-Nat3p expressed per litre of culture. The urea-solubilised, purified His-Nat3p was 
pooled. The secondary structure was then determined using circular dichroism (CD) at 25 °C 
(CD described in Section 2.5.6, and results shown in Figure 4.8).  
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Figure 4.8: CD spectrum of unfolded Nat3p. Nat3p was present in LEW buffer containing 6 M urea, at 25 °C. The 
spectrum appears similar to that expected for unordered protein. The region of the spectrum at wavelengths lower 
than 210 nm (within the red box) does not represent signal, but rather the result of noise caused by strong 
absorbance of urea in this region. 
 
Figure 4.8 shows that the CD spectrum for urea-solubilised His-Nat3p resembles that of a 
spectrum for unordered protein (Figure 2.4). This finding confirmed that the urea-solubilised 
His-Nat3p was unfolded. It should be noted that the region of the spectrum spanning 
wavelengths below 210 nm (within the red box in Figure 4.8) does not represent a real signal. 
The presence of urea in the solution causes a significant absorbance at lower wavelengths, and 
in such a case of very low signal the CD spectrometer averages the noise from the signal 
towards ‘0’. 
 In addition, since signal strength is proportional to the concentration of the protein sample, 
the overall signal strength of the spectrum in Figure 4.8 is significantly lower than would be 
expected for a solution of protein at 2 mg/ml. It is known that the molar ellipticity of 
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unstructured protein is much lower than that of highly structured protein, and this provides 
further evidence for the unfolded state of His-Nat3p when solubilised in 6M urea. 
The purified chemically solubilised protein was at this stage pooled, and used in subsequent 
refolding experiments. 
4.2.6 Refolding of His-Nat3p from Insoluble Inclusion Bodies 
To attempt to refold a protein from inclusion bodies, it is first important to understand the 
cause of inclusion body formation. This process involves competition between the pathways of 
folding and misfolding (aggregation) as shown in Figure 4.9. 
 
Figure 4.9: A simplified model of correct folding versus misfolding and aggregation. The correct protein folding 
pathway (1) often competes with misfolding (2) and aggregation (3). Aggregation occurs among intermediates with 
exposed hydrophobic patches, which are buried in the correctly folded protein (blue lines, hydrophilic solvent-
exposed parts of the protein; red lines: hydrophobic patches).(Vallejo and Rinas, 2004) 
 
Aggregation generally occurs when non-native, hydrophobic interactions occur between 
protein-folding intermediates. Once the refolding process moves beyond such intermediates, 
the correct folding pathway is favoured, and aggregation does not occur. Therefore, the key 
for successful renaturation, especially at high protein concentrations, is the prevention of 
hydrophobic intermolecular interaction during the first steps of refolding.   
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There are a variety of methods as well as buffer conditions that have been successful in the 
production of active protein from IBs. However, the technique remains highly empirical, and 
the benefit of each of these refolding techniques and additives has to be elucidated 
experimentally for a given renaturation system as they are not equally advantageous for all 
proteins. In addition, even when a protein is apparently soluble under certain renaturation 
conditions, it does not ensure that it is folded into the native form.  
However, there are a few rules that appear to apply to most systems. For example, 
dithiothreitol (DTT) or 2-mercaptoethanol is generally required. These substances reduce non-
native inter- and intramolecular disulfide bonds, possibly formed by air oxidation during cell 
disruption, and maintain the reduced state of cysteines.   
Secondly, the yield of correctly refolded protein has been consistently seen to decrease with 
increasing initial concentration of unfolded protein, regardless of the refolding method applied 
(De Bernardez Clark et al., 1998, Gu et al., 2001, Katoh and Katoh, 2000, Tikhonov et al., 2002, 
Tran-Moseman et al., 1999, Vallejo and Rinas, 2004). This is due to the fact that while protein 
refolding involves intramolecular interactions and follows first-order kinetics (De Bernardez 
Clark et al., 1998, Goldberg et al., 1991, Kiefhaber et al., 1991, Zettlmeissl et al., 1979), protein 
aggregation involves intermolecular interactions and, thus, is a kinetic process of second or 
higher order, which is favoured at high protein concentrations (De Bernardez Clark et al., 1998, 
Goldberg et al., 1991, Kiefhaber et al., 1991, Zettlmeissl et al., 1979).  
Finally, temperature is known to have a strong effect on in vivo protein aggregation (Schein, 
1989), and is the most important physical variable influencing the refolding yield. (Buchner et 
al., 1992, West et al., 1998, Yoshii et al., 2000). In general, lower temperatures have been seen 
to suppress aggregation and support the correct folding pathway, partly by slowing down the 
rate of protein folding. 
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 The above information was used to plan a methodology for the attempted refolding of Nat3p 
from inclusion bodies. Various parameters were tested and optimised, and the results 
presented below. According to the principles outlined above, all refolding experiments were 
carried out at 4°C, in the presence of DTT and starting with low initial concentration of Nat3p. 
4.2.6.1 Testing Refolding Techniques 
 
The IBs were solubilised in LEW buffer + 6 M urea. In order to limit this test to a comparison of 
the effectiveness of each technique in refolding Nat3p, it was decided to use standard LEW 
buffer as the refolding buffer in each case. The three re-folding techniques tested are detailed 
below, followed by a description of the results observed.  
4.2.6.1.1 Refolding by Rapid Dilution 
The basis of this procedure is to dilute the concentrated protein-denaturant solution into a 
refolding buffer that allows the formation of the native structure of the protein at a 
concentration low enough to avoid concentration-induced aggregation; and also drops the 
denaturant concentration below the critical concentration to allow folding. In this study, a 
modified version of this technique, where the solubilised, denatured protein is added in pulses 
into the refolding buffer (Buchner et al., 1992, Fischer et al., 1992, Katoh and Katoh, 2000, 
Terashima et al., 1996, Vallejo and Rinas, 2004) was used. This has the advantage of greater 
final concentrations of refolded protein. 
The concentration of protein in the protein-denaturant solution was determined, and an 
appropriate dilution made in 10 ml of refolding buffer (stirring briskly at 4°C) to give a final 
concentration of around 10 µg/ml. The addition of protein was repeated at 30 minute 
intervals, until the concentration of protein reached around 50 - 100 µg/ ml. The protein was 
left to refold overnight, and then concentrated to 1 ml using a spin column concentrator 
(Invitrogen) to result in a protein solution of approximately 0.5 mg/ml. 
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4.2.6.1.2 Membrane Controlled Denaturant Removal 
In this method dialysis systems are utilized for denaturant removal. In contrast to the direct 
dilution method, the change from denaturing to native buffer conditions occurs gradually.  
500 µl of protein-denaturant solution was placed in dialysis tubing, and dialysed against 500 ml 
of refolding buffer. Dialysis was carried out at 4 °C, overnight. 
4.2.6.1.3 On-column Protein Refolding  
In this method the solubilised and unfolded Nat3p was bound to metal-chelating affinity resin 
and subsequent refolded by gradually removing the denaturant via buffer exchange. The 
process is based on the formation of a stable complex between the His-tag on the N-terminus 
of Nat3p, and the chelated Ni2+ on the chromatographic resin (Figure 2.2). On-column refolding 
of unfolded and solubilised protein allows for the physical separation of aggregation-prone 
folding intermediates in the porous structure of the resin (Batas and Chaudhuri, 1996).  
The column was equilibrated with 3 ml LEW containing 6 M urea, and 1 ml of the denaturant-
protein solution loaded onto the column (in the same buffer).  The column was then washed 
with 5 ml refolding buffer, before elution in the same refolding buffer containing 250 mM 
imidazole.  
4.2.6.1.4 Results Observed 
Initial refolding of Nat3p proved predominantly unsuccessful, with production of visible 
precipitate using all three refolding techniques.  
4.2.6.2 Optimising Refolding Buffer Conditions 
 
The lack of any significant difference observed between the three refolding techniques tested 
suggested that the conditions within the refolding buffer were not conducive to correct folding 
in the case of His-Nat3p. It was thus decided to vary refolding buffer conditions to attempt to 
145 
 
improve refolding.  The optimization of a refolding buffer is a daunting task, as literature has 
shown this process to be highly empirical in nature. A thorough literature review was thus 
undertaken to limit the range of buffer components for testing to a realistic number. 
 It is know that the degree of aggregation that occurs during refolding is largely dependent on 
concentration of strong and weak denaturants, pH, temperature, and the redox environment.  
Ionic strength, divalent cations, polymers and cofactors can also promote refolding of some 
proteins. 
Possibly the most commonly used refolding aiding agent used today is L-arginine (De 
Bernardex Clark et al., 1999). It impedes aggregate formation by enhancing the solubility of 
folding intermediates, presumably by shielding hydrophobic regions of partially folded chains. 
In addition, it has been shown that numerous other low molecular weight additives such as 
detergents and glycerol improve refolding yields by suppressing aggregation (De Bernardex 
Clark et al., 1999). High-molecular weight additives such as polyethylene glycol have also been 
seen to enhance protein refolding yields (Cleland and Wang, 1990). Osmolytes such as proline 
and sucrose have also been observed to behave as chemical chaperones, assisting in the 
correct refolding of proteins (Kim et al., 2006). The mechanisms of interactions of these 
refolding aiding agents with the folding intermediates often remain obscure although it is clear 
that all these substances suppress aggregation in favour of the productive folding pathway 
(Arakawa and Tsumoto, 2003). 
Based on the available information, a variety of refolding conditions were screened to attempt 
to optimise the correct refolding of Nat3p. Tris-HCl or phosphate buffer at pH 4, 7 and 8.5 
were used as the base buffer (to optimize pH requirements for Nat3p). A summary of additives 
to this base buffer is tabulated below in Table 4.1. 2 mM DTT was added to each buffer prior to 
refolding. Because protein concentration is known to directly influence the rate of aggregation, 
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the refolding technique that keeps concentration at a minimum during refolding, i.e. refolding 
by rapid dilution, was used in these experiments. 
Table 4.1: Constituents that were varied when optimising refolding buffer conditions. 
The different concentrations/amounts tested in each case are listed, as are the roles each are postulated 
to play in aggregation prevention and the appropriate references used. 
Condition/Additive Concentration Reference 
 
Arginine 0.4 and 1.0 M 
(De Bernardex Clark et al., 1999) 
(Reddy et al., 2005) 
 
Osmolytes: 
Proline 
Glycerol 
Sucrose 
 
 
1.5 M 
20, 30, 40 % 
0.5 and 1 M 
 
(Ignatova and Gierasch, 2006) 
(Samuel et al., 2000) 
 
Detergents and 
surfactants: 
Polyethylene glycol  
Tween 
Triton-X 100 
SDS 
 
 
 
0.05 % (w/v) 
0.1 – 1 % 
10 mM 
0.8 % 
 
 
 
(Cleland and Wang, 1990) 
(Bam et al., 1996) 
 (Wetlaufer and Xie, 1995) 
 
 
n-hexanol 
 
5 mM 
 
(Wetlaufer and Xie, 1995) 
 
Salts: 
NaCl 
KCl 
 
 
0, 0.5 and 1.0 M 
0, 0.5 and 1.0 M 
 
 
Urea 
 
0.2 M 
 
 
4.2.6.2.1 Results of Refolding Buffer Optimisation 
Various combinations of the anti-aggregation buffer components Table 4.1Table 4.4 were 
screened in order to optimize His-Nat3p refolding. Very surprisingly, visible precipitation of 
His-Nat3p was reduced only when salt (Either NaCl or KCl) was not present in the refolding 
buffer.  The apparently soluble His-Nat3p was analysed using both SDS- and native-PAGE 
(Section 2.5.1 and 2.5.2). This is because while SDS-PAGE gives some indication of the size of 
the protein when denatured, native-PAGE is more useful in this case as it gives information of 
the size of proteins when folded. 
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Figure 4.10: Native and SDS-PAGE of His Nat3p refolded in salt-free buffer.  The SDS gel shows the presence of a 
large dense band, indicating high concentrations of His-Nat3p. The native gel shows no corresponding band. 
According to Figure 4.10, the SDS-gel shows the presence of a high concentration of the 
apparently soluble His-Nat3p, represented by a dense band. However, there is no 
corresponding band on the native gel. This implies that even though no visible precipitate of 
His-Nat3p was observed in salt-free buffer, aggregation is occurring to a level where the 
aggregated protein is too large to enter the native gel. Smearing towards the top of the native 
gel indicates presence of large protein molecules- likely to be aggregated Nat3p. 
The aggregation state of this soluble His-Nat3p was further investigated using Dynamic Light 
Scattering (DLS) as described in section (2.5.8). This technique is useful for analysing the size 
distribution of macromolecules in solution. According to the DLS results obtained (Figure 4.11), 
the size of the particles in the Nat3p solution were in the range of several thousand kDa. This 
meant the Nat3p was forming very large and polydisperse aggregates. 
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Figure 4.11: Dynamic light scattering of Nat3p in salt-free buffer analysed at 4 °C. The observed MWs are 
extremely large, representative of severe and extensive aggregation. 
Further screening of refolding buffer conditions (Table 4.1) led to the discovery that 10 mM 
phosphate buffer (pH8) containing both 0.4 M arginine and 0.01% SDS appeared to have an 
effect in reducing aggregation. This was deduced from further native-PAGE (Figure 4.12), DLS 
(Figure 4.13) and CD (Figure 4.14) analysis.   
 
Figure 4.12: Native PAGE gel of Nat3p in different refolding buffer conditions. The states of aggregation of Nat3p 
varydepending on refolding buffer conditions.Lanes  M=  marker, 1,= LEW buffer, 2 and 3=  10 mM Phosphate 
buffer, pH 6 and 8 respectively;  4 and 5- 10 mM Phosphate buffer, pH 6 and 8 respectively, both containing 0.4 M 
arginine and 0.01% SDS. 
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Samples  of  His-Nat3p refolded  by rapid dilution in 10 mM phosphate buffer pH 8 with 0.4 M 
arginine and 0.01 % SDS was seen to enter the native gel (Lane 5, Figure 4.12) when compared 
to His-Nat3p refolded in LEW or phosphate buffer without additives (Lanes 1-3 in Figure 4.12). 
Other buffers screened yielded similar results to those seen in Lanes 1-3, Figure 4.12 and 
images of the corresponding native gels are thus not included. 
 Although the presence of 0.4 M arginine and 0.01 % SDS did appear to suppress aggregation 
to some extent, the majority of His-Nat3p remained in some state of aggregation judging by 
the very small amount of protein that was able to migrate into the native gel (compared to SDS 
gel as seen in Figure 4.10). Additionally, this protein had an apparent size of greater than 200 
kDa using the marker (Lane M) as a reference.  
DLS analysis (Figure 4.13) showed that the size of Nat3p molecules in 0.4 M arginine and 0.01 
% SDS were smaller than seen previously (Figure 4.11), however, the apparent molecular 
weight was still up to 8 times that of Nat3p ( 23 kDa), indicating aggregation was still taking 
place. 
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Figure 4.13: DLS of Nat3p in 10 mM phosphate buffer pH 8 with 0.4 M arginine and 0.01 % SDS at 4 °C. The 
observed MWs are in the range of 150 kDa and very polydisperse, indicating the presence of aggregation. 
 
The CD spectrum of His-Nat3p in this buffer yielded a spectrum which indicated the presence 
of ordered secondary structure (Figure 4.14).  
 
Figure 4.14: CD of 0.5 mg/ml Nat3p in 10 mM phosphate, pH 8.0, 0.4 M arginine and 0.01 % SDS. The spectrum  
shows  the presence  of ordered  secondary  structure,  primarily alpha  helical  with  some  beta  sheet  component.  
Secondary structural information was obtained by deconvolution using a web-based deconvolution program (K et 
al., 2005). 
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The shape of the spectrum and analysis of it shows primarily alpha helical content, with some 
beta sheet component (Compare to characteristic curves in Figure 2.8). This implies that at 
least some of the His-Nat3p that was previously completely unordered (Figure 4.8) now had 
some structure. However, as seen before in Figure 4.8, the rather low molar ellipticity suggests 
the presence of unordered structure. Finally, the thermal stability of this re-folded protein was 
tested, as detailed in Section 2.5.6.2. While increasing the temperature usually results in the 
loss of ordered secondary structure towards a disordered structure, represented in CD by a 
change in the spectrum, this was not seen to be the case with His-Nat3p. No change in the CD 
spectrum was observed, even when the sample was heated to 90 °C. This observation offered 
further evidence for the presence of a large proportion of unordered protein within the test 
sample. All these data therefore indicate that although some structural component was 
restored to this apparently soluble His-Nat3p on refolding in 10 mM phosphate (pH8), 0.4 M 
arginine and 0.01% SDS, the majority of the protein appeared to still be unstructured, forming 
aggregates.  
4.2.7 Improving Soluble Expression of Nat3p in vivo 
Following the limited success of both co-expression studies, and in vitro refolding of chemically 
solubilised His-Nat3p, the final alternative involved attempting to improve the expression of 
soluble Nat3p in vivo. A number of explanations for IB formation in vivo have been proposed.  
Some of these, as reviewed by Carrio and Villaverde (Carrio and Villaverde, 2001), include the 
following:  
 The concentration of recombinantly expressed proteins within the cell often exceeds 
physiological levels, resulting in aggregation.  
 The high rate of expression required to produce large amounts of heterologous 
proteins leads to the rapid accumulation of protein in the cell, and increases the 
probability of aggregation (Singer and Lindquist, 1998).  
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 These high expression levels also place additional strain on, and may saturate, the 
cellular folding machinery, increasing the number of protein misfolding events (Moore 
et al., 1993).  
 Aggregation can also occur in the reducing environment of bacterial cells as a result of 
a lack of disulphide bond formation (Schaffner et al., 2001).  
It can be said, in summary, that IB formation occurs as a result of the accumulation of 
denatured protein and the metabolic burden on the host cell. Since both these factors can be 
at least partially controlled by a number of environmental factors, the formation of soluble 
protein in vivo is also under some level of control. 
The methods used to attempt to improve His-Nat3p solubility in vivo include: lowering 
temperature and induction levels to lower recombinant protein concentration; use of E. coli 
strains developed for increasing soluble protein expression; use of solubility-enhancing fusion 
partner; use of additives thought to induce the expression of protein-folding chaperones. 
Details and results are described below.  
4.2.7.1 Protein Expression at Reduced Temperatures. IPTG Concentration and 
Induction Time 
  
A well-known technique for reducing in vivo aggregation is lowering cultivation and/or 
induction temperature. This is because the aggregation reaction is favoured at higher 
temperatures because of the strong temperature dependence of the hydrophobic interactions 
involved (Kiefhaber et al., 1991). In addition, heat-shock proteases that are induced under 
over-expression conditions are eliminated at lower temperatures (Arnold and Ulbrich-
Hofmann, 2001, Chesshyre and Hipkiss, 1989, Emerick et al., 1984, Sachdev and Chirgwin, 
1998, Speed et al., 1996, Vasina and Baneyx, 1996). Furthermore, the activity and expression 
of a number of E. coli chaperones have been shown to be increased at temperatures around 
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30°C (Ferrer et al., 2003, Mogk et al., 2002). The increased stability and potential for correct 
folding of proteins at low temperatures are partially explained by these factors, and also of 
course the lower rates of protein production. 
Low induction levels have also been found to result in higher amounts of soluble protein 
(Weickert et al., 1996). This is a result of the reduction in cellular protein concentration, which 
favours folding. 
For the above reasons, the lowest temperature allowing growth and expression of the strains 
used, which was 16 °C, was used to improve expression of soluble protein. Various IPTG 
concentrations (1, 0.4, 0.2 and 0.1 mM) and induction times (3 hours, 6 hours, 12 hours and 
overnight) were also systematically tested to optimise recombinant expression of soluble 
Nat3p. Figure 4.15 shows an SDS-gel of total His-Nat3p expression resulting from varying IPTG 
concentrations and induction times. According to this figure, and as expected, an increase in 
both IPTG concentration and induction time had the effect of increasing total His-Nat3p 
expressed. However, even the lowest concentration of protein was found to be insoluble when 
analysed further (gel not shown). 
 
Figure 4.15: SDS-gel of the effect on Nat3p expression of induction time and IPTG concentration. (Labelled as 
appropriate at the top of each lane); M= marker. 
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4.2.7.2 E. coliStrains Used to Increase Soluble Expression 
Although the most commonly used strain of E. colifor the expression of recombinant proteins 
is BL21(DE3), a number of specialized host strains have been developed to aid the soluble 
expression of high levels of recombinant protein. Five different E. coli strains were used in this 
study to optimise the over-expression of Nat3p. These strains are listed in Table 4.2.  
Table 4.2: E. coli strains used to optimise His-Nat3p expression in vivo, and their applications. 
E. coli strain Application 
BL21(DE3)pLysS (Novagen®) Expression from T7 promoter, tight regulation 
Tuner™(DE3)pLysS (Novagen®) Protein expression varies linearly with IPTG concentration 
Rosetta™(DE3)pLysS 
(Novagen®) 
Expression from T7 promoter with codon bias correction 
C41(DE3)pLysS (Miroux B and 
Walker JE 1996) 
Improved expression of toxic and membrane proteins 
C43(DE3)pLysS (Miroux B and 
Walker JE 1996) 
Improved expression of toxic and membrane proteins 
 
Unfortunately, soluble His-Nat3p expression was not seen to vary significantly among the five 
different strains tested (gel not shown). 
4.2.7.3 Tagged Soluble Partners 
 
A valuable tool for recombinant protein expression and purification is the use of epitope 
tagging in which a polypeptide tag is fused to the target protein in a suitable expression vector. 
Some larger fusion tags, when fused to an insoluble protein, can render the fusion protein 
soluble. The first fusion tag to be developed specifically for this purpose was E. coli thioredoxin 
(Lavallie et al., 1993). Subsequently, a large fusion tag of 495 amino acids was created from the 
E. coli nusA (nusA) gene following a solubility analysis of the E. coli genome. Other fusion tags 
reported to enhance solubility are glutathione S-transferase (GST) and maltose-binding protein 
(MBP). Korf et al. compared the nusA, His, MBP, and GST fusion tags for yield of soluble 
expressed fusion protein and found that MBP and nusA fusions were more likely to produce 
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soluble fusion proteins than His and GST (Korf et al., 2005). The fusion of small ubiquitin-
related modifier (SUMO) to the N-terminus of under-expressed proteins was also shown to 
dramatically enhance their expression (Malakhov et al., 2004) and solubility (Marblestone et 
al., 2006) in E. coli.  
pET14b vectors carrying MBP, NusA and SUMO respectively, were kindly donated by Dr. 
Manfred Konrad ( Max-Planck Institute for Biophysical Chemistry, Goettingen), as was pGEX-Rb 
(carrying GST).  The NusA and SUMO were both additionally His-tagged to facilitate purification 
post-expression. MBP can be purified by binding to amylose resin, and GST by binding to 
glutathione resin. 
All four constructs were designed for the gene of interest to be cloned within the MCS using 
restriction enzymes Nde1 and BamH1, to result in the cloned fragment joined with the 
solubility enhancing protein at its N-terminus.  The constructs also contain a sequence for a 
thrombin cleavage site between the cloned gene and solubility tag, to allow thrombin-
mediated post-purification separation of the protein from its fusion tag.  An example of the 
cloning region described is illustrated in Figure 4.16, with the pET14b-SUMO sequence of this 
region. 
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Figure 4.16: Multiple cloning site sequence of pET14b.  The Nde1/BamH1 cloning site in pET14b-SUMO, followed 
by a sequence coding for a thrombin cleavage site (lower case), SUMO-tag (green) and His-tag (red) at its N-
terminus. The constructs of pET14b-MBP and pET14b-NusA were identical, with the coding region for SUMO being 
replaced with that for MBP and NusA respectively. 
A list of the fusion partners, along with their sizes and the purification methods required are 
listed in Table 4.3 below. 
Table 4.3: Fusion proteins used in this study to enhance solubility and simplify purification. 
Fusion Partner Molecular Weight (kDa) Purification Method 
6 x His – SUMO 12.2 IMAC 
MBP 45 Amylose 
6 x His – NusA 58.4 IMAC 
GST 27.3 Glutathione-Sepharose 
 
In order to produce solubility-tag –Nat3p fusion proteins, the NAT3 gene was first amplified 
from S. cerevisiae genomic DNA using PCR (with primer set 14,Table 2.5) as described in 
Section 2.2.1.1. The amplified fragment was then digested with Nde1 and BamH1 (Section 
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2.2.4) and ligated into pGex, pET14b-MBP, pET14b-NusA and pET14b-SUMO respectively 
(Section 2.2.5). Ligated constructs were used to transform (2.2.8.1) XL1-Blue competent cells 
(2.2.7), and colonies screened for the presence of NAT3 insert ,using T7 and T7-reverse primers 
(2.2.1.2). Plasmid DNA was extracted from colonies that screened positive (2.2.9), and this 
DNA was sequenced to confirm the presence and integrity of insert.  Successful cloning was 
followed by transformation of  BL21(DE3)pLysS with each new construct, and subsequent 
protein expression (as described in Section 2.4.1).  
Expression trials showed that SUMO-, GST- and MBP-Nat3p fusions were insoluble (gel not 
shown). 
The NusA-Nat3p fusion expressed from pET14b-NusA, however, showed significant expression 
of soluble protein (Figure 4.17). Lane S of the SDS gel in 4.2.11 shows soluble expression of 
NusA alone. While some of the NusA-Nat3p expressed was insoluble (Lane +N, I), the majority 
of the fusion protein expressed was in the soluble fraction.  
 
Figure 4.17: An SDS gel showing Results of expression studies from pET14b-NusA-Nat3p. Uninduced (UI), induced 
(I), insoluble (IS) and soluble (S) fractions of the solubility enhancer alone, as well as fused to Nat3p (+N). Induction 
conditions: 0.2 mM IPTG, at 16°C for 16 hours. 
 
Once it was seen that the NusA-Nat3p fusion was soluble, and easily and effectively purified, 
the NusA tag was cleaved from Nat3p to test whether Nat3p remained soluble without its 
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solubility enhancing tag. Thrombin was used to cleave NusA from Nat3p. The thrombin 
cleavage reaction was attempted with NusA-Nat3p bound to the nickel-chelating column, as 
well as post-elution in solution. In both cases Nat3p appeared to aggregate instantaneously on 
cleavage of NusA. This aggregation appeared in the form of visible precipitate in the case of 
cleavage in solution.  In the case of on-column cleavage, Nat3p did not wash off the column, 
leading to the suggestion that it remained as precipitated aggregate on the resin. This was 
confirmed by washing the column with 6 M urea, whereby Nat3p was solubilised by the 
denaturant and stripped from the column (as confirmed by SDS-PAGE). These results could be 
explained by the fact that by virtue of its extremely high solubility, and large size in comparison 
to Nat3p (58.4 kDa as opposed to 22.9 kDa for Nat3p), NusA may confer solubility to the fusion 
despite Nat3p remaining misfolded and insoluble. An alternative explanation is of course that 
Nat3p in its native state is highly hydrophobic, and therefore innately insoluble. 
4.2.7.4 Additives to Improve Soluble Expression of Nat3p 
 
The final attempt in obtaining soluble Nat3p in vivo for further investigation was the use in 
growing cultures of additives that have been shown to assist in protein folding in vivo. The 
benefit of adding to culture media agents that promote folding is as empirical and 
unpredictable as the other approaches described above for obtaining soluble recombinant 
protein. In fact a number of studies have shown that certain strategies that may increase the 
yield of certain proteins actually have detrimental effects on the expression of others. Once 
again, after thorough literature review and based on previous success and availability of 
reagents, a number of additives were screened to improve soluble expression of Nat3p. These 
additives, along with their postulated roles and appropriate references are listed in Table 4.4 
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Table 4.4: A list of additive used for the in vivo enhancement of expression of soluble Nat3p 
Additive Role Time of 
Addition 
Conc. Reference 
Ethanol Upregulates the 
synthesis of heat- 
shock proteins 
Added to 
media 
3 % (Thomas et al., 1997) 
Glycerol Reduces acetic acid 
production. Chemical 
chaperone 
Added to 
media 
10 % (Strandberg and Enfors, 
1991), (Martinez et al., 
1995) 
Arginine Unclear- thought to 
repress aggregation 
At induction 0.4 M (Schaffner et al., 2001) 
Benzyl Alcohol Induction of 
endogenous 
chaperones 
20 minutes 
before 
induction 
10 mM (De Marco  A et al., 2005) 
Chloramphenicol Arrests protein 
synthesis and shifts 
equilibrium from in 
vivo protein 
precipitation to 
refolding 
Different 
times post-
induction 
200 µg/ml (Carrio et al., 2000) 
 
Of the additives tested (Table 4.4), the treatment of cells with chloramphenicol had a positive 
impact on the expression of soluble His-Nat3p in vivo.  The basis of this treatment is that 
misfolded, insoluble proteins formed after IPTG induction can be resolubilised and refolded if 
protein synthesis was inhibited. This is achieved by adding chloramphenicol to concentrations 
far greater than the amount that can be degraded by the chloramphenicol acetyltransferase 
encoded on the pLysS plasmid (Carrio et al., 2000, Carrio and Villaverde, 2001). This is used in 
the BL21(pLysS) strain to improve repression of expression pre-induction. 
In this case standard expression of His-Nat3p expression in 1 L of culture was carried out as 
described in Section 2.4.1, until the point of induction. Once the culture had reached an OD of 
0.6, the cells were induced with IPTG at a final concentration of 1 mM, and allowed to shake 
vigorously overnight at 30 °C. The cells were then harvested by centrifugation, and 
resuspended in 500 ml LB. At this point chloramphenicol was added to the LB to a final 
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concentration of 200 µg/ml. The cells were then returned to 37 °C and allowed to shake for a 
further two hours before being harvested for the last time.  
Harvested cells were lysed and analysed by SDS page as described earlier in Section 4.2.1. 
 
Figure 4.18: SDS-PAGE gel of chloramphenicol treatment on Nat3p expression in vivo. Expression and IMAC 
purification of soluble His-Nat3p in vivo in the absence (A) and presence (B) of chloramphenicol treatment of the 
culture. M= marker, I = induced, S= soluble, IS= insoluble, FT= flow through from IMAC purification, E1-E4= 1.5 ml 
eluted fractions. (Insoluble Nat3p was solubilised in urea and runs slightly lower on SDS gel, as seen in B). 
 
Figure 4.18 shows SDS-gels describing the purification of soluble His-Nat3p with (B) and 
without (A) chloramphenicol treatment. As can be seen in Lanes I and S on both gels, while 
most His-Nat3p expressed was insoluble in the untreated cells, a significant amount of the 
Nat3p expressed in the chloramphenicol-treated cells was soluble. The Nat3p in Lane IS is seen 
to run slightly lower than Nat3p in the other lanes because of the presence of urea used to 
solubilise the insoluble protein prior to loading on the SDS-gel.  
Lanes E1-E4 (Figure 4.18) show that this soluble His-Nat3p could also be purified on a nickel 
chelating column. However, interestingly, not all the soluble His-Nat3p appeared to bind to the 
nickel-chelating column, as seen by the apparent presence of some His-Nat3p in the flow-
through (Gel B, Lane FT). It may potentially be that a side-effect of chloramphenicol treatment 
is some N-terminal clipping of His-Nat3p, which results in a loss of the His-tag, although this 
was not confirmed. 
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The purified His-Nat3p fractions (E1 – E4, Figure 4.2.3, B) were subsequently pooled.  The 
concentration of the purified protein was determined to be 0.2 mg/ml giving a final yield of 0.8 
mg of His-Nat3p per litre. This yield is an order of magnitude larger than seen when previously 
purified (4.2.1). Nat3p was then dialysed against 10 mM TRIS, 100 mM NaCl, pH 8 buffer for 
immediate use in the fluorescence-based assay that was designed to monitor Nat3p binding to 
ACoA (Section 4.2.8).  
4.2.8 Nat3p Acetyl Co-A binding fluorescence assay   
A detailed in Section 4.1, Nat3p is a member of the GNAT superfamily of proteins. All 
structurally characterised members of this family of acetyltransferases were seen to share a 
core structural fold, comprising four motifs (A-D) as seen in Figure 4.2.2. In Section 4.2.2 the 
structure of Nat3p was predicted based on this shared core GNAT fold, using structural 
alignments of known members of the GNAT family. A strong structural alignment was 
observed in motifs A, B and D.   
In GNATs, the binding of acetyl-CoA induces sometimes-dramatic changes in the conformation 
of regions of the fold, primarily in the conformation motif A and occasionally in the ‘‘P loop’’ 
which coordinates the pyrophosphate moiety. This change can generate additional structural 
elements that are necessary for cognate substrate recognition and binding. Based on the high 
degree of identity of Nat3p to other GNAT members observed through the molecular 
modelling, it was proposed that this change in conformation of the GNAT fold on binding to 
ACoA is also likely to occur in Nat3p.  
An assay was designed to monitor potential changes in the structure of Nat3p. This assay was 
based on intrinsic Nat3p fluorescence conferred by two Trp residues, in position 39 and 74 of 
the sequence. Figure 4.19 shows Nat3p sequence data superimposed on the structure of 
human analogue GCN5, with ACoA bound in a cleft between the two sides. Helices are shown 
red (except for α1 and α2, which are deleted in Nat3p and highlighted yellow) and the 
remaining, mainly beta sheet, shown blue. The positions of the two Trp residues in Nat3p are 
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shown in green. Binding of ACoA can be expected to potentially change the conformation of 
the cleft, thus changing the environment of Trp 74. 
 
Figure 4.19: Nat3p sequence data superimposed on the GCN5 (IZ4R) structure. Helices are shown red (except for 
α1 and α2, which are deleted in Nat3p and highlighted yellow) and the remaining, mainly beta sheet, shown blue. 
The positions of the two Trp residues in Nat3p are shown in green. 
 
On the basis of the above information, in an in vitro Nat3p solution, any changes in intrinsic 
Nat3p fluorescence on the addition of ACoA can be attributed to a change in the electronic 
environment surrounding either/both Trp residues. This in turn is likely to be the result of a 
change in structural conformation upon substrate binding. Therefore, by measuring changes in 
the fluorescence signal, the potential binding of ACoA to Nat3p can be monitored. Emission 
and excitation spectra of the protein were measured, and these were used to determine the 
optimum emission and excitation wavelengths in this experiment.  These were initially chosen 
at the maxima, giving an excitation wavelength of 280 nm and an emission wavelength of 330 
nm, respectively. 
However, the absorbance spectra of ACoA (Figure 4.20) showed that ACoA had an absorbance 
peak at 260 nm, and significant absorbance at 280 nm. This would produce significant inner-
filter effect (IFE), where molecules other than the fluorophore absorb excitation energy in the 
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solution, hence reducing the observed fluorescence signal. To avoid this, excitation wavelength 
was shifted to 285 nm, at which absorbance by ACoA was much lower. The small remaining 
absorbance of excitation radiation by ACoA was corrected for as discussed below. 
 
Figure 4.20: Absorbance scan of ACoA, and Nat3p before and after the addition of ACoA. The absorbance scan 
(250 – 400 nm) shows that fter the addition of 1.72 µM ACoA. ACoA has an absorbance peak at 260 nm, and also 
some absorbance at 285 nm, the excitation wavelength for the assay.. 
 
To start the experiment ACoA was added in 5 µl steps from a 50 µM stock to  1 ml of purified 
Nat3p (at approximately 0.2 mg/ml). Care After each addition of ACoA the mixture was excited 
at 285 nm and the intensity of fluorescence emission at 330 nm was monitored. ACoA was 
added until a final concentration of 2 µM was reached. Over the course of the experiment, a 
significant change in the fluorescence signal was observed due to the addition of ACoA (Figure 
4.21). 
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Figure 4.21: Change in tryptophan fluorescence with the addition of ACoA to purified Nat3p. ACoA was added in 5 
µl increments from a 50 µM stock. The solution was excited at 285 nm (4 nm bandwidth) and emission measured at 
330 nm (16 nm bandwidth). 
 
Figure 4.21 shows a change in fluorescence signal was observed on addition of ACoA. The 
reduction in fluorescence signal is presumed to be as a result of the quenching of Trp 
fluorescence caused by conformational changes that arise on ACoA binding.  
With respect to these raw data, the inner filter (or self-absorbance) effect must be considered 
before assuming that the measured signal is directly proportional to the conformational 
change. In this case the inner filter effect is caused by progressive absorption of the 
fluorescence excitation light by ACoA (Figure 4.20) as it penetrates the solution, thereby 
producing progressively less fluorescence signal.  
A simple approximation allows this to be corrected for: 
 Absorbance = -log10 [Transmittance] 
Transmittance = 10-Absorbance 
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Fluorescence  Absorbance by the fluorophore, but this will be reduced by absorbance by the 
non-fluorescent species 
This absorbance due to the non-fluorescent species will be dependent upon its concentration. 
Thus, if it is being added to the solution there will be two effects seen upon the fluorescence: 
one from the conformational change of Nat3p, and one due to the absorbance of ACoA. If 
plotted on a semi-log plot, then the IFE will be a straight line that can be corrected for (Figure 
4.22)  
 
Figure 4.22: Correction of IFE. The black line represents Log fluorescence change due to ACoA. The difference 
between the red and black lines represents actual Log fluorescence quenching by virtue of a conformational change 
in Nat3p. 
 
Figure 4.22 shows the raw fluorescence change observed on a logarithmic scale (red line on 
the graph in Figure 4.21) against concentration of ACoA. Any conformational changes occurring 
by Nat3p binding to ACoA are likely to take place at the start of the experiment, resulting in 
change in fluorescence signal at lower ACoA concentrations. When ACoA is in excess [ACoA] at 
1 µM or more in Figure 4.21 and Figure 4.22, the continued reduction in fluorescence observed 
is caused solely by absorbance of excitation energy by ACoA (IFE). Therefore, extrapolating 
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backwards from this the log fluorescence data isolates the IFE (represented by the black line in 
Figure 4.22).  The difference between the two lines is then representative of the actual change 
in intrinsic fluorescence signal from the Nat3p Trp(s) on addition of ACoA.   This change in 
fluorescence can be fitted by a hyperbolic curve representing a simple binding model to 
determine an affinity for ACoA (Figure 4.23). 
 
Figure 4.23: Change in Nat3p fluorescence on addition of ACoA, post-IFE-correction. 
 
The binding curve in Figure 4.23 shows that the apparent binding affinity for ACoA of Nat3p is 
around 0.26 µM. This is in the region of binding affinities that have been determined for other 
GNAT members (Langer et al., 2002). 
  
4.2.9 Site-directed mutagenesis of the Trp residues in Nat3p 
As seen in Figure 4.19, the two Trp residues in the Nat3p sequence are predicted to be located 
such that a change in conformation of the domain would potentially alter their electronic 
environments. To elucidate the source of the fluorescence change observed in the assay in 
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Section 4.2.8, it was decided to use site-directed mutagenesis (Primers and methods detailed 
in Section 2.2.2) to change both Trp residues (at positions 39 and 74 of the Nat3p sequence) to 
Gly and Phe respectively. Phe was chosen as it is a bulky amino acid, and therefore should 
potentially minimise any significant alterations in the conformation when replacing Trp. 
Although sufficient soluble Nat3p to carry out these investigations was not obtained at this 
point, these NAT3 mutants were used in genetic studies in Chapter 5, to analyse the 
significance of Trp39 and Trp74 residues on Nat3p function in vivo in S. cerevisiae. 
4.2.10 Cloning of NatA and NatC 
Following the data obtained from investigations into Nat3p, and given the limited information 
on a molecular level currently available on NATs in general, it was decided to clone 
constituents of both the NatA and NatC, the other two main S. cerevisiae N-terminal NAT 
complexes, as targets for future study. 
All genes (NatA: NAT1, NAT5 AND ARD1; NatC: MAK3, MAK10 AND MAK31) were amplified 
from yeast genomic DNA using PCR (Primer sets 6 – 13, Table 2.3). The resultant fragments 
were cloned into expression vector pET14b-SUMO. 
 In two cases (ARD1 and NAT1), an internal BamH1 site was present within the coding 
sequence of the gene of interest. With the cloning strategy used for expression, these had to 
be removed by site-directed mutagenesis to allow full-length clones to be expressed. 
 Although in the case of NAT1 this site was successfully removed via site-directed mutagenesis 
and fusion PCR prior to cloning into pET14b-SUMO (Sections 2.2 for details on techniques 
used), the cloning of ARD1 was not successful.  Details of all constructs are listed in  Table 4.5. 
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Table 4.5: Genes from S. cerevisiae NatA and NatC cloned in this study 
Gene Complex Internal 
BamH1 sites 
Successfully 
cloned 
Nat1 NatA 1 Yes 
Nat5 NatA - Yes 
Ard1 NatA 1 No 
Mak3 NatC - Yes 
Mak10 NatC - Yes 
Mak31 NatC - Yes 
  
4.2.11 Expression of Nat5p 
Of the cloned S. cerevisiae N-terminal NAT genes, the gene products of MAK3 and NAT5 are 
known members of the GNAT superfamily.  To determine the extent of their potential 
structural similarity to Nat3p, the structure of Mak3p and Nat5p was predicted by threading 
their sequences through the low-redundancy dataset used to model Nat3p (Section 4.2.2). The 
results of this predictive modelling showed that the GNAT motifs A, B and D were conserved in 
both Mak3p and Nat1p (Figure 4.24). In addition, Mak3p and Nat1p predicted structures also 
contained the helix-loop-helix region of motif A that, while present in all other structurally 
characterised GNATs, was seen to be deleted in Nat3p (Section 4.2.2).  
 
Figure 4.24: Structure and sequence alignment of the  α1 and α2 helices of 23 GNATs. The helices are highlighted in 
yellow and this entire region is missing in the Nat3p alignment but present in both Mak3p and Nat5p. Of the two, 
Nat5p has a more extensive α1 and α2 helical region. 
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The left panel in Figure 4.24 is the alignment of GNAT structures (Figure 4.2) rotated to show 
the α1 and α2  region (highlighted in yellow). Although this region aligns very poorly between 
structures due to the varying lengths and orientations of the helix-loop-helix in each case, it 
can be seen that in every case this region is present and provides a shield protecting the 
hydrophobic core β-sheet (green) from exposure.  
The right panel in Figure 4.24 shows the sequence alignment of these same GNATs in this 
region (also highlighted yellow). Here it can clearly be seen that the sequence coding for the 
helix-loop-helix is deleted in Nat3p, but present in both Nat5p and Mak3p. The alignments also 
showed that Nat5p is predicted to have a larger α1 and α2 helix-loop-helix protecting the inner 
hydrophobic β-sheet core.  Based on this information, and given the prediction made that this 
would be important for protein solubility, it was decided to attempt the expression and 
purification of Nat5p.  
Initial expression trials (as detailed in Section 2.4.1) of SUMO-Nat5p were thus undertaken, 
and the protein was seen to be soluble. Subsequent IMAC purification (Section 2.4.2.2) 
resulted in purified, soluble SUMO-Nat5p (Lane 2, Figure 4.25). The concentration of the 
purified protein was assayed and determined to be around 0.8 mg/ml, giving a final yield of 4.8 
mg per litre of culture. 
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Figure 4.25: SDS-gel showing soluble SUMO and SUMO-Nat3p. The proteins were expressed under standard 
conditions (1 mM IPTG, 16 °C , overnight), and purified via IMAC. Lane 1 shows soluble SUMO, and lane 2 the 
soluble SUMO-Nat5p fusion. 
 
This result is in agreement with and acts as evidence for the theory proposed earlier that the 
deletion of the helix-loop-helix in Nat3p results in it being much less stable and more 
hydrophobic than a protein where this motif is present, such as Nat5p. 
4.2.12 Crystallisation of SUMO-Nat5p 
The soluble, purified SUMO-Nat5p was concentrated using a spin concentrator to a 
concentration of about 5 mg/ml. At this concentration, the protein was used in crystal screens 
(Hampton Screens I and II).  After two weeks, crystals of SUMO-Nat5p were seen in Buffer 
condition 11 from Hampton Crystal Screen II ® (Figure 4.26). 
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Figure 4.26: Crystal resulting from preliminary crystal screen of SUMO-Nat5p. The crystal was formed from SUMO-
Nat5p at 5 mg/ml, in Buffer Condition 11 from Hampton Crystal Screen II®. 
 
The crystal was an irregular hexaganoid shape, measuring approximately 200 µM at its longest. 
With further refinement screens, a crystal of sufficient size to be used for X-ray diffraction is 
likely to be obtained- an important step towards acquiring structural information about Nat5p. 
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4.3 Discussion 
Nat3p, the catalytic subunit of the NatB acetylase complex was initially expressed 
recombinantly in E. coli expression strain BL21(DE3) pLysS, from expression vector pJC20-HisN, 
and found to be insoluble. 
 Nat3p inclusion bodies were successfully solubilised in 6 M urea, and the unfolded, His-tagged 
protein was effectively purified by IMAC. Refolding experiments were largely unsuccessful. 
Nat3p was seen to aggregate consistently in all refolding buffers, except in the absence of salt. 
However, although visible precipitate in this case was absent, the combined results from CD 
and DLS analysis showed that Nat3p was still present in the form of incompletely folded, large 
aggregates in solution, even in the presence of numerous aggregation inhibitors. The extreme 
tendency of Nat3p to aggregate in the presence of even low concentrations of salt is 
symptomatic of acute hydrophobicity.  
The enhancement of expression of soluble Nat3p in vivo was attempted using various 
strategies. The fusion of NusA to Nat3p resulted in high levels of soluble fusion protein. 
However, Nat3p was, once again, seen to aggregate on cleavage of the solubility tag, inferring 
either misfolding or intrinsic insolubility. 
The addition of high concentrations of chloramphenicol to the post-induction culture has been 
previously shown to reverse inclusion body formation, allegedly by slowing protein synthesis 
and shifting the equilibrium from protein aggregation to protein folding. This method 
produced some soluble Nat3p in vivo, although the proportion of total Nat3p that was soluble 
was very low. Potential reasons for this include the possibility that chloramphenicol was able 
to slow down the synthesis, and therefore rate of folding, of Nat3p to levels lower than 
achievable by other methods attempted in this study (including lowering temperature and 
IPTG concentration), boosting its chances for folding correctly. This would also offer some 
rationalization for the chronic failure of all refolding attempts.  Another possibility is that high 
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concentrations of chloramphenicol result in a uniquely stressed intracellular environment, 
which in turn leads to the synthesis of proteins that are not otherwise present. These may be 
chaperones, or simply fortuitously beneficial to the correct folding of Nat3p. 
The soluble Nat3p showed signs of functionality in a fluorescence-based substrate (ACoA)- 
binding assay. Intrinsic Nat3p fluorescence, attributable to two tryptophan residues (Trp39 and 
Trp74) was monitored. The addition of ACoA resulted in a change in the fluorescence signal, 
which is strongly indicative of a change in Nat3p conformation as a result of binding the ACoA.  
This is indicative that the presence of Mdm20p may not be essential for Nat3p to function. 
Nat3p is a known member of the GNAT superfamily of N-acetyl transferases. Based on this 
information, and because all known structures of GNAT proteins have strongly conserved 
motifs (despite very low sequence identityy), the 3D structure of Nat3p was predicted based 
on existing GNAT structures. Using vector-based molecular modelling with VAST and cn3D 
(NCBI), the sequence of Nat3p was threaded through 23 sequences from a low-redundancy 
dataset of GNAT protein structures. 
An initial alignment of the 23 structures highlighted the conserved motifs (Figure 4.2.2 and 
4.2.3): an N-terminal beta strand (β1) followed by two helices (α1 and α2); three antiparallel 
beta strands (β2, β3 and β4) and then a ‘‘signature’’ central helix (α3); a fifth beta strand (β5), a 
fourth helix (α4) and a final beta strand (β6). The predicted structure of Nat3p has most, but 
not all, of the above domains conserved. Notably, the N-terminal helices, present in all GNAT 
structures so far available, appear to be deleted in Nat3p. This is noteworthy because it 
provides a potential ‘docking’ site against the beta sheet, for mdm20p, the auxiliary subunit of 
NatB. In addition it opens up the possibility that Nat3p has such low inherent solubility by 
virtue of the exposed hydrophobic beta sheet that is not afforded protection by the N-terminal 
helices.  
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Most constituent proteins from the two other major yeast N-acetyl transferase complexes 
(NatA and NatC) were cloned during this study, for use in potential future investigations. Of 
the available clones, Nat5p (from NatA) and Mak31p (from NatC) are GNATs which are closely 
related to Nat3p. The 3D structure of these proteins was also predicted using the same 
methodology as that used to model Nat3p. The results indicated that both proteins had some 
additional alpha-helical component that was seen to be missing in Nat3p. Of the two, Nat5p 
was predicted to have a more extensive N-terminal alpha helix than Mak31p, and was 
therefore used to test the hypothesis that these helices confer increased solubility to the 
protein by protecting the hydrophobic beta sheet from exposure to solution. 
Despite its structural homology, Nat5p has not been ascribed to be the catalytic subunit of the 
NatA complex due to a lack of observable phenotype in Nat5Δ deletion strains.  Therefore, the 
question of its catalytic competence was not addressed. However, the lack of phenotype may 
also potentially be because the function of Nat5p is redundant, and this could be evaluated in 
future. 
In contrast to SUMO-Nat3p, SUMO-Nat5p expressed in vivo was almost exclusively soluble, 
corroborating the above hypothesis. The soluble fusion was concentrated to 5 mg/ml and 
formed crystals in Buffer Condition 11 from Hampton Screen ll®.  
In conclusion, Nat3p appears to be innately highly insoluble. This can putatively be explained 
by the predicted structure of Nat3p, where a hydrophobic beta sheet is exposed because the 
N-terminal helices that obscure it in virtually all other GNAT proteins are deleted in Nat3p. This 
hypothesis is substantiated by the increased solubility of Nat5p, whose predicted structure 
includes this helical component. Future work to investigate this further could also include the 
engineering of a 15-residue extension at the N-terminus of Nat3p, and analysis of the 
stability/solubility of this protein when expressed. 
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5 Effects of Nat3p and Tms on cell size and morphology. 
5.1 Introduction 
Both Tpm1p and Nat3p have been described in some detail in the Chapter 1 (Sections 1.1 and 
1.2). The work in this chapter aims to describe quantitatively, the effects of these proteins, and 
of the novel crTms, on the cell size, morphology and actin cytoskeleton of S. cerevisiae to 
better understand their roles in vivo. The investigation involves cell biology studies of deletion 
mutants and their rescue by different expression constructs. The cells are then stained and 
visualised using fluorescence microscopy to allow quantitative and qualitative analysis of 
effects on cell size, morphology and the actin cytoskeleton.   
The detailed objectives are then to: 
1) To enhance our current understanding of the roles of Nat3p and Tpm1p within yeast. by 
quantitatively characterising the phenotype of NAT3Δ mutants and TPM1Δ deletion mutants in 
terms of cell size, morphology, actin cytoskeleton and DNA distribution.  It is hoped that the 
results of this study will provide a more detailed phenotypic description of these mutants than 
presently available. 
2) To clarify whether Nat3p has major substrates, other than Tpm1p, whose lack of acetylation 
in NAT3Δ cells contributes to the abnormal phenotypes observed. The objectives to reach this 
aim include quantitatively comparing and contrasting the phenotypes of TPM1Δ and NAT3Δ  
mutants, and  assessing the ability of TPM1 with an N-terminal dipeptide (Ala-Ser) extension to 
suppress NAT3Δ defective phenotypes. Tpm1p with a dipeptide extension was previously 
shown to possess functionality closest to that of acetylated Tpm1p. This makes the AS-TPM1 a 
more suitable representative of native TPM1 than the TPM1-5 mutant used previously. This 
study should therefore resolve the question regarding how much of the NAT3Δ phenotype can 
be attributed to lack of functional Tpm1p. 
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3) To investigate the potential functions of the novel crTms by testing their ability to rescue 
TPM1Δ mutants. This will tell us whether they are able to function in a manner similar to 
Tpm1p in vivo in S. cerevisiae. 
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5.2 Results 
5.2.1 Complementation Studies 
As explained in the introduction, the first objective was to carry out a quantitative phenotypic 
analysis of NAT3Δ and TPM1Δ yeast deletion mutants, and then to observe the effects on the 
defective phenotypes of over-expressing various genes. The complementation analyses are 
described here in more detail: 
5.2.1.1 NAT3Δ  
 
For the NAT3Δ mutant, it was decided to over-express NAT3, AS-TPM1 and NAT3W74F. It was 
expected that over-expression of NAT3 would suppress the defective phenotypes of this 
knockout. As discussed previously, it remains unclear whether the phenotypic defects of 
NAT3Δ cells are due primarily to the production of unacetylated (and therefore non-functional) 
Tpm1p. The over-expression of AS-TPM1 (henceforth, in this chapter, referred to as TPM1 for 
brevity) will help determine the extent of the phenotypic defect that can be ascribed to a 
defective Tpm1p. NAT3W74F is a mutant of NAT3, where the codon for Trp, in position 74 of 
Nat3p, has been replaced with the codon for Phe. Referring to Chapter 4, Section 4.2.9 (and 
Figure 4.19), this Trp can be seen to be located in some proximity to the putative binding sites 
for ACoA as well as Mdm20p. The importance of this residue to the function of Nat3p in vivo 
was investigated by expressing this mutant in NAT3Δ yeast cells.  
5.2.1.2 TPM1Δ 
 
The genes used to complement the TPM1Δ mutant were TPM1, and the N. crassa Tms. 
Because AS-Tpm1p has been showed to exhibit native Tpm1p -ike properties in vitro, the 
expression of TPM1 was expected to correct for defects observed in TPM1Δ in vivo in S. 
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cerevisiae. It was hoped that over-expressing the N. crassa Tms in this knockout strain would 
give some insight into their roles. 
5.2.2 Creating Yeast Expression Constructs 
In order to over-express genes in S.cerevisiae, it was required that these genes be present in a 
suitable expression vector. YEp512N was the expression vector of choice. Yeast genes were 
cloned into this vector using restriction enzymes Nde1 and BamH1, as described previously 
(Section 2.2). The constructs made for this investigation are listed in Table 5.1. 
Table 5.1: Backbone and insert for each new yeast expression construct created for this study 
Backbone vector Insert 
Yep512N ASTPM1 
Yep512N NAT3 
Yep512N NAT3 W39F 
Yep512N NAT3W74F 
Yep512N crTm123 
Yep512N crTm161 
 
5.2.3 Transformation of S. cerevisiae 
Once all the yeast expression constructs had been made, they were used to transform S. 
cerevisiae as described in Section 2.2, to produce a number of new yeast strains. WT and both 
mutant strains were also transformed with blank Yep512N to ensure that the phenotype 
observed when a cloned gene was over-expressed was a result of this over-expression only, 
and not caused by the vector itself. A list of these strains is tabulated in Table 5.2.  
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Table 5.2: New yeast strains produced for this study 
Strain Vector Transformed New Strain 
WT YEp512N  
TPM1Δ YEp512N  
NAT3Δ YEp512N  
TPM1Δ YEp512N -TPM1 TPM1Δ-TPM1 
TPM1Δ YEp512N -crTm123 TPM1Δ-crTm123 
TPM1Δ YEp512N -crTm161 TPM1Δ-crTm161 
NAT3Δ YEp512N -NAT3 NAT3Δ-NAT3 
NAT3Δ YEp512N *-His-NAT3 NAT3Δ-His-NAT3 
NAT3Δ YEp512N -NAT3-W39F NAT3Δ-NAT3-W39F 
NAT3Δ YEp512N -NAT3-W74F NAT3Δ-NAT3-W74F 
NAT3Δ YEp512N -TPM1 NAT3Δ-TPM1 
 
5.2.4 Expression of Tms and Nat3p in S.cerevisiae 
All transformants were grown under identical conditions, as described in Section 2.7. The 
genes cloned in YEp512N are expressed under the GAL10 promoter. This means that in the 
presence of glucose, the expression of the cloned genes is repressed, whereas in the presence 
of galactose expression is induced. Where the expression of the transformed genes was not 
required, cells were thus grown with glucose as the carbon source. When over-expression of 
the cloned genes was needed, cells were grown in media containing galactose as the sole 
carbon source (Details in Section 2.7.1). 
 The extent of over-expression of Tpm1p, His-Nat3p, crTm123p and crTm161p in S. cerevisiae 
was estimated by induction with galactose as described above, followed by subsequent 
purification and SDS-PAGE analysis. The Tms were purified by boiling and iso-electric 
precipitation (Section 2.4.2.1); and His-Nat3p by IMAC (Section 2.4.2.2.3). Figure 5.1 shows an 
SDS-PAGE analysis of the protein products from the strains that were induced with galactose. 
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Figure 5.1: SDS-PAGE gel of purified Tms and Nat3p over-expressed in S. cerevisiae. S. cerevisiae culture was 
grown on galactose overnight to induce expression of tmp1, crTm123, crTm161 and NAT3 gene products. Tpm1p, 
crTm123p and crTm161p were purified from yeast liquid culture by boiling and iso-electric precipitation. His-Nat3p 
was purified by IMAC. 
 
Lane 1 in Figure 5.1 shows a distinct band that is the right size for yeast Tpm1p. Similarly, lanes 
3 and 4 show bands that represent the over-expression of crTm161p and Tm123p respectively. 
The bands in this case are not as distinct. This is likely because the molecular weight of these 
Tms is less than half that of Tpm1p. Lane 2 shows His-Nat3p that was over-expressed and then 
purified. Once again, the band intensity is not as strong as that for Tpm1p. In this case the 
explanation is more likely that because Nat3p is an enzyme whose native cellular 
concentration is only about 600 copies per cell, it is perhaps unstable at higher than its 
physiological concentration. This may also be a possible explanation for the observation in 
Chapter 4, that Nat3p expressed recombinantly aggregated readily at high concentrations.  
Direct injection mass spectrometry analysis of these samples was attempted for additional 
verification. However, these attempts were unsuccessful due to the presence of large amounts 
of salts and contaminants in the extracts. 
5.2.5 Assaying sensitivity at 37°C 
The results from 5.2.4 were indicative that in the presence of galactose, the cloned genes were 
being over-expressed. This experiment investigated the sensitivity of each strain to an elevated 
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temperature of 37 °C. In order to analyse the temperature sensitivity of the strains, each was 
serially diluted on a plate of solid YPD media, and allowed to grow for 3 days at 37 °C (Figure 
5.2). Where the cloned genes were to be repressed, glucose was provided as the carbon 
source. Conversely, where over-expression of the cloned genes was desired, the medium 
contained galactose. Figure 5.2 shows both dishes after 72 hours at 37 °C. 
 
Figure 5.2: Complementation assay of ΔTPM1 and ΔNAT3 strains transformed with Tms and NAT3. Growth  at 
37°C of ΔTPM1 mutants transformed with (2-TPM1, 3-crTm161, 4-crTm123) and ΔNAT3 mutants transformed with 
(5-TPM1, 6-NAT3, 7-His-NAT3) on galactose (induced) and glucose (uninduced).   Serial 1/10 dilutions of the 
following isogenic series of strains grown on media selective for YEP512N (*), for 3 days. 1-Wild type S. cerevisiae 
also transformed with blank YEP512N. Upper panel is a photograph of the pates, the lower panel is image processed 
to outline colonies for increased clarity. 
 
In each case, the initial dot (extreme left) was a 2 µl drop of culture at an OD600 of 0.1. Each 
subsequent dot from left to right represents a 10 fold dilution of the dot before it. The results 
are represented numerically in Table 5.3. 
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Table 5.3: Results of dot blot to assay growth of yeast strains at 37 °C.  
The growth is listed as the maximum dilution at which each strain remained viable 
 
Strain 
Maximum dilution at which 
cells grow at  37 °C 
1 Wild Type 104 
2 TPM1Δ 10 
3 NAT3Δ 0 
4 TPM1Δ- TPM1 104 
5 TPM1Δ- crTm123 104 
6 TPM1Δ- crTm161 104 
7 NAT3Δ-NAT3 10 
8 NAT3Δ-His-NAT3 10 
 NAT3Δ-TPM1 10 
 
According to the results from the dot blots in Figure 5.2, and Table 5.3, the mutant strains 
(grown on glucose) were unable to sustain growth at 37 °C; while the TPM1Δ mutants were 
able to grow to some degree after being diluted 10 fold, the NAT3Δ mutants showed the more 
severe phenotype as they were unable to grow at all. These results are initially indicative that 
NAT3Δ and TPM1Δ mutants do not behave in an identical fashion at 37 °C. 
In the presence of galactose as the carbon source (Figure 5.2, left dish) the cloned genes were 
over-expressed. Here it can be seen that TPM1Δ strain is able to grow at similar a similar rate 
as wild-type cells when TPM1 is over-expressed in the cells (Table 5.3).  This indicates that the 
over-expression of unacetylated Tpm1p, with an N-terminal Ala-Ser extension is able to 
completely rescue the temperature sensitivity phenotype of TPM1Δ in vivo. 
Interestingly the TPM1Δ knockouts over-expressing both crTm123 and crTm161 were also able 
to grow at 37 °C at the same rate as wild-type cells (Figure 5.2, Table 5.3). This suggests that 
heterologous expression of both crTms is also able to rescue defective temperature sensitivity 
phenotype displayed by TPM1Δ. It can then be inferred that these ultra-short Tms are able to 
perform similar roles in stabilizing the actin cytoskeleton. 
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The phenotype of temperature sensitivity displayed by NAT3Δ was only partially suppressed by 
the over-expression of NAT3. This can be seen in Figure 5.2, row 6, where the cells were able 
to grow at 37 °C up to only a 10 fold dilution. Although minimal, this rescue was more 
substantial than that observed by the over-expression of both TPM1 and His-NAT3 (Rows 5 
and 7 respectively, Figure 5.2). In both these cases, the defective phenotype of the NAT3Δ 
knockouts remained almost unchanged.  
The fact that the over-expression of TPM1 was able to completely reverse this phenotype in 
TPM1Δ cells, but had almost negligible effects on the NAT3Δ strain, provides additional 
evidence that the phenotypes displayed by NAT3Δ knockouts are caused not only by 
unacetylated Tpm1p, but also additional unacetylated proteins. 
These results were then used to plot histograms that graphically represent the distribution of 
cell size and circularity. Beyond a certain size, the number of cells was observed to be very low. 
The plots therefore concentrate on the regions where the main size distribution was observed. 
Figure 5.3 below shows the analysis of cell size and circularity of wild-type cells, compared to 
NAT3Δ and TPM1Δ knockout cells. 
184 
 
 
Figure 5.3: Analysis of cell size and circularity of WT and knockout strains: (A) Example optical microscope images 
of WT and knockout cells; (B) The relative distribution of S. cerevisiae cell size for wild type (WT-red), ΔNAT3 
(dNAT3-green) and ΔTPM1 (dTPM1-blue) cells; (C) The relative distribution of S. cerevisiae cell circularity for wild 
type (WT-red), ΔNAT3 (dNAT3-green) and ΔTPM1 (dTPM1-blue) cells All strains were analysed when in mid-log 
phase, as determined by OD600 measurements 
 
Figure 5.3-A shows that when compared with the wild-type (WT) strain, NAT3Δ cells exhibited 
severely abnormal morphology. Phenotypes included smaller cell size, multiple budding, 
apparent difficulties in division of cells.  TPM1Δ cells (Figure 5.3-A) also displayed 
morphological abnormalities.  The cells were more spherical in shape and more heterogeneous 
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in cell size than wild-type controls, with many larger but also some smaller cells. The daughter 
cells of this strain were smaller than normal and the mother cells larger when compared to 
wild-type cells. This phenotype has been previously observed (Liu and Bretscher, 1992) and 
attributed to the fact that while in exponentially growing wild-type cells, all the growth is 
directed to the bud and the mother cell maintains a constant size during the cell cycle, TPM1Δ 
cell growth is less directed and both the mother and daughter cells grow.  
The histogram representation of the distribution of cell size in the wild-type, NAT3Δ and 
TPM1Δ strains shows clear differences in distribution (Figure 5.3-B).  There is a distinct 
heterogeneity in the size of TPM1Δ strains. While the average cell size is almost 10% larger 
than wild-type cells, statistical data showed the presence of a large number of cells which are 
significantly smaller than wild type cells. In the case of NAT3Δ, cell size is consistently smaller 
than in the wild-type strain.  
The analysis of wild-type cells in terms of their circularity showed a mildly bimodal distribution; 
with about half the cells being elongated and a third more spherical (Figure 5.3-C, red line). 
This may be because while wild-type mother cells are more likely to be elongated or oval in 
shape, budding daughter cells are spherical. NAT3Δ cells also displayed a bimodal distribution 
with respect to cell circularity, but with a larger proportion of the cells tending to be circular 
(Figure 5.3-C, green line). Most striking was the morphology of TPM1Δ cells, which were 
almost exclusively spherical in shape (Figure 5.3-C, blue line). Since Tpm1p has a major role in 
stabilization of actin cables, which in turn are important in giving the cell its shape, it was 
expected that the TPM1Δ cells differ in shape from the wild-type cells. Once again, the cell size 
and morphology of the two knockout strains are not identical, suggesting that lack of 
acetylation of substrates other than Tpm1p also contribute to the NAT3Δ phenotype. 
Figure 5.2.7 shows the analysis of cell size and circularity of wild-type cells, compared to 
NAT3Δ and NAT3Δ cells over-expressing NAT3, TPM1 and NAT3-W74F. 
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Figure 5.4: Analysis and complementation of cell size and circularity of NAT3Δ strains.  NAT3Δ strains were 
complemented by over-expression of NAT3, TPM1 and NAT3-W74F. (A) Example optical microscope images of 
NAT3Δ cells, and those over-expressing NAT3, TPM1 and NAT3-W74F; (B) The relative distribution of S. cerevisiae 
cell size for wild type (WT-cyan), NAT3Δ (dNAT3-red), over-expressed NAT3 (NAT3-green), over-expressed TPM1 
(TPM1-black) and over-expressed NAT3-W74F (W74F-blue)cells; (C) The relative distribution of S. cerevisiae cell size 
for wild type (WT-black), NAT3Δ (dNAT3-green), over-expressed NAT3 (NAT3-blue), over-expressed TPM1 (TPM1-
red) and over-expressed NAT3-W74F (W74F-cyan)cells . All strains were analysed when in mid-log phase, as 
determined by OD600 measurements. 
Figure 5.4-A shows example images of cells belonging to the NAT3Δ knockout strain, and also 
NAT3Δ over-expressing NAT3, TPM1 and NAT3-W74F. It can clearly be seen that the cells of 
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each strain display distinct cell size and morphology.  The over-expression of NAT3 in the 
NAT3Δ cells appeared to suppress the multiple budding defects, as did the over-expression of 
the NAT3-W74F mutant. Interestingly, over-expression of TPM1 did not appear to negate the 
multiple budding defects seen in the NAT3Δ knockout. NAT3Δ cells were seen to be 
significantly smaller in size that wild-type cells (Figure 5.4-B). The size distribution analysis of 
the cells (Figure 5.4-B) showed that wild-type size distribution was restored in NAT3Δ cells 
over-expressing TPM1 and NAT3-W74F. However, over-expressing NAT3 actually shifted the 
distribution of cells so that the average cell size of the NAT3Δ-NAT3 strain was 14 % larger than 
average wild-type cell size. 
The simplest explanation for over-expression of Nat3p causing additional cell size defects is 
that, as under native conditions there are only 639 molecules of Nat3p per cell in S.cerevisiae, 
the over-expression of this enzyme may result in an abnormally high cellular concentration, 
which has adverse effects on cell size. Interestingly, the over-expression of Nat3p mutant, 
W74F appears to restore wild-type cell-size to NAT3Δ cells. This may be because the 
functionality of this mutant may be diminished by virtue of the point mutation. Since higher 
than normal concentrations of Nat3p appear to cause defects in cell size, the mutant may be 
providing more native-like levels of Nat3p function.   
The quantitative analysis of cell size distribution (Figure 5.4-C) showed that the increased 
tendency for spherical cells observed in the NAT3Δ strain (green line) was only completely 
repressed in the presence of NAT3-W74F over-expression (cyan line). The over-expression of 
NAT3, once again, did not restore wild-type phenotype (blue line). TPM1 over-expression did 
cause a change in the cell circularity defect observed in NAT3Δ cells, but wild-type distribution 
of cell circularity was not completely restored. These data indicate that the over-expression of 
ASTPM1 alone is unable to correct for the defects in circularity observed in NAT3Δ cells.   
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Figure 5.5 shows the analysis of cell size and circularity of wild-type cells, compared to TPM1Δ 
and TPM1Δ cells over-expressing ASTPM1 crTm123 and crTm161. 
 
Figure 5.5: Analysis and complementation of cell size and circularity of TPM1Δ strains. TPM1Δ strains were 
complemented by over-expression of  TPM1 crTm123 and crTm161 (A) Example optical microscope images of 
TPM1Δ cells, and those over-expressing ASTPM1, crTm123 and crTm161; (B) The relative distribution of S. cerevisiae 
cell size for wild type (WT-red), TPM1Δ (dTPM1-blue), over-expressed TPM1 (TPM1-green), over-expressed 
crTm123 (crTm123-black) and over-expressed crTm161 (crTm161- cyan)cells; (C) The relative distribution of S. 
cerevisiae cell circularity for wild type (WT-black), TPM1Δ (dTPM1-red), over-expressed TPM1 (TPM1-blue), over-
expressed crTm123(crTm123-green) and over-expressed crTm161 (crTm161-cyan)cells . All strains were analysed 
when in mid-log phase, as determined by OD600 measurements. 
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Figure 5.5-A shows that the heterogeneity observed in the cell size of the TPM1Δ strain and 
the pronounced circularity of these cells appear to be negated by the over-expression of 
ASTPM1, crTm123 and crTm161. These findings are corroborated in the quantitative analysis 
of cell size and circularity of these strains (Figure 5.5-B and -C respectively). 
 This result is therefore a strong indication that unacetylated Tpm1p with an N-terminal 
dipeptide extension functions like native Tpm1p in vivo in S.cerevisiae. 
In addition, the over-expression of both N.crassa Tms also apparently restores wild-type cell-
size and circularity phenotypes to TPM1Δ cells. These data suggest that both the crTms are 
able to carry out the role of Tpm1p in maintaining the S. cerevisiae actin cytoskeleton to a 
significant degree. This further suggests that unlike the two S. cerevisiae isoforms which are 
thought to perform distinct function (Drees et al., 1995), the N.crassa isoforms may perform 
similar roles. This may be related to the fact that TPM1 and TPM2 are products of separate 
genes, while crTm123 and crTm161 are spliced from a single gene.  However, further knockout 
studies with N.crassa will need to be carried out to provide further information with which the 
roles of the two Tm isoforms can be deciphered. 
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5.2.6 Analysis of the actin cytoskeleton and nuclear material 
In order to visualise actin cables in each strain, the S. cerevisiae cells were stained with 
Rhodamine-labelled phalloidin when in mid-log phase, as detailed in Section 2.7.  The cells 
were subsequently mounted on glass sides using Vectashield®, a mounting medium which 
both preserved fluorescence and counterstained DNA with DAPI (4',6-diamidino-2-
phenylindole). The excitation and emission wavelengths of the two fluorophores are listed in 
Table 5.4.  
Table 5.4: Excitation and emission wavelength for DAPI and Rhodamine-Phalloidin 
Fluorophore Excitation (nm) Emission (nm) 
DAPI 358 473 
Rhodamine-Phalloidin 558 578 
 
Figure 5.6 shows the stained actin and DNA within wild type cells. 
 
Figure 5.6: WT  Yeast cells stained with rhodamine-labelled phalloidin and DAPI. Both images were then merged 
(using Image J) to give a false-colour image incorporating both stains (DAPI in green and rhodamine-labelled 
phalloidin in red). Actin cables, cortical patches and nuclei are labelled. 
Figure 5.6 shows, F-actin cables extending through the cell towards polarized growth. Actin 
cortical patches are clearly visible (when stained with rhodamine-labelled phalloidin) in wild-
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type yeast cells.  Nuclear material dividing between mother and daughter cells (coloured 
green) can also be observed travelling along the actin cables. 
Figure 5.7 illustrates examples of NAT3Δ cells. 
 
Figure 5.7: NAT3Δ cells stained with rhodamine-phalloidin and DAPI. As in Figure 5.6. F-actin is seen to be rather 
diffuse throughout the cell and there is a lack of actin cables. Cells display severely abnormal morphology, multiple 
budding and an apparent inability to dived, as seen by multiple nuclei within single large cells. 
 
In contrast, NAT3Δ strains exhibit very diffuse distribution of actin within the cells. In addition, 
no actin cables are seen. Most striking is the severely defective morphology of the cells. 
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Multiple budding can be seen to occur, as can a lack of polarity and an apparent inability of the 
cells to divide, as evidenced by multiple nuclei within single, enlarged cells.  
 
Figure 5.8 TPM1Δ cells stained with rhodamine-phalloidin and DAPI.  As in Figure 5.6. Actin is seen to be rather 
diffuse throughout the cell and there is a lack of actin cables. Cells appear spherical when compared to WT cells. 
 
TPM1Δ strains (Figure 5.8) also display diffuse actin, and no actin cables. However, no cell 
division defects were observed. Cells appear spherical when compared with wild-type cells 
(Figure 5.6). Based on these images, the differences in phenotypes for the two deletion 
mutants were seen to differ considerably. 
Figure 5.9 shows the actin and nuclei of TPM1Δ cells over-expressing TPM1, crTm123 and 
crTm161; and NAT3Δ cells over-expressing NAT3, TPM1 and NAT3-W74F. 
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Figure 5.9: The actin and DNA within rescued mutant strains. NAT3, TPM1 and NAT3-W74F were over-expressed in 
NAT3Δ cells (right); TPM1, crTm123 and crTm161 were over-expressed in TPM1Δ cells (left) 
 
Figure 5.9 shows that in the case of TPM1Δ, the actin cable defect was corrected on over-
expression of TPM1, crTm123 and crTm161. The cells were also less spherical and more 
comparable in shape to the wild-type strain. This suggests that over-expression of all three 
constructs completely negated TPM1Δ phenotypes. 
In NAT3Δ cells, actin cables are restored when NAT3, NAT3W74F  and TPM1 were over-
expressed. However, over-expression of NAT3 resulted in cells that were considerably larger 
than cells of the wild-type strain (Top right, Figure 5.9). Potential explanations for this are 
considered in the Discussion (Section 5.3). Also, while the over-expression of TPM1 restored 
actin cables to this strain, it did not suppress the cell morphology defect (Figure 5.9).  
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5.3 Discussion 
The disruption of TPM1 caused a number of defective phenotypes in S. cerevisiae cells. These 
included heterogeneity in cell-size distribution and significantly more spherical cells than in the 
wild-type cells, as determined by a quantitative analysis. Additionally, TPM1Δ deletion mutants 
were also temperature sensitive, being unable to grow at 37 °C. The actin cables present in 
wild-type cells were also absent in TPM1Δ. Tpm1p is responsible for stabilising actin filaments. 
As discussed in the introduction, (Section 5.1) the actin cytoskeleton in yeast regulates a 
number of major cellular processes, including vesicular transport, secretion and cell polarity.  
Therefore, the majority, if not all, the observed phenotypes of TPM1Δ cells can be attributed 
to a weak/non-functional actin cytoskeleton.  
In the presence of over-expression of TPM1, all the abnormal phenotypes described above 
were completely repressed, restoring actin cables, as well as wildtype cell size and 
morphology. These data suggest that Tpm1p, with an Ala-Ser N-terminal extension, has native-
Tpm1-like functionality when expressed in vivo. 
Interestingly, both novel N. crassa Tms were also able to repress TPM1Δ defective phenotypes. 
Although the roles of these tropomyosins are yet to be studied, this suggests that both 
crTm161p, and the ultra-short crTm123p are able to stabilise the actin cytoskeleton in in vivo 
in yeast, despite significant differences in size and sequence.  
NAT3Δ deletion mutants also exhibited multiple phenotypic defects including extreme 
temperature sensitivity, multiple-budding, defects in cell size and morphology, lack of actin 
cables and abnormalities in cell and nuclear division. Most of these phenotypes also relate to 
cytoskeletal function, suggesting that the actin cytoskeleton within these cells is severely 
compromised. Although some of these phenotypes are shared with TPM1Δ, there are a 
number that are unique to NAT3Δ and were not negated by the over-expression of TPM1. The 
defects that TPM1 over-expression was not able to suppress included multiple budding and 
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abnormal cell morphology and cytokinesis. Since TPM1 deletion mutants did not display 
abnormalities in cytokinesis, perhaps in the absence of Tpm1p in the cell, Nat3p is able to up-
regulate Tpm2p-actin interactions via Tpm2 acetylation so that the actin-based contractile ring 
required for cell division is able to function. In cells where NAT3 is disrupted, this regulation 
may be lost as a result, leading to defective cytokinesis. The information currently available on 
the effect of TPM2 complementation on the phenotypes of the TPM1Δ deletion strain remains 
unclear (i.e. published data v. personal communication). A more comprehensive analysis of 
cytokinesis in these strains will help improve understanding of the potential roles of Tpm12p 
and Tpm2p in cell division. 
Alternatively, other proteins requiring N-terminal N-acetylation by Nat3p to function may have 
potential roles in cell cycle regulation and DNA processing, or may be involved in a signal 
transduction cascade regulating cytoskeletal dynamics. 
These data do provide strong evidence, however, that the NAT3Δ phenotype is not solely a 
consequence of unacetylated TPM1. 
The multiple-budding phenotype observed in NAT3Δ cells was suppressed by over-expression 
of NAT3.  However, this complementation resulted in an average cell size that was significantly 
larger than that of wild-type cells, as determined by quantitative analysis. A potential 
explanation involves the difference in cellular concentration of Nat3p in wild-type cells, and in 
cells where NAT3 is being over-expressed. The possibility that the N-terminal acetylation of 
Tms by Nat3p is a mechanism by which Tm-actin interactions are regulated was suggested in 
the introduction (Section 5.1). In normal yeast cells, the N-terminal acetylation of Tm by Nat3p 
may be higher where actin stabilisation is required (i.e. in a structural cytoskeletal role), and 
lower where rapid turnover of actin cable is required. If the over-expression of NAT3 results in 
a cellular concentration that is higher than normal, this may result in a larger than normal 
proportion of Tm being N-terminally acetylated within the cell. This may potentially result in a 
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higher than physiological concentration of large Tm-stabilised actin filaments that resist 
depolymerisation by APBs such as ADF (Figure 1.8). The larger stabilised cytoskeleton may 
therefore result in larger than normal cells. Further experiments, such as a more quantitative 
analysis of the distribution of actin cables within cells expressing various amounts of NAT3, 
would be required to assess this possibility. 
Interestingly, the over-expression of the NAT3W74F mutant completely suppressed the 
phenotypic defects seen in NAT3Δ deletion mutants. This may be an indication that disruption 
of the Trp74 residue reduces the functionality of the gene product by some extent. The levels 
of functional protein may thus be closer to physiological levels when NAT3W74F is over-
expressed, resulting in a phenotype that is also closer to the wild type.  
Further genetic investigations can be carried out in future to deduce which residues are 
important for Nat3p catalytic function. There are two Cys residues in positions 97 and 120 of 
the Nat3p sequence. The phenotypic effect of site-directed mutagenesis of these residues 
could potentially shed light on whether Nat3p uses the ping-pong mechanism to acetylate its 
substrates. Similarly, the mutation of residues in the P-loop of Nat3p may give additional 
information about their roles in the catalytic mechanism of this enzyme. 
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6 Summary 
 
Novel isoforms of tropomyosin from the filamentous fungus N. crassa were identified from an 
EST database and found to be products of alternative splicing. The two isoforms were a 123-
residue protein and a 161-residue protein, designated crTm123p and crTm161p respectively.  
crTm123p is the smallest naturally occurring tropomyosin to be identified to date. Both 
isoforms were cloned from N.crassa cDNA, expressed and characterised. Both were 
determined to possess certain properties similar to those of previously characterised fungal 
tropomyosins. These included the requirement of an Ala-Ser dipeptide extension at their N-
terminus in order to bind to actin; similar binding affinities for actin; and almost identical 
secondary structure, as analysed using circular dichroism.  
However, the N. crassa tropomyosins also possess some unique properties. Their innate 
thermostability, particularly that of crTm123p, is significantly higher than that of previously 
characterised tropomyosins. This is an indication that the end-to-end interactions forming the 
tropomyosin polymers are particularly robust. The isoforms appear to compete with each 
other to bind to actin, suggesting that both isoforms are not able to bind to the same actin 
filament simultaneously, and may therefore have independent roles in cytoskeletal regulation.  
Both isoforms also formed crystals that differ significantly in nature from the platelet-like 
crystals normally formed by other tropomyosins. 
The expression of Nat3p from an E. coli expression system resulted in largely insoluble protein. 
Several different approaches were implemented to enhance soluble expression including the 
use of different strains, induction conditions, refolding strategies and the use of additives. 
Soluble expression was enhanced in vivo by the addition of chloramphenicol to the post-
induction culture. The binding of Nat3p to ACoA was investigated using a specially developed 
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fluorescence assay, which was then used to determine a binding affinity of Nat3p for ACoA. 
This was seen to be in the range determined for other GNATs. These data provide evidence 
that Nat3p binds to ACoA in vivo, resulting in a conformational change in the protein. It is 
proposed that this change allows the subsequent binding of Mdm20p, and potentially the 
positioning of the protein substrate for acetylation.The molecular structure of Nat3p was 
predicted based on the core GNAT fold, using a VAST alignment of 25 known GNAT structures. 
Results of this prediction suggest the deletion in Nat3p of a key helix-loop-helix motif that is 
conserved throughout the GNAT family.  It is proposed that this deleted helix-loop-helix is the 
potential docking site for Mdm20p, the auxiliary subunit of the NatB complex. It is also 
proposed that this deletion confers high instability and thus insolubility to Nat3p by leaving 
exposed the core hydrophobic beta-sheet.  
The latter hypothesis was tested by the recombinant expression of Nat5p. This is also a 
member of the GNAT protein family, and a similar alignment showed that the helix-loop-helix 
region of Nat5p was intact. This protein was expressed and was highly soluble, providing 
evidence for the hypothesis that the helix-loop-helix region in the GNAT fold is important for 
the stability and solubility of the protein. SUMO-Nat5p was subsequently purified, 
concentrated and crystallised for further structural analysis. 
Finally, genetic studies involving tropomyosins and Nat3p in S. cerevisiae showed differences 
between phenotypes observed for NAT3Δ and TPM1Δ deletion mutants. This suggests that the 
NAT3Δ phenotype is not caused solely or primarily by the absence of functional Tpm1p. This 
suggestion was corroborated when over-expression of ASTPM1 was not able to correct NAT3Δ 
defects, even though it was able to restore the defective phenotypes of TPM1Δ to wild type. 
These findings are a strong indication that there are substrates other than Tpm1p that 
contribute to the NAT3Δ deletion mutant phenotypes. That the over-expression of ASTPM1 
completely suppressed the defective phenotypes of TPM1Δ deletion mutants in terms of cell 
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size, morphology and actin cable formation suggests that unacetylated Tpm1p is able to 
function like native Tpm1p in vivo when it has an Ala-Ser N-terminal extension. Very 
interestingly, the over-expression of the N. crassa tropomyosin isoforms, both of which are 
shorter than Tpm1p, were also able to fully restore TPM1Δ deletion mutant phenotype to wild-
type phenotype. 
In summary, this thesis has made a contribution to the understanding of the mechanism of 
function of the N-terminal N-acetyltransferase Nat3p and its structure, and shed light on 
potential roles of its substrates other than Tpm1p.  
The discovery and characterisation of the novel N. crassa tropomyosins has identified the first 
instance of alternative splicing in fungal tropomyosins, and also the smallest known isoform of 
tropomyosin- information than may help improve current understanding of tropomyosin 
evolution and function in cytoskeletal regulation. 
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